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ABSTRACT 
 
Abnormal kidney development is a relatively prevalent health issue; however, the 
genetic basis is mostly unknown. The aim of this thesis is to identify genes important in 
kidney development and disease and to study their molecular functions. We hypothesized 
that human diseases associated with kidney anomalies can uncover novel genes important 
in kidney development and disease. The thesis is divided into three independent projects 
that examined three genes (i.e. Zeb2, Ilk, Robo2) at three stages of mouse kidney 
development: nephrogenesis, glomerular podocyte, and early ureteric bud outgrowth. 
In the first project, we identified Zeb2, a gene encoding the zinc finger E-box 
binding homeobox 2 transcription factor that is mutated in the Mowat Wilson syndrome, 
as a novel gene important in nephrogenesis. Zeb2 conditional knockout mice (Zeb2 cKO) 
develop glomerulocystic kidney disease with many atubular glomeruli and decreased 
expression of proximal tubular markers before cyst formation. These data suggest that 
abnormal nephrogenesis leads to the congenital atubular glomeruli and primary 
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glomerular cysts in the Zeb2 cKO mice. This study implies that ZEB2 is a novel candidate 
gene for glomerular cystic disease in patients. Additionally we found that Pkd1, the gene 
mutated in autosomal dominant polycystic kidney disease, is upregulated in non-cystic 
glomeruli and knockout of one copy of the Pkd1 gene exacerbates the cystic phenotype of 
the Zeb2 cKO mice. These findings suggest a genetic interaction between Zeb2 and Pkd1 
and that Zeb2 might be a novel PKD1 modifier.  
In the second project, we studied the roles of integrin-linked kinase (ILK) and 
roundabout 2 (ROBO2) in glomerular podocytes. We found that ILK and ROBO2 form a 
protein complex, and that loss of Robo2 improves survival and alleviates the podocyte 
and basement membrane abnormalities seen in Ilk knockout mice. In the third project, 
using microarray gene expression analysis, we found lower gene expression levels of 
extracellular matrix proteins during early ureteric bud outgrowth in the Robo2 
homozygous knockout embryos as compared to wild type controls. These findings 
suggest that ROBO2 may regulate extracellular matrix components in the kidney. 
In conclusion, we found a new role for Zeb2 in nephrogenesis, and identified a 
novel function of Robo2 in regulating extracellular matrix gene expression in podocytes 
and during early kidney development.  
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CHAPTER ONE: Introduction 
 
Each year about 6% of infants worldwide (~ 8 million children) including 3% of 
all live births in the United States (>120,000 babies) are born with a serious birth defect 
of genetic origin (CDC, 2008; MOD, 2006; Yoon et al., 1997). Kidney and urinary tract 
developmental disorders account for 20-30% of all birth defects identified in the prenatal 
period, with limited diagnostic options (Deshpande and Hennekam, 2008; Pohl et al., 
2002; Woolf, 2000). Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) 
(Sargent, 2000; Williams et al., 2008a) are a group of renal tract birth defects that 
includes congenital kidney anomalies such as duplex multicystic dysplastic kidneys, renal 
cystic diseases, and congenital podocytopathies, and ureteric defects such as obstructive 
uropathy and vesicoureteral reflux (VUR) (Toka et al., 2010). The overall incidence of 
CAKUT in children is estimated over 1% and they are among the most common 
problems encountered by pediatric nephrologists and urologists (Peters et al., 2010; 
Sargent, 2000; Williams et al., 2008a). CAKUT is also the leading cause of chronic 
kidney disease and renal failure in children (Neild, 2010; Sanna-Cherchi et al., 2009; 
Toka et al., 2010).  
During pregnancy, routine prenatal ultrasound examination enables early 
detection of many urinary tract anomalies in fetuses (Nguyen et al., 2010). Although 
some CAKUT phenotypes will resolve spontaneously in many babies after birth, the 
prenatal diagnosis of CAKUT during pregnancy brings a heavy psychological burden on 
the parents. When an anomaly is detected during obstetric ultrasound scan, the decision 
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regarding the pregnancy is strongly influenced by the definitive diagnosis and prognosis 
of the condition (Deshpande and Hennekam, 2008). Since a long list of genetic 
syndromes and chromosomal abnormalities is associated with CAKUT, the decision 
regarding diagnosis and intervention can be difficult. The decision becomes all the more 
difficult as only few causative genes have been identified so far in patients with isolated 
or non-syndromic CAKUT. Therefore, it is important to discover novel causative genes 
for CAKUT. A better understanding of kidney development is also necessary to the 
elucidation of the genetic basis of these disorders, which can also lead to new treatments, 
as exemplified by the use of CoQ10 to treat congenital podocytopathy in patients with 
mutations in the ADCK4 gene (Ashraf et al., 2013).  
In this thesis, I performed three research projects using mouse genetic approaches 
to better understand the molecular functions of three genes (i.e. Zeb2, Ilk, Robo2) that 
play important roles at three different stages of kidney development and their associated 
kidney diseases. The first project focused on the identification of Zeb2 as a novel gene 
important in nephrogenesis and glomerulocystic kidney disease. The second project 
studied the genetic interaction between integrin linked kinase (Ilk) and roundabout 2 
(Robo2) in kidney podocyte development and congenital podocytopathy. The third 
project explored the molecular abnormalities that lead to abnormal ureteric bud 
outgrowth, the formation of multiple ureteric buds and the associated CAKUT phenotype 
in Robo2 and Slit guidance ligand 2 (Slit2) knockout mice. 
To better understand these three projects, I will first summarize here some 
background information regarding kidney development and disease, as well as the human 
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genetics and mouse genetics tools available today to explore the pathogenesis of 
CAKUT. More detailed background information will be provided in each project 
separately. 
 
1.1 Kidney and urinary tract development and function 
1.1.1 Kidney and urinary tract anatomy 
 
The urinary system is a multi-component organ system, whose primary function is 
to produce, transport, store, and eliminate urine in order to maintain body homoeostasis 
by controlling the water and ionic balance of the blood (Rasouly and Lu, 2013). The 
kidney eliminates nitrogenous waste, maintains the volume, composition, and pressure of 
the blood, and the density of the bones (Bover and Cozzolino, 2011). Anatomically, the 
urinary system can be subdivided into an upper unit, the kidney, which filters and 
modifies the blood to produce urine, and a lower unit consisting of the ureter, the bladder, 
and the urethra, which transports, stores and eliminates the urine from the body (Rasouly 
and Lu, 2013). The nephron is the major component of the kidney, which filters the blood 
and maintains body homeostasis. A human kidney contains average 1 million nephrons 
(ranging between 200,000 and 1.8 million), which comprise intricately patterned and 
functionally compartmentalized epithelial structures (Hughson et al., 2003). The nephron 
can be further divided into the glomerulus, the proximal tubule, the loop of Henle, and 
the distal tubule. 
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1.1.2 Kidney and urinary tract development.  
 
The kidney and ureter originate from the intermediate mesoderm in early embryos 
when an epithelial outpouching called the ureteric bud (UB) sprouts from the caudal 
region of the Wolffian duct (also called the nephric duct) and invades adjacent 
metanephric mesenchyme (MM) (Illustration 1.1A) (Davidson, 2008). After the UB 
invasion into the MM, a reciprocal induction between the tip of the UB and the MM 
results in multiple rounds of UB branching morphogenesis to form the collecting system 
(the collecting duct), while mesenchymal-to-epithelial transition (MET) of the MM leads 
to the formation of the nephron (Saxen, 1987). These developmental processes ultimately 
give rise to a functional kidney that starts to produce urine at ~10 weeks of gestation in 
human and ~E16.5 in mice. At the same time, the trunk of the UB (i.e. the UB portion 
remaining outside of the MM) elongates without branching to form the ureter, a muscular 
tube structure transporting urine from the kidney to the bladder (Illustration 1.1C) (Airik 
and Kispert, 2007). Together with the differential growth in the caudal part of the body 
during fetal development, the elongation of the ureter leads to the ascent of the kidney to 
its final position in the retroperitoneal space behind the abdominal cavity.  
At each round of ureteric branching, the MM becomes compacted and forms 
aggregates that undergo mesenchymal-to-epithelial transition. The aggregates of MM 
first form spheres of polarized epithelia with de novo generation of a central lumen, 
called renal vesicles. Each sphere then elongates to form the comma-shaped body (C-
shaped body), and then the S-shaped body during nephrogenesis. The proximal end of the 
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S-shaped body forms the glomerulus, which connects to the proximal tubule that is 
derived from the mid-region of the S-shaped body, and the distal tubule that is derived 
from the distal-region of the S-shaped body. The distal tubule ultimately fuses with the 
tip of the adjacent ureteric bud to complete the connection of developing nephron to the 
collecting duct. 
 
 
 
 
 
 
 
 
 
 
 
 
Illustration 1.1: Urinary tract development and Structure  
(A) Early development of the urinary tract (4th week of gestation in human and E10.5 in 
mice). An epithelial diverticulum called ureteric bud (UB) emanates from the Wolffian 
duct and grows into an adjacent group of mesenchymal cells (metanephric mesenchyme). 
(B) Elongation of the ureter and formation of the kidney (metanephros) during 
development. The common nephric ducts shorten, expand and integrate into the 
urogenital sinus (the future bladder) close to the region where the future bladder neck is 
located. (C) Structure of mature urinary tract in human and mice. Urine flows from the 
renal pelvis in the kidney through the ureter to the bladder for storage and eliminates to 
the outside through the urethra. The ureter is connected to the kidney at the ureteropelvic 
junction (UPJ) and connected to the bladder at the ureterovesical junction (UVJ). Inside 
the bladder, two ureteric orifices and the internal urethral orifice form the trigone. The 
urethral sphincter complex includes the lissosphincter which is a continuation of the 
bladder smooth muscle and the rhabdosphincter which consists of striated muscles. (D) 
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Transverse section of the mature ureter depicts four layers of cells: urothelium, stromal 
cells, smooth muscle cells and adventitial fibroblasts (Rasouly and Lu, 2013). 
  
  
7 
1.1.3 The renal corpuscle structure  
 
The glomerular filtration barrier is the major structure that filters the blood to 
produce the primary urine. The glomerulus receives the blood from an afferent arteriole 
and drains into an efferent arteriole. The high pressure in the glomerulus capillaries 
enables blood filtration. The interior surface of the capillaries comprises the fenestrated 
endothelial cells. Numerous endothelial cell fenestrae of 60-80nm diameter enable the 
first filtration of plasma solutes and small molecular weight proteins. The endothelial 
cells sit on a thick (250-350nm) glomerular basement membrane (GBM) that also filters 
the blood. The podocytes line the other side of the GBM. The podocytes extend their cell 
bodies to form long filopodia structures called foot processes that interdigitate and wrap 
around the capillaries. The foot processes of neighboring podocytes are separated by 
filtration slits that are bridged by a cell adhesion structure called the slit diaphragm 
through which the blood is filtered to form the primary urine in the Bowman’s space. The 
Bowman’s space is enclosed by the Bowman’s capsule that is lined by parietal epithelial 
cells. The capsule has two poles: the vascular pole, where the afferent and the efferent 
arterioles enter into and exist from the sphere, and the urinary pole which is connected to 
the proximal tubule and enable the drainage of the urine. The glomerular filtrate (i.e. 
primary urine) then passes through the renal tubules where it is modified and partially 
reabsorbed into the blood stream and ultimately enters into the collecting ducts to form 
the final concentrated urine.  
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1.2 Human Genetics of CAKUT 
 
CAKUT is a genetically heterogeneous developmental disorder with a variable 
phenotype that can be caused by mutations in one single gene that controls early kidney 
and urinary tract development (Lu et al., 2007b; Sanyanusin et al., 1995; Ulinski et al., 
2006).  
Linkage analysis has been used to uncover monogenic disease causal genes in 
CAKUT. For example, SIX1 (SIX homeobox 1) mutations were identified by linkage 
analysis in a large family with branchiootorenal (BOR) syndrome (Ruf et al., 2003). 
Another type of linkage analysis that requires less family members is homozygosity 
mapping, which relies on the assumption that the disorder is recessive and the patients 
inherited the same mutation linked to the same haplotype from both parents. 
Homozygosity mapping tools combined with next-generation sequencing tools has led to 
the discovery of TRAP1 (TNF receptor-associated protein 1 ) mutations in individuals 
with CAKUT and VACTERL association (vertebral defects, anal atresia, cardiac defects, 
tracheo-esophageal fistula, renal anomalies, and limb abnormalities) (Saisawat et al., 
2014) and SDCCAG8 (serologically defined colon cancer antigen 8) mutations as the 
cause of a retinal-renal ciliopathy (Otto et al., 2010). However, when large families are 
not available, a combination of several smaller pedigrees with similar phenotypes needs 
to be used to perform linkage analysis. 
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1.2.1 Genetic heterogeneity of CAKUT impedes linkage and association studies in 
CAKUT families 
 
Several genome-wide linkage and association studies in CAKUT families did not 
find evidence of linkage nor detect any association with functional candidate genes 
(Cordell et al., 2010; van Eerde et al., 2007). Since many studies support a genetic basis 
for these developmental disorders (as opposed to environmental and non genetic causes) 
(Connolly et al., 1997; Feather et al., 2000; Kaefer et al., 2000; Noe, 1992; Noe et al., 
1992; Peeden and Noe, 1992; Scott et al., 1997; Van den Abbeele et al., 1987), the 
genetic heterogeneity is probably one of the explanations for such negative results. When 
families with a similar phenotype but different genetic etiologies are combined, the 
linkage analysis cannot identify the different loci. Another potential challenge for these 
studies is the variability of the manifestations and high rates of spontaneous resolution of 
the CAKUT phenotype (e.g. VUR and hydronephrosis) during the life of an individual. In 
addition, the penetrance of the mutations may be incomplete. Therefore, disease-free 
individuals cannot necessarily be classified in the linkage or association studies as 
unaffected (Eccles et al., 1996). Finally, mutations in the same gene can cause both 
syndromic and non-syndromic forms of CAKUT, which further complicates the research 
approach in combining families with variable CAKUT phenotypes. However, sequencing 
candidate genes that cause syndromic forms of CAKUT (e.g. FRAS1, FREM2, GRIP1, 
FREM1, ITGA8, and GREM1), has recently led to the identification of mutations in 
familial cases of isolated CAKUT (Kohl et al., 2014).  
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1.2.2 Genomic imbalances and chromosomal rearrangements as a tool to uncover genes 
associated with CAKUT. 
 
Another approach to identify new CAKUT genes is to look for genes disrupted by 
genomic imbalances in patients with a CAKUT phenotype. Translocations can disrupt 
genes that are important in kidney development and enable the discovery of those genes 
(Higgins et al., 2008). The hypothesis in this case is that these genes might be mutated in 
other patients with CAKUT without genomic imbalances. For example, mutant EYA1 
was discovered as the cause of the BOR syndrome thanks to a translocation disrupting it 
in one patient (Kalatzis et al., 1996). Similarly, the associations between ROBO2 and 
NFIA with CAKUT were originally identified in patients with chromosomal 
translocations (Lu et al., 2007a; Lu et al., 2007b). 
Other types of genomic imbalances are microdeletions and microduplications. 
According to the literature, 10-17% of CAKUT patients carry microdeletions 
(Bachmann-Gagescu et al., 2010; Sampson et al., 2010; Weber et al., 2011) and several 
microdeletion syndromes were reported with an increased risk for CAKUT. The analysis 
of these genomic imbalances is however more challenging since the microdeletions and 
microduplications usually encompass multiple genes. 
 
 
  
11 
1.3 Mouse models as a tool to study birth defects of the kidney  
 
1.3.1 Mouse models for urinary tract development  
 
Mice genetics provide excellent tools to study genes and signaling pathways 
important for the urinary tract development (Mendelsohn, 2009). The mouse is the model 
of preference for CAKUT research because the developmental structures of the urinary 
tract in lower model organisms (e.g. zebrafish) are too different from the human's. The 
high similarity between human and mouse genomes and the advanced genetic 
engineering technologies plus large accessible mutant mouse resources, provide excellent 
research tools to characterize the effects of human mutations in mouse models in vivo 
(Blake et al., 2011; Diez-Roux et al., 2011; Finger et al., 2011; McMahon et al., 2008).  
However, several cases have been reported in which the knockout mice reproduce 
only some of the human disease phenotype, or exhibit a more severe phenotype, or no 
phenotype at all (Elsea and Lucas, 2002; Routtenberg, 1995). Therefore, the extrapolation 
from mice models to patients needs to be done with caution. 
 
1.3.2 Genetic tools in mouse genetics 
 
Spatially and temporally controlled gene deletions and gene expressions in mice 
can be done using the Cre-lox system (Sauer, 1998). Cell-specific deletions of genes of 
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interest in the mouse urinary tract enable studying the function of genes that cause early 
embryonic lethal phenotype in germline knockout mice before kidney initiation. The Cre 
recombinase recognizes specific DNA sequences named loxP sites and can excise the 
DNA between these loxP sites. The activity of the Cre-recombinase is regulated by the 
promoter of the targeted genes. Since the excision is at the DNA level, it introduces 
genomic changes that will be retained in all the descendants of the cells expressing the 
Cre (Illustration 1.2). For example, the Pax2-Cre transgene enables to specifically delete 
genes in the entire urinary tract (MM and the UB tissue lineages) (Ohyama and Groves, 
2004). Additional kidney and urinary tract specific Cre lines include the Six2-Cre in the 
MM nephron lineage (Kobayashi et al., 2008), the Nphs2-Cre in the podocytes (Moeller 
et al., 2003), the Hoxb7-Cre in the Wolffian duct and UB (Yu et al., 2002), and the 
Tbx18-Cre in the ureteral mesenchymal cells (Wang et al., 2009). The research presented 
in this thesis used three different Cre recombinases (Pax2-cre, Six2-cre and Nphs2-cre). 
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Illustration 1.2: Scheme of the Cre-lox system. 
The Cre recombinase (red) recognizes specific DNA sequences named loxP sites. The 
Cre recombinase excises the DNA between two loxP sites. 
 
1.3.3 Genetic interaction analysis 
 
In genetic interaction, or epistasis, the phenotypic effects of one gene are 
modified by one or several other genes. Genetic interaction is defined as a deviation from 
the expected additive effect of the combination of two mutations. Genetic interaction can 
reveal the relationship between genes and pathways. Genetic interactions can be 
alleviating or aggravating. They can reflect different molecular mechanisms such as 
physical complex formation between the proteins encoded by different genes, redundancy 
in the function of those proteins, linear and non-linear regulatory relationships, or activity 
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in the same pathway (Lehner, 2011). Experiments using mutations in genes of interest 
have identified numerous examples of epistasis such as genetic interaction among Hnf1b, 
the Wilms’ tumor suppressor-1 (WT1) transcription factor and the canonical Notch 
signaling during the formation of podocytes (Naylor et al., 2013). Genetic interaction 
analysis also revealed that Frem1, which encodes an extracellular protein, genetically 
interacts with Slit3 in the development of renal agenesis phenotype (Beck et al., 2013). 
 
1.4 Genes and pathways associated with kidney development and disease 
 
The combined analysis of patients with CAKUT and animal models has led to the 
discovery of many genes and pathways important in kidney development and disease. 
Many common molecular signaling pathways important in other organ system 
development have also been shown to play significant roles in the development of the 
kidney and urinary tract. These include the receptor tyrosine kinase (RTK) signaling 
pathway (e.g. Gdnf, Ret) (Costantini, 2010), the Wnt signaling pathway (e.g. Ctnnb1, 
Wnt7b, Wnt9b, Fzd1) (Trowe et al., 2012), the Hedgehog signaling pathway (e.g. Shh. 
Gli3, Smo, Tshz3) (Cain et al., 2011; Caubit et al., 2008; Yu et al., 2002), the TGF-β 
signaling pathway (e.g. Bmp4, Smad4) (Brenner-Anantharam et al., 2007; Miyazaki et al., 
2000; Tripathi et al., 2012), the retinoic acid mediated nuclear receptor signaling pathway 
(e.g. Rara, Rarb) (Batourina et al., 2005; Kam et al., 2012; Mendelsohn, 2009), and the 
renin-angiotensin system (e.g. Agt, Ren, Agtr1, Agtr2) (Gribouval et al., 2005; Nishimura 
et al., 1999; Oliverio et al., 1998; Tsuchida et al., 1998). The thesis research presented 
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here discusses the roles of several CAKUT genes in pathways such as the TGF-β 
signaling pathway, the receptor tyrosine kinase (RTK) signaling pathway, the integrin 
and extracellular matrix pathway, and the Wnt signaling pathway, in pathogenesis of the 
CAKUT phenotypes observed. 
 
1.5 Examples of birth defects of the kidney 
 
In this thesis, several types of birth defects of the kidneys are discussed, including 
renal cystic disease, congenital podocytopathies, and glomerular basement membrane 
diseases. I will give here a short overview of these groups of disorders and detailed 
information is provided in the introduction of each specific project in relevant chapters. 
 
1.5.1 Renal cystic diseases 
 
Renal cystic disease is a relatively frequent disorder and its prevalence increases 
with age (Eknoyan, 2009). However, the etiology and significance of different renal 
cystic diseases is highly variable. Renal cystic diseases can be classified based on the 
timing of cyst appearance, the location that forms the cyst in the kidney (e.g. collecting 
ducts, tubules, glomeruli), and whether they are inherited or acquired.  
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1.5.2 Congenital Podocytopathies 
 
Podocytopathies are the diseases attributed to damage or dysfunction of the 
podocytes. They are characterized by the presence of a large amount of protein in the 
urine (proteinuria) (Singh et al., 2015). The functional or structural alteration in the 
podocytes can be caused by inherited or acquired disorders.  
 
1.5.3 Glomerular basement membrane diseases 
 
Since the components of the glomerular basement membrane are produced both 
by the podocytes and the endothelial cells, some of the GBM diseases may also be 
classified as podocytopathies. Diseases of the GBM can be inherited or secondary to 
other diseases which include the nail patella syndrome, Alport syndrome, thin GBM 
disease, membranous nephropathy, Goodpasture’s disease, fibrillary glomerulonephritis, 
and diabetic nephropathy. 
 
1.6 Human syndromes associated with an increased risk for CAKUT 
 
CAKUT phenotype has been reported in many syndromes. To understand the 
scope of the problem in a systematic way for syndromes associated with an increased risk 
for CAKUT, I searched the Online Mendelian Inheritance in Man (OMIM) and compiled 
a list of CAKUT associated syndromes (syndromes with an increased risk for CAKUT 
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compared to the general population, but in which the renal anomalies are not the major 
symptom) (Table 1.1). Many of the syndromes are caused by mutations in genes known 
to play a role in kidney development (marked in yellow in Table 1.1). Other syndromes 
are caused by mutations in genes encoding proteins playing roles in the cilia, which role  
has been extensively studied in normal kidney development (Arts and Knoers, 2013) 
(marked in blue in Table 1.1). These known genes were good positive controls supporting 
our hypothesis that syndromes associated with CAKUT can be caused by genes important 
in kidney development. 
 
Some other CAKUT associated syndromes are caused by microdeletion/ 
microduplication encompassing a large number of genes. The microdeletion/ 
microduplication syndromes are more challenging to study because the CAKUT 
phenotype might be caused by a combined effect of loss of several genes. We have 
performed some preliminary analysis on the genes deleted in patients with CAKUT 
phenotype such as the 1q21.1 microdeletion-microduplication syndrome. After a review 
of the genes in the minimal critical region deleted in this syndrome, we studied the Bcl9 
gene and its closest family member Bcl9-2. This research is still in progress and not 
presented here. 
 
Finally, some syndromes with an increased risk for CAKUT are caused by 
mutations in a single gene and its functions in kidney development are often unknown. 
For example, Mowat Wilson syndrome is a CAKUT associated syndrome caused by 
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mutations in ZEB2. Although the function of ZEB2 has been relatively well 
characterized, little is known in terms of its function in kidney development. This also led 
us to hypothesize that ZEB2 plays a role in kidney development and that loss of ZEB2 
results in congenital renal anomalies. The detailed analysis of Zeb2 conditional knockout 
mice will be presented in the project one of my thesis research and is described in the 
Chapter two below.   
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Table 1.1: Syndromes Associated with increased risk for CAKUT 
Gene  Chr Human disease OMIM Ref 
MBTPS2 Xp22.12-
p22.11  
BRESEK/BRESHECK syndrome  308205 (Naiki et al., 2012) 
OFD1 Xp22.2 Orofaciodigital syndrome I 311200 (Feather et al., 1997) 
ATRX Xq21.1 Alpha-thalassemia/mental retardation 
syndrome 
301040 (Cole et al., 1991) 
AGTR2 Xq22-q23 X-linked mental retardation-88  300852 (Nishimura et al., 1999) 
 Xq27-q28 Microphthalmia, syndromic 1 309800 (Forrester et al., 2001) 
NOTCH2 1p12-p11 Hajdu-Cheney syndrome 102500  
NFIA 1p31.3-
p31.2 
Deletion syndrome 613735 (Lu et al., 2007a) 
 1p32-p31  Microdeletion syndrome  613735 (Lu et al., 2007a) 
 1q21.1 Microdeletion syndrome  612474  
 1q21.1 Microduplication syndrome 612475 (Brunetti-Pierri et al., 
2008; Mefford et al., 2008; 
Rosenfeld et al., 2012) 
TMCO1 1q24.1 Craniofacial dysmorphism, skeletal 
anomalies, and mental retardation 
syndrome 
213980 (Xin et al., 2010) 
IFT172 2p23.3 Short-rib thoracic dysplasia 10 with or 
without polydactyly 
615630 (Halbritter et al., 2013) 
ZEB2 2q22.3 Mowat Wilson syndrome 235730 (Garavelli and Mainardi, 
2007) 
 3pter-p25 3p- syndrome 613792 (Mowrey et al., 1993) 
IFT122 3q21.3-
q22.1 
Cranioectodermal dysplasia 1 218330 (Eke et al., 1996) 
WDR19 4p14 Short-rib thoracic dysplasia 5 with or 
without polydactyly 
614376 (Huber and Cormier-Daire, 
2012) 
WFS1 4p16.1 Wolfram syndrome  222300 (Salih and Tuvemo, 1991) 
NIPBL 5p13.2 Cornelia de Lange syndrome 1 122470 (Selicorni et al., 2005) 
OCLN 5q13.2 Band-like calcification with simplified 
gyration and polymicrogyria 
251290 (LeBlanc et al., 2013) 
TFAP2A 6p24.3 Branchio-oculo-facial syndrome 113620 (Lin et al., 2000) 
FOXC1 6p25 Axenfeld-Rieger syndrome type 3 602482 (Kume et al., 2000; 
Weisschuh et al., 2008) 
RMND1 6q25.1 Combined oxidative phosphorylation 
deficiency 11 
614922 (Taylor et al., 2014) 
BMPER 7q14.3 Diaphanospondylodysostosis 608022 (Funari et al., 2010) 
GLI3 7p13 Pallister-Hall syndrome 146510 (Cain et al., 2011; Narumi 
et al., 2010) 
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 7q11.23 Williams syndrome  194050 (Schulman et al., 1996) 
 7q11.2-
q21.3 
EEC1 syndrome 129900 (Tucker and Lipson, 1990) 
 8p11.23-
p11.22 
Kallmann syndrome 2  147950 (Levy and Knudtzon, 
1993) 
GLIS3 9p24.2 Diabetes mellitus, neonatal, with 
congenital hypothyroidism 
610199 (Kang et al., 2009; Senee et 
al., 2006) 
LMX1B 9q33.3 Nail-patella syndrome 161200 (Dreyer et al., 1998) 
 10q24 Split-hand/foot malformation 3, 
duplication syndrome 
246560 (Keymolen et al., 2000) 
 11p15-
p14 
Microdeletion syndrome 606528 (Bitner-Glindzicz et al., 
2000) 
LRP4 11p11.2 Cenani-Lenz syndactyly syndrome 212780 (Li et al., 2010) 
DHCR7 11q13.4 Smith-Lemli-Opitz syndrome 270400 (Goldenberg et al., 2004) 
KMT2D 12q13.12 Kabuki syndrome 1 147920 (Hannibal et al., 2011) 
PTPN11 12q24.13 LEOPARD syndrome 1 151100 (Swanson et al., 1971) 
 14q32 Hemifacial microsomia 164210 (Castori et al., 2006) 
INF2 14q32.33 Charcot-Marie-Tooth disease, 
dominant intermediate E 
614455 (Boyer et al., 2011) 
IFT43 14q24.3 Cranioectodermal dysplasia 3 614099 (Arts et al., 2011) 
STRA6 15q24.1 Microphthalmia 601186 (Pasutto et al., 2007) 
WDR73 15q25.2 Galloway-Mowat syndrome 251300 (Colin et al., 2014) 
TBC1D2
4 
16p13.3 DOOR syndrome 220500 (Le Merrer et al., 1992) 
THOC6 16p13.3 Microcephaly, mental retardation, and 
distinctive facies, with cardiac and 
genitourinary malformations 
613680 (Beaulieu et al., 2013) 
PMM2 16p13.2 Congenital disorder of glycosylation, 
type Ia 
212065 (Chang et al., 1993) 
SALL1 16q12.1 Townes-Brocks syndrome 107480 (Albrecht et al., 2004) 
 16p11.2 Microdeletion syndrome 613444 (Bachmann-Gagescu et al., 
2010) 
KANSL1 17q21.31 Microdeletion syndrome 610443 (Tan et al., 2009) 
RAI1 17p11.2 Smith-Magenis syndrome 182290 (Greenberg et al., 1996) 
WNT3 17q21.31 Tetra-amelia syndrome 273395 (Bermejo-Sanchez et al., 
2011) 
KCTD1 18q11.2 Scalp-ear-nipple syndrome 181270 (Plessis et al., 1997) 
ATP5A1 18q21.1 Mitochondrial complex (ATP 
synthase) deficiency, nuclear type 4 
615228 (Jonckheere et al., 2013) 
CCBE1 18q21.32 Hennekam lymphangiectasia- 235510 (Cormier-Daire et al., 
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lymphedema syndrome 1  1995) 
RLP11 19q13.2 Diamond-Blackfan anemia 1  105650 (Willig et al., 1999) 
SALL4 20q13.2 Duane-radial ray syndrome 607323 (Sakaki-Yumoto et al., 
2006) 
PIGT 20q13.32 Multiple congenital anomalies-
hypotonia-seizures syndrome 3 
615398 (Kvarnung et al., 2013) 
TBX1 22q11.21 Velocardiofacial syndrome 192430 (Ryan et al., 1997) 
 22q11.2 Opitz GBBB syndrome  145410 (Wilson and Oliver, 1988) 
 22q11 Cat eye syndrome 115470  
  Hardikar syndrome  612726 (Poley and Proud, 2008) 
  Fryns syndrome 229850 (Slavotinek, 2004) 
 
Abbreviation: Chr: chromosomal location. Yellow: genes known to play a role in 
kidney development, Blue: genes encoding ciliary proteins 
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1.7 General Hypothesis and Specific Aims 
 
1.7.1 General Hypothesis 
 
The general hypothesis of this thesis is that human syndromes associated with an 
increased risk for CAKUT are caused by mutations of genes important in kidney 
development and disease.  
The specific hypotheses for each of the projects presented in this thesis are 
described in each relevant chapter. 
 
1.7.2 Specific Aims 
 
Aim 1: To determine whether the Zeb2 gene plays a role in kidney development and 
whether loss of Zeb2 in mice causes congenital renal disease. 
 
Aim 2: To explore the potential genetic interaction between Ilk and Robo2 in glomerular 
podocytes. 
 
Aim 3: To explore the molecular defects during early ureteric bud outgrowth in Slit2 and 
Robo2 knockout mice. 
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CHAPTER TWO: Loss of Zeb2 causes glomerulocystic kidney disease in mice 
 
2.1 Summary 
 
ZEB2 is a zinc finger E-box binding homeobox transcription factor. Mutations in 
ZEB2 cause Mowat-Wilson syndrome, an autosomal dominant disorder associated with 
kidney disease. Here we show that Zeb2 conditional knockout mice with either Pax2-cre 
or Six2-cre developed primary glomerulocystic kidney disease starting at embryonic day 
E16.5. Zeb2
flox/flox
;Pax2-cre
+
 mice died at birth and Zeb2
flox/flox
;Six2-cre
+
 mice developed 
renal failure by 8 weeks of age. Atubular glomeruli were observed in Zeb2 knockout 
mice, explaining the presence of glomerular cysts in the absence of tubular dilatation. 
Decreased expression of early renal proximal tubular markers was detected in Zeb2 
knockout embryonic kidneys at E14.5 preceding glomerular cyst formation, suggesting 
that primary renal tubule defects in early nephrogenesis contribute to the formation of 
congenital atubular glomeruli. Furthermore, gene expression analysis revealed an 
upregulation of PKD1 expression in the glomeruli of Zeb2 knockout mice. Together, our 
results suggest that Zeb2 plays an important role in normal nephron development and loss 
of Zeb2 leads to primary glomerulocystic kidney disease in mice. Our findings may be 
added to the ill-described kidney phenotype in Mowat-Wilson syndrome, and suggest that 
ZEB2 might be a novel candidate gene in patients with glomerular cystic disease.   
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2.2 Background and Introduction  
 
In order to identify a novel gene associated with abnormal kidney development in 
human patients, we first reviewed the syndromes that include CAKUT as part of their 
clinical presentation (OMIM clinical synopsis), which have been described in the 
introduction chapter (Table 1.1). In this project, we focused on the ZEB2 gene that causes 
the Mowat Wilson syndrome (MWS), a human syndrome associated with ill-defined 
kidney birth defects. 
 
2.2.1 Mowat Wilson syndrome. 
 
MWS is a rare syndrome characterized by distinctive facial features, moderate to 
severe intellectual disability, large intestine blockage (Hirschsprung disease), congenital 
heart defects, and renal anomalies (OMIM 235730) (Garavelli and Mainardi, 2007). At 
least 13% of the MWS patients were found to have renal anomalies including 
hydronephrosis and vesicoureteral reflux (Garavelli and Mainardi, 2007), however, the 
specific kidney phenotype is not well described. The prevalence of MWS is estimated to 
be 1:50,000-1:70,000 live births although it may be under-diagnosed (Engenheiro et al., 
2008; Ghoumid et al., 2013; Wenger et al., 2014). The MWS is a dominant disorder 
caused by heterozygous loss-of-function mutations (e.g. non-sense, frameshift or 
deletion) in the ZEB2 gene (Garavelli and Mainardi, 2007). Atypical presentations of 
MWS were also reported in patients with ZEB2 heterozygous missense mutations 
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(Heinritz et al., 2006). In sum, MWS is due to reduced levels of the ZEB2 protein, 
suggesting that the level of ZEB2 is important for normal development.   
 
2.2.2 ZEB2 protein 
 
ZEB2, also called Smad Interacting Protein 1 (SIP1), is a member of the ZEB 
family of two-handed zinc finger/homeodomain transcription factors. ZEB2 is a 1214-
amino acid protein and is highly conserved in vertebrates with 92% identity between 
humans and Xenopus. It also shares 69% similarity to its closest family member, ZEB1 
(Grabitz and Duncan, 2012). 
ZEB transcription factors have two separate clusters of zinc fingers at the N-
terminus and at the C-terminus (Illustration 2.1), which bind the DNA for transcriptional 
regulation. Both ZEB2 and ZEB1 bind a 5’-CACCT sequence (Verschueren et al., 1999). 
As its name suggests, ZEB2/SIP1 can bind activated R-SMADs. Specifically, SMAD1, 
SMAD2 and SMAD3 have been experimentally shown to bind ZEB2 after TGF-β 
activation (Verschueren et al., 1999). ZEB2 also has a CID repressor domain that 
interacts with CtBP (Postigo and Dean, 1999). Post-transcriptional modification of ZEB2 
by sumoylation at Lys-391 and Lys-866 can reduce its transcriptional activity (Long et 
al., 2005). 
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Illustration 2.1: The ZEB2 protein structure 
The ZEB2 transcription factor has two zinc finger domains on the N and the C ends of 
the protein enabling its biding to the DNA. ZEB2 has a SMAD Binding domain (SBD), a 
CtBP interacting domain (CID), a homeobox domain (HD and 2 sumoylation sites (K391 
and K866). 
 
 
2.2.3 Role of ZEB2 in development and cancer. 
 
ZEB2 plays a role in ocular lens development, brain development and neural crest 
migration, as well as in cancer progression (Comijn et al., 2001; Miquelajauregui et al., 
2007; Seuntjens et al., 2009; Van de Putte et al., 2003b; Yoshimoto et al., 2005).  
At embryonic day E8.5, two cell populations express Zeb2 mRNA, the 
neuroepithelium and the neural crests (Van de Putte et al., 2003a). Zeb2 homozygous null 
mouse embryos exhibit severe defects at E8.5 and die at E9.5 before organogenesis, 
impeding research on the role of Zeb2 in the development of most organs (Van de Putte 
et al., 2003a). Therefore, a conditional Zeb2 allele was generated to investigate the role of 
Zeb2 during organogenesis (Higashi et al., 2002). 
 
As opposed to the activating function of Zeb2 on Foxe3 during lens development 
(Yoshimoto et al., 2005), ZEB2 represses the expression of Sfrp1 (an extracellular 
inhibitor of Wnt signaling) during hippocampal development (Miquelajauregui et al., 
  
27 
2007). ZEB2 also modulates CNS myelination, where it activates Smad7 expression 
(Weng et al., 2012). Interestingly, SMAD7 represses the Wnt signaling pathway, 
suggesting an opposite effect of ZEB2 activity on the Wnt pathway during myelination 
and hippocampus development.  
In post-mitotic neurons of the embryonic neocortex, ZEB2 regulates neuron 
progenitors non-cell autonomously via direct repression of neurotrophin-3 (Ntf3) in the 
post-mitotic neurons (Seuntjens et al., 2009). 
 
In the cancer field, ZEB2 is a mesenchymal marker and is associated with 
epithelial to mesenchymal transition (EMT) (Comijn et al., 2001; Vandewalle et al., 
2005). ZEB2 regulates and is regulated by the miR-200 family (Bracken et al., 2008), 
which also regulates EMT. However, EMT rarely occurs during normal development, 
accordingly, deletion of Zeb2 during lens development in the epithelial layer leads to the 
dysregulation of genes distinct from those discovered in the cancer field (Manthey et al., 
2014a; Manthey et al., 2014b).  
  
In sum, ZEB2 can have many functions depending on the cell types and the 
developmental stages. ZEB2 can be both an activator and a repressor of gene expression. 
It can bind activated Smads but its activity does not always depend on it. ZEB2 can 
regulate the expression of Foxe3 in the lens, Sfrp1 in the hippocampus, Ntf3 in the 
neurons and E-cadherin in cancer cells. Interestingly, ZEB2 target gene Sfrp1 (Leimeister 
et al., 1998), Ntf3 (Good and George, 2001), Smad7 (Banas et al., 2007) and the miR-200 
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family (Patel et al., 2012) are all expressed in the kidney. However, the function of ZEB2 
during kidney development is unknown. This thesis research is the first study of the 
impact of loss of Zeb2 on kidney development. 
 
2.2.4 Glomerulocystic kidney disease (GCKD) as a specific form of renal cystic disease 
 
Most of the renal cystic diseases are characterized by primary renal tubular 
dilatation. Glomerulocystic kidney disease (GCKD) is a special form of renal cystic 
disease characterized by the dilatation of the Bowman’s space (Wood et al., 2015). In 
1993, Bernstein defined GCKD as a disease entity (Bernstein, 1993). Two- to threefold 
dilatation of Bowman’s space in more than 5% of identifiable glomeruli in the plane of a 
kidney section define GCKD (Bernstein, 1993; Lennerz et al., 2010). Although most of 
the glomerular cysts are associated with tubular dilatation, a subset of “primary” (also 
called “isolated”) glomerular cystic disease does not display tubular dilatations (Lennerz 
et al., 2010), and the glomerular cysts are mainly located in the subcapsular area of the 
renal cortex (Romero et al., 1993; Wood et al., 2015). Ultrasound and nonenhanced CT 
have limited capacity to identify glomerular cysts, and only nonenhanced T2-weighted 
MR imaging enables their detection, limiting the diagnosis of GCKD in the population 
(Wood et al., 2015). Nevertheless, several syndromes have glomerular cysts as part of 
their phenotype. These include tuberous sclerosis complex (TSC1 – OMIM 191100 and 
TSC2 – OMIM 613254) (Murakami et al., 2012), Zellweger syndrome (also called 
cerebrohepatorenal syndrome that is mainly caused by mutations in the PEX1 gene - 
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OMIM 214100) (Bernstein, 1993), and the X-linked dominant oral-facial-digital 
syndrome type 1 (OFD1 – OMIM 311200) (Feather et al., 1997). In addition, mutations 
in UMOD (Rampoldi et al., 2003) and HNF1β genes are reported to cause glomerular 
cysts (Bingham et al., 2001; Loftus and Ong, 2013). Glomerular cysts can also be found 
in patients with ciliopathies (e.g. polycystic kidney disease, Bardet-Biedl Syndrome, 
nephronophthisis, etc.) and obstructive uropathy (Bissler et al., 2010). 
 
2.2.5 Genes associated with glomerular cysts in mice 
 
Glomerular cysts have been reported in several mouse models such as the Wwtr1, 
Glis3, Ofd1 and Pkhd1 germline knockout mice, the Hnf1β and Dicer conditional 
knockout mice, and the Pkd1 overexpression transgenic mice (Ferrante et al., 2006; 
Hossain et al., 2007; Kang et al., 2009; Massa et al., 2013; Patel et al., 2012; Pritchard et 
al., 2000a; Williams et al., 2008b). In the Hnf1βflox/flox;Six2-cre+ model, the glomerular 
cysts develop because of a lack of proximal tubules development (Massa et al., 2013). In 
other models, both glomerular cysts and tubular cysts are observed.  
 
Interestingly, two of the genes that cause glomerular cysts in knockout mice also 
interact with SMADs (Hossain et al., 2007; Kang et al., 2009; Makita et al., 2008). The 
Wwtr1 gene encodes the TAZ protein that can shuttle SMADs between the cytoplasm and 
the nucleus and, like ZEB2, TAZ can also induce EMT (Varelas et al., 2008; Yang et al., 
2012). One of transcription factors interacting with TAZ is the Kruppel-like zinc finger 
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protein (encoded by Glis3 gene). Knockout of Glis3 in mice also cause glomerular cysts 
(Kang et al., 2009).  
 
In both Pkd1 transgenic mice and Dicer conditional knockout mice (using Ksp-
cre), increased Pkd1 levels are associated with glomerular cyst formation (Patel et al., 
2012; Thivierge et al., 2006). Interestingly, in the Dicer cKO, the same microRNA family 
that is repressed by ZEB2, miR200, was shown to regulate Pkd1 levels (Brabletz and 
Brabletz, 2010; Patel et al., 2012).  
 
2.3 Hypothesis. 
 
Although abnormalities of the kidneys are relatively common in Mowat Wilson 
syndrome (Garavelli and Mainardi, 2007), they have not been well characterized and the 
potential pathogenic role of ZEB2 mutations in kidney development has not been 
examined. In this research project, we hypothesized that ZEB2 plays a role in kidney 
development and loss of ZEB2 results in congenital renal anomalies. To test this 
hypothesis, we analyzed a Zeb2 floxed conditional knockout (cKO) mouse line (Higashi 
et al., 2002) as Zeb2 null mice die at E9.5 before kidney development begins (Van de 
Putte et al., 2003a). 
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2.4 Materials and Methods 
 
2.4.1 Mice Strains 
 
Zeb2 conditional knockout mice with two LoxP sites flanking the exon seven 
(Zeb2
flox/flox
) were kindly provided by Dr. Yujiro Higashi (Osaka University, Osaka, 
Japan) (Higashi et al., 2002). Mice with the Pax2-cre
+
 allele were obtained from the 
Mutant Mouse Regional Resource Centers (MMRRC) (Stock number: 010569-UNC) 
(Ohyama and Groves, 2004). Mice with the Six2-cre
+
 allele (Stock number 009606) 
(Kobayashi et al., 2008) and Pkd1 floxed allele (Stock number 010671) were purchased 
from the Jackson laboratories (Stock number 009606) (Piontek et al., 2004).  
Briefly, the Zeb2 (Zeb2
flox/flox
) mice were crossed with the Pax2-cre mice to 
generate Zeb2
flox/+
;Pax2-cre
+
, which were then bred with Zeb2
flox/flox 
and Zeb2
flox/+
;Pax2-
cre
+ 
mice to produce Zeb2
flox/flox
;Pax2-cre
+
 conditional knockout (cKO) offspring and 
controls (Zeb2
flox/+ 
and Zeb2
flox/flox 
mice without the Pax2-cre allele and Zeb2
+/+
;Pax2-
cre
+
 mice).  
The Zeb2 (Zeb2
flox/flox
) mice were also crossed with the Six2-cre mice to generate 
Zeb2
flox/+
;Six2-cre
+
 mice. The Zeb2
flox/+
;Six2-cre
+
 mice were bred with Zeb2
flox/flox 
homozygotes
 
and Zeb2
flox/+ 
heterozygote
 
mice (without the Six2-cre allele because Six2-
cre homozygotes are lethal) to produce Zeb2
flox/flox
;Six2-cre
+
 conditional knockout 
offspring and controls (Zeb2
flox/+ 
and Zeb2
flox/flox 
mice without the Six2-cre transgene and 
Zeb2
+/+ 
; Six2-cre
+
 mice). 
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Mouse embryos were staged by designating the day that the vaginal plug was 
observed in the dam as E0.5. The conditional knockout mice were analyzed from 
embryonic stage E14.5 to postnatal 8 weeks old. All animal studies were approved by the 
Institutional Animal Care and Use Committee of Boston University Medical Campus 
(#14388). 
 
2.4.2 Mouse DNA extraction and genotyping 
 
Mice were genotyped using DNA samples that were extracted from mouse tails 
using hotshot NaOH method as previously described (Truett et al., 2000). 
 
All genotyping was performed using a PCR method on thermal cycler Veriti FAST 
(Life Technologies) or MyClycler (BioRad). The presence of the Pax2-cre allele was 
deleted using primers designed specifically to the Pax2-cre transgene. The presence of 
the Six2-cre allele was detected using generic primers for “Cre recombinase”. The 
presence of the Zeb2 floxed allele was detected as previously described (Higashi et al., 
2002). The presence of Pkd1 floxed or mutant alleles were detected as previously 
described (Piontek et al., 2004).  
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2.4.3 Tissue collection and preparation 
 
The mouse kidneys at defined ages and embryonic stages were dissected and fixed 
overnight in 4% paraformaldehyde. The samples were then washed 2 times in PBS on ice 
and preserved in 70% EtOH until they were processed for paraffin embedding. Serial 4-7 
μm tissue sections were cut using a MT-920 microtome (Microm). For 
immunofluorescence staining, mouse kidneys were fixed in 4% formaldehyde followed 
by incubation in 30% sucrose /PBS overnight at 4°C, embedded in OCT compound 
(Tissue-Tek), and cryosectioned at 10 μm using a Microm HM 550 cryostat (Thermo 
Scientific).  
 
2.4.4 Histological analysis 
 
Paraffin embedded kidney sections were stained by hematoxylin and eosin, 
Periodic acid–Schiff (PAS) stain and Masson Trichrome stain, and were examined using 
a Nikon or Olympus light microscope. 
 
2.4.5 Immunohistochemistry  
 
For immunohistochemistry, sections were pretreated to quench endogenous 
peroxidase (3.0% hydrogen peroxide in PBS) and endogenous biotin (Avidin-Biotin 
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blocking kit, Vector Laboratories, Burlingame, CA). Mitotic cells were detected with 
phospho-histone H3 (ser 10) (pHH3) antibody (Cell Signaling Technology #9701, 
Beverly MA) at 1:200 dilution. Proximal tubules were stained with biotinylated Lotus 
tetragonolobus agglutinin (LTL) (Cat #B1325, Vector Labs), distal tubules and collecting 
ducts were stained with biotinylated Dolichos biflorus agglutinin (DBA) (Cat #B-1035, 
Vector Labs). Apoptosis was detected as previously described using the TUNEL reaction 
(terminal deoxynucleotidyl transferase [TdT]-mediated dUTP-biotin nick-end labeling). 
(Omori et al., 2000). Fragmented DNA was detected using Apoptag® (Chemicon, 
Temecula, CA) with DAB development (Biogenex, San Ramon, CA) and hematoxylin 
counterstaining. To quantify apoptosis in the C-shaped body (CSB) and S-shaped body 
(SSB) in developing kidney, all CSB and SSB were counted first and then all CSB and 
SSB with at least one TUNEL positive cell were counted again in one slide per kidney. 
The counting was performed without the knowledge of the genotypes of the slides. 
 
To quantify the proliferation in the Bowman’s capsules, all glomeruli were 
counted first and then all the glomeruli with at least one pHH3 positive cell on their 
Bowman’s capsules were counted again in one slide per kidney. 
 
2.4.6 Immunofluorescence staining 
 
For immunofluorescence staining, frozen sections of mouse kidneys were 
permeabilized with 0.1% PBS- Triton X-100 for 10 min and blocked in 5% goat serum 
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for 1hr. Primary antibodies were incubated overnight at 4°C followed by secondary 
antibodies incubated at RT for 1hr. The following primary antibodies were used: WT1 
(Cat# sc-192, Santa Cruz Biotechnology), Polycystin-1 (Cat# sc-130554, Santa Cruz 
Biotechnology), Laminin (Cat# L9393, Sigma), GFP (Cat# GFP-1020, Aves). Tissue 
sections were mounted in media containing DAPI and imaged by a Zeiss confocal 
microscope. The immunofluorescent TUNEL staining was performed using the 
ApopTag® Red In Situ Apoptosis Detection Kit (Millipore, S7165). 
 
2.4.7 Urine protein and renal function analysis 
 
Urine protein excretion was detected by SDS-PAGE followed by Coomassie blue 
staining and quantified using ImageJ. Urine creatinine was measured using the Crystal 
Chem Kit (Crystal Chem, Catalog# 80350). Urine albumin/creatinine ratios were 
calculated. Serum values were obtained from blood samples at time of euthanasia for 
blood urea nitrogen using the Catalyst Dx® Chemistry Analyzer by IDEXX. 
 
2.4.8 Glomerular count and cysts assessment 
 
Bowman’s space dilatation was defined when the glomerular tuft occupied less 
than two third of the bowman space. To compare the number of glomeruli with and 
without cysts between wild-type and conditional knockout mice, H&E-stained median 
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sagittal sections from one or two kidneys were analyzed for each animal. A total of 8 
Zeb2
flox/flox
; Pax2-cre
+
 kidneys and 7 littermate controls at E18.5 were analyzed for 
glomerular cystic phenotype. The ratio of glomerular cysts (i.e. glomeruli with 
identifiable glomerular tuft and Bowman’s space dilatation) to the total number of 
glomeruli was calculated in mouse embryonic kidneys between E16.5 and E18.5.  
 
2.4.9 Assessment of glomerulotubular integrity 
 
Since the proximal tubular cells encroach the bowman capsule, the connection 
between the proximal tubule and the glomerulus can be visualized using the proximal 
specific marker LTL. Glomerulotubular integrity was assessed by analyzing the 
connection between the proximal tubules and the glomeruli on LTL stained kidney 
sections as described previously (Forbes et al., 2011; Galarreta et al., 2014). All 
glomeruli were counted on the kidney sections and scored on the basis of presence 
(positive) or absence (negative) of LTL staining in the Bowman’s capsule. Quantification 
of glomerulotubular integrity was presented as the percentage of LTL-positive glomeruli 
in total glomeruli as previously described (Forbes et al., 2011). A total of 5 
Zeb2
flox/flox
;Six2-cre
+
 kidneys and 5 littermate controls at 12 days old of age were 
analyzed. Results were presented as the percentage of LTL-positive glomeruli as 
previously described (Forbes et al., 2011). 
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2.4.10 TaqMan real-time PCR gene expression analysis  
 
Total RNA was extracted from E14.5, E18.5 and P8 kidneys of control and Zeb2 
cKO using the miRNeasy Micro kit (Cat# 217084, Qiagen). cDNA was synthesized from 
total RNA using the Verso cDNA Synthesis Kit (Cat# AB-1453, Life Technologies) and 
the TaqMan MicroRNA Reverse Transcription kit (Cat# 4366596, Life Technologies). 
Gene expression was analyzed using the 7500FAST real-time PCR machine with 
TaqMan probes purchased from Life Technologies. Relative gene expression data were 
analyzed by the delta-delta-Ct method and were normalized to the either Gapdh or 
Ppp1r3c. A total of three E14.5, five E18.5 and five P8 knockout mice and littermate 
controls were analyzed.  
 
2.4.11 Statistical analysis 
 
A minimum of three mice were used for each analysis, unless stated otherwise. 
Data are represented as means +/- standard deviation. Statistical analysis was performed 
by using the Student t-test; significance was determined at p < 0.05. 
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2.5 Results 
 
2.5.1 ZEB2 is broadly expressed in the developing kidney 
 
Based on the in situ hybridization (ISH) data from publically available databases 
(e.g. GUDMAP and GenePaint), Zeb2 is broadly expressed in mouse developing kidney 
between E13.5 and E15.5. The microarray gene expression data from the GUDMAP also 
reveal that Zeb2 is expressed at a high level in the developing medullary interstitium, the 
developing podocytes and the tissues of the urinary tract such as the ureter (Figure 2.1) 
(Harding et al., 2011; McMahon et al., 2008; Visel et al., 2004). 
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Figure 2.1: Zeb2 mRNA is broadly expressed in the developing mouse kidney and 
urinary tract.  
ISH data show that Zeb2 mRNA is expressed in (A) mouse E13.5 kidney (whole mount 
ISH from GUDMAP), (B) mouse E14.5 kidney (section ISH from Gene Paint) and (C) 
mouse E15.5 kidney (whole mount ISH from GUDMAP). (D) Microarray gene 
expression heatmap data from GUDMAP show that Zeb2 mRNA is expressed in the renal 
vesicles, the podocytes, the medullary interstitium and the S-shaped body of developing 
kidney. 
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To study Zeb2 expression in mouse kidney, we confirmed the expression of Zeb2 
mRNA during murine development using real-time RT-PCR on kidney extract from 
wild-type mice. Zeb2 mRNA was expressed throughout kidney development and in adult 
kidneys (Figure 2.2, A). We then used a Zeb2-EGFP reporter mouse to visualize the 
expression pattern of Zeb2 in the kidney. The Zeb2-EGFP reporter mouse was generated 
by knocking in a Zeb2-Egfp fusion element in the Zeb2 locus, generating a ZEB2-EGFP 
fusion protein (Nishizaki et al., 2014). In the mouse brain, the GFP expression pattern is 
consistent with Zeb2 mRNA expression as previously reported (Nishizaki et al., 2014), 
validating this Zeb2-EGFP reporter stain. Using an anti-GFP antibody to enhance the 
GFP signal, ZEB2 was detected in the developing kidney at E16.5 (Figure 2.2, B-J). In 
addition to the stromal cells, ZEB2 was detected in a subset of cells in the nephron, 
including the S-shaped bodies (Figure 2.2D), glomeruli (Figure 2.2G) and renal tubules 
(Figure 2.2J).   
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Figure 2.2: ZEB2 is highly expressed in developing mouse kidney  
(A) Zeb2 mRNA is expressed throughout development and adulthood by RT-PCR. (B-J) 
ZEB2 expression (red) was detected using the ZEB2-EGFP reporter mouse at E16.5 with 
an antibody against GFP. The nephrons and collecting ducts were delineated with a 
laminin antibody (green). (B) Transverse section of the whole kidney at low 
magnification (10x). (C and F) Higher magnification of the white box in (E) shows ZEB2 
expression in the kidney cortex, 20x magnification. (D) Higher magnification of the 
white box in (C) shows an S-shaped body (SSB) and ZEB2 positive cells (arrows), 40x 
magnification. (G) Higher magnification of the white box in (F) shows a glomerulus (g) 
and ZEB2 positive cells (arrows), 100x magnification. (J) Higher magnification of the 
white box in (I) shows a tubule (t) and ZEB2 positive cells (arrows).  
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2.5.2 Loss of Zeb2 leads to glomerular kidney cysts formation 
 
Generation of a kidney specific Zeb2 knockout mouse 
 
Zeb2 null mice die at E9.5 before kidney development initiation (Higashi et al., 
2002; Van de Putte et al., 2003a). To determine the role of Zeb2 in kidney development, 
we crossed a Zeb2 floxed conditional knockout mouse line (Zeb2
flox/flox
) with a Pax2-cre
+
 
deleter strain that expresses Cre recombinase in both the ureteric bud and the 
metanephric mesenchyme (Illustration 2.2) (Levinson et al., 2005; Narlis et al., 2007; 
Ohyama and Groves, 2004). Kidney samples were collected between E14.5 and P0 
(Table 2.1). 
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Illustration 2.2: Zeb2 floxed allele  
The Zeb2 floxed allele used in project one: the exon 7 of Zeb2 is flanked by two loxP 
sites (red arrows). Exon 7 encodes the middle part of the ZEB2 protein with the Zinc 
Fingers located on the N terminus of the protein (Higashi et al., 2002). 
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Table 2.1: Kidney samples collected from the Zeb2 conditional knockout mice in 
project one. 
Embryonic kidney samples collected. 
     A. Frozen kidneys (OCT) 
     Genotype E14.5 E15.5 E16.5 E17.5 E18.5 
Zeb2
flox/flox
 and Zeb2
flox/+
 (wt) 
 
10 
  
2 
Zeb2
flox/flox
;Pax2-cre+ 
 
2 
  
3 
Zeb2
flox/+
;Pax2-cre+ 
 
5 
  
1 
Zeb2
flox/flox
 and Zeb2
flox/+
 (wt) 19 5 7 6   
Zeb2
flox/flox
;Six2-cre+ 5 3 3 3   
Zeb2
flox/+
;Six2-cre+ 5 5 1 0   
      B. Paraffin embedding (PFA fixed) 
     Genotype E14.5 E15.5 E16.5 E17.5 E18.5 
Zeb2
flox/flox
 and Zeb2
flox/+
 (wt) 3 4 
 
9 13 
Zeb2
flox/flox
;Pax2-cre+ 2 1 
 
3 8 
Zeb2
flox/+
;Pax2-cre+ 2 5 
 
0 4 
Zeb2
flox/flox
 and Zeb2
flox/+
 (wt) 7 18 8 
 
  
Zeb2
flox/flox
;Six2-cre+ 6 5 5 
 
  
Zeb2
flox/+
;Six2-cre+ 6 2 7     
 
C. RNA (RNAlater) 
     Genotype E14.5 E15.5 E16.5 E17.5 E18.5 
Zeb2
flox/flox
 and Zeb2
flox/+
 (wt) 
 
8 5 3 8 
Zeb2
flox/flox
;Pax2-cre+ 
 
3 2 2 8 
Zeb2
flox/+
;Pax2-cre+ 
 
1 2 0 2 
Zeb2
flox/flox
 and Zeb2
flox/+
 (wt) 10 8 6 
 
  
Zeb2
flox/flox
;Six2-cre+ 6 3 5 
 
  
Zeb2
flox/+
;Six2-cre+ 3 2 1     
 
P8 and P12 kidney samples collected. 
 Genotype Paraffin RNA 
Zeb2
flox/flox
 and Zeb2
flox/+
 (wt) 34 13 
Zeb2
flox/flox
;Six2-cre+ 11 5 
Zeb2
flox/+
;Six2-cre+ 15 7 
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Kidney specific Zeb2 knockout embryos develop cysts (using the Pax2-cre allele) 
 
The E18.5 Zeb2
flox/flox
;Pax2-cre
+ 
homozygous embryos did not display discernible 
gross structural defects of the kidney or the ureter. However, the histological examination 
of kidneys from 14 Zeb2
flox/flox
;Pax2-cre
+ 
homozygous embryos between E16.5 and 
E18.5 revealed that 14/14 (100%) homozygotes developed renal cysts (Figure 2.3 and 
Table 2.2), while none of the 12 littermate controls developed renal cysts (Figure 2.3 and 
Table 2.2). The Zeb2
flox/flox
;Pax2-cre
+
 embryos had a similar number of glomeruli as their 
wild-type littermate controls (Table 2.2), indicating that there was no reduction in 
nephron number. Accordingly, the renal cysts were initiated at E16.5 as no cysts could be 
detected at E15.5 (Figure 2.4). In the Zeb2 conditional knockout embryos the renal cysts 
were apparently from a glomerular origin as 47% of the glomeruli were cystic and 30% 
of the cysts had a visible glomerular tuft at E16.5 (Table 2.2 and Table 2.3). This 
phenotype is sufficient for a diagnosis of glomerulocystic kidney disease (GCKD) 
according to the established criteria (Lennerz et al., 2010).  
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Figure 2.3: Loss of Zeb2 in the metanephric mesenchyme and the ureteric bud leads 
to renal cysts development 
Loss of Zeb2 in the metanephric mesenchyme and the ureteric bud using the Pax2-cre
+
 
allele leads to renal cysts development.
 
(A, B) Congenital kidney cysts were observed at 
E16.5 in the Zeb2
flox/flox
;Pax2-Cre
+
 embryos and not in littermate controls. (C, D) Kidney 
cysts at E18.5 the Zeb2
flox/flox
;Pax2-Cre
+
 embryos and not wild type littermate controls. 
cy- cysts, g- glomerulus (H&E staining, n≥3 in each group, 20x magnification) 
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Table 2.2: Cystic phenotype observed in H&E stained histological samples of Zeb2 
flox/flox
;Pax2-cre
+
 and wild-type littermates between E16.5 and E18.5  
 
E16.5 E17.5 E18.5 
 
Zeb2
+/+
 
Zeb2
flox/flox
; 
Pax2-cre
+
 
Zeb2
+/+
 
Zeb2
flox/flox
; 
Pax2-cre
+
 
Zeb2
+/+
 
Zeb2
flox/flox
; 
Pax2-cre
+
 
Embryos  
with kidney 
cysts  
(more than 1 
cyst) 
0/2 
(0%) 
3/3 
(100%) 
0/3 
(0%) 
3/3 
(100%) 
0/7 
(0%) 
8/8 
(100%) 
Glomerular 
Cysts/  
Number of 
glomeruli 
(n= number 
of kidneys 
analyzed)  
1/48 
2%, 
(n=4) 
26/55 
47%, 
(n=5) 
0/40 
0%, 
(n=3) 
18/59 
30.5%, 
(n=4) 
1/363 
0.2%, 
(n=13) 
61/391 
15.6%, 
(n=15) 
 
Table 2.3: Percentage of cysts with glomerular tuft analyzed on H&E stained 
histological samples between E16.5 and E18.5 
 Cysts with Glomerular tuft / total cysts 
(n= number of kidneys analyzed) 
 Zeb2 
flox/flox
; Pax2-cre
+
 
E16.5  26/85 
(30.6%, n=5) 
E17.5  18/46 
(39%, n=4) 
E18.5  61/226 
(27%, n=15) 
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Figure 2.4: No glomerular cysts were observed in E15.5 Zeb2
flox/flox
;Six2-cre
+
 kidney.  
No glomerular cysts were observed in the Zeb2
flox/flox
;Six2-cre
+ 
embryonic kidney at 
E15.5 compared to the Zeb2
+/+
 wild type littermate controls (n=3). 20 x magnifications. 
 
 
No tubular cysts in the Zeb2
flox/flox
;Pax2-cre
+ 
kidneys  
 
Since glomerular cysts are usually secondary to tubular cysts, we decided to 
determine whether Zeb2 mutant embryonic kidneys also developed renal tubular cysts. 
We examined the kidney sections with both proximal tubule specific marker Lotus 
tetragonolobus lectin (LTL) and distal tubules and collecting duct specific marker 
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Dolichos biflorus agglutinin (DBA). The cysts were negative for both LTL and DBA 
staining at embryonic stage E18.5, suggesting that the Zeb2
flox/flox
;Pax2-cre
+
 homozygous 
embryos develop primary glomerular cysts (Figure 2.5). 
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Figure 2.5: Deletion of Zeb2 in the metanephric mesenchyme and the ureteric bud 
leads to glomerular cysts formation.  
Deletion of Zeb2 in the metanephric mesenchyme and the ureteric bud does not lead to 
tubular or collecting duct cysts. (A) None of the cysts in the Zeb2 
flox/flox
;Pax2-Cre
+
 
kidneys at E18.5 is positive for the collecting duct and distal tubules marker, Dolichos 
biflorus agglutinin (DBA) staining (10x and 20x magnification). (B) None of the cysts in 
the Zeb2 
flox/flox
;Pax2-Cre
+ 
kidneys at E18.5
 
is positive for the proximal tubules marker, 
Lotus tetragonolobus lectin (LTL) staining (10x and 40x magnification) (n≥3 for each 
group, g-glomerulus, cy-cyst) 
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Zeb2
flox/flox
;Pax2-cre
+ 
pups die at birth 
 
After genotyping 96 three-week old weanlings of Zeb2
flox/+
;Pax2-cre
+
 
heterozygous matings, I did not find any Zeb2
flox/flox
;Pax2-cre
+ 
homozygotes (Table 2.4). 
I then analyzed newborn mice and E18.5 embryos from timed-pregnant females. Five 
dead newborn Zeb2
flox/flox
;Pax2-cre
+ 
homozygotes and 21/55 (38%) E18.5 homozygous 
embryos were found (Table 2.4), suggesting that Zeb2
flox/flox
;Pax2-cre
+ 
homozygotes die 
at birth. 
 
Table 2.4: Mendelian distribution of Zeb2 conditional knockout using Pax2-cre. 
Genotype  (a) 3 weeks  (b) E18.5  
 Observed  Expected  Observed  Expected 
(range) 
Zeb2
flox/+
;Pax2-cre
+ 
 23  36 10 20-21 
Zeb2
+/+
;Pax2-cre
+ 
 28  18 10 10-11 
 
Pax2-cre
-
 45 24 14 13-14 
Zeb2
flox/flox
;Pax2-cre
+ 
 0  18 21 10-11 
Total  96  55  
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Nephron-specific Zeb2 knockout embryos develop cysts (using the Six2-cre allele) 
 
Generation of a nephron specific Zeb2 knockout mouse 
 
Zeb2
flox/flox
;Pax2-cre
+
 homozygous mice died after birth, which precludes a 
longitudinal analysis of glomerulocystic kidney disease progression in adult mice. To 
study the effect of Zeb2 deletion and glomerular cystic phenotype on the postnatal kidney 
and to further delineate the role of ZEB2 in nephron development, we crossed Zeb2
flox/flox
 
mice with nephron-specific Six2-cre mice and analyzed kidney phenotype in 
Zeb2
flox/flox
;Six2-cre
+
 homozygous mice. SIX2 is a nephron progenitor marker and is 
expressed in the cap mesenchymal cells that give rise to all segments of the nephron 
including the parietal and visceral epithelial cells (i.e. podocytes) in the glomeruli and the 
proximal and distal tubular epithelial cells (Kobayashi et al., 2008). As described in the 
methods, the Zeb2
flox/flox
 mice were crossed with mice expressing the Six2-cre allele 
(Kobayashi et al., 2008).  
 
Zeb2
flox/flox
;Six2-cre
+ 
mice develop GCKD 
 
Histological examination of the kidneys from nine Zeb2
flox/flox
;Six2-cre
+ 
homozygous embryos revealed that, like the Zeb2
flox/flox
;Pax2-cre
+
 embryos, all 
homozygous embryos had glomerular cysts starting at E16.5 (Figure 2.6A). At postnatal 
day 12 (P12), the glomerular cysts in the Zeb2
flox/flox
;Six2-cre
+
 mice were mainly located 
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in the subcapsular region of the kidney that is consistent with the GCKD diagnosis 
(Figure 2.6B) (Lennerz et al., 2010). The cysts were also negative for both LTL and DBA 
staining (Figure 2.7), confirming their glomerular origin. In comparison, none of the five 
wild-type littermate controls had a cystic phenotype at P12 (Figure 2.6 and Figure 2.7). 
 
Figure 2.6: Deletion of Zeb2 in the tubular epithelial cells, podocytes and glomerular 
parietal cells using Six2-cre
+
 leads to glomerular cysts development.  
Deletion of Zeb2 in the tubular epithelial cells, podocytes and glomerular parietal cells 
using Six2-cre
+
 leads to glomerular cysts development. (A) Congenital kidney cysts were 
observed in the Zeb2 
flox/flox
;Six2-Cre
+ 
embryonic kidneys at E16.5 and not in littermate 
controls (H&E staining, 20x magnification). (B) Mainly subcapsular kidney cysts were 
observed at P12 in the Zeb2
flox/flox
;Six2-Cre
+
 kidneys but not in littermate controls (H&E 
staining, 20x magnification).   
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Figure 2.7: Deletion of Zeb2 in the tubular epithelial cells does not cause tubular 
cysts  
(A) At P12 none of the cysts in the Zeb2
flox/flox
;Six2-Cre
+
 kidneys is positive for the 
proximal tubules marker, Lotus tetragonolobus lectin (LTL) staining (10x and 20x 
magnification). (B) At P12 none of the cysts in the Zeb2
flox/flox
;Six2-Cre
+
 kidneys is 
positive for the collecting duct and distal tubules marker, Dolichos biflorus agglutinin 
(DBA) staining (10x and 20x magnification). (n≥3 for each group, g-glomerulus, cy-cyst) 
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Kidney failure before 2 months of age in Zeb2
flox/flox
;Six2-cre
+
 mice. 
 
To determine the longitudinal effect of glomerulocystic kidney disease on kidney 
structure and function, we followed the Zeb2
flox/flox
;Six2-cre
+
 mice to adulthood. At 7 
weeks of age, all Zeb2
flox/flox
;Six2-cre
+
 mice (n=5, 100%) developed macroscopic renal 
cysts that were visualized on the surface of the kidney (Figure 2.8A). Histological 
analysis revealed the presence of numerous large glomerular cysts in the subcapsular area 
of the renal cortex (Figure 2.8B). Although no significant interstitial fibrosis was 
observed (Figure 2.9A), some remaining non-cystic glomeruli in adult Zeb2
flox/flox
;Six2-
cre
+
 mice displayed glomerulosclerosis lesions (Figure 2.9B), which were not present at 
E18.5 (Figure 2.10). By 8 weeks of age, all Zeb2
flox/flox
;Six2-cre
+
 mice (n=5, 100%) 
developed albuminuria (Figure 2.11, A and B) with significantly elevated serum blood 
urea nitrogen (BUN) levels (Figure 2.11C). These data reveal that loss of Zeb2 in 
developing nephrons causes glomerulocystic kidney disease, glomerulosclerosis, 
albuminuria and renal failure in adult mice. 
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Figure 2.8: Cystic kidney disease in adult Zeb2
flox/flox
;Six2-Cre
+
 mice  
(A) Macroscopic images of kidneys from 7-week old control mice and Zeb2
flox/flox
;Six2-
Cre
+
 mice. The Zeb2
flox/flox
;Six2-Cre
+ 
mice have pale and cystic kidneys as compared to 
wild-type littermate (n=5 in each group). (B) Histological images of kidneys from control 
mice and Zeb2
flox/flox
;Six2-Cre
+
 mice. Large cysts, mainly in the subcapsular area of the 
cortex in the 7-week old Zeb2
flox/flox
;Six2-Cre
+
 mice as compared to wild-type littermate 
(overall view at 2.5x magnification and enlargement at 10x magnification) (n=3 in each 
group).  
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Figure 2.9: Glomerulosclerosis in adult Zeb2
flox/flox
;Six2-Cre
+
 mice  
(A) Little fibrosis is observed (blue) in the kidneys of the 7 weeks old Zeb2
flox/flox
;Six2-
Cre
+
 mice (Masson Trichrome staining- MTS, 10x (upper panels) and 60x (lower panels) 
magnifications) (B) Glomerulosclerosis is observed in pink in the non-cystic glomeruli of 
the 7 weeks old Zeb2
flox/flox
;Six2-Cre
+ 
mice (Periodic acid Schiff -PAS staining, 10x 
magnifications in upper panels and 60x magnifications in lower panels) (n=3 in each 
group).  
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Figure 2.10: No glomerulosclerosis is observed at E18.5 in Zeb2
flox/flox
;Pax2-Cre
+ 
mice 
Glomerulosclerosis was not observed in E16.5 (A) and E18.5 (B) Zeb2
flox/flox
;Pax2-Cre
+ 
mice (Periodic acid Schiff -PAS staining, 20x magnification). 
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Figure 2.11: Proteinuria and renal failure in adult Zeb2
flox/flox
; Six2-cre
+
 mice  
(A-B) The Zeb2
flox/flox
;Six2-cre
+
 mice develop albuminuria by 5 weeks old. (A) 
Representative SDS-page and Coomassie blue staining shows proteinuria/ albuminuria in 
two Zeb2
flox/flox
;Six2-cre
+
 5 weeks old mice as compared to two littermate controls (n=5 
mice in each group). alb: albumin standard. (B) Increased urine Albumin to Creatinine 
Ratio-uACR in 5 weeks old Zeb2
flox/flox
; Six2-cre
+
 mice (n=4 mice in each group, *p-
value< 0.05) (C) Kidney failure with significantly elevated BUN in 5 weeks old 
Zeb2
flox/flox
; Six2-cre
+
 mice (n=3 mice in each group, **p-value< 0.001). Results are 
represented as means +/- standard deviation. 
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2.5.3 GCKD in Zeb2 knockout mice is due to atubular glomeruli formation 
 
One common cause of acquired glomerular cysts is the loss of glomerulotubular 
junction integrity leading to atubular glomeruli (Chevalier and Forbes, 2008; Gibson et 
al., 1996). Glomerulotubular integrity can be quantified by examining the connection of 
the proximal tubule to the Bowman’s capsule with the proximal tubule marker LTL 
(Forbes et al., 2011). To determine whether the Zeb2 knockout mice have decreased 
glomerulotubular integrity, we examined glomeruli from five P12 Zeb2
flox/flox
;Six2-cre
+
 
mice and five littermate controls. We found that only 63/604 (10%) glomeruli had a 
visible LTL positive staining (i.e. glomerulotubular junction) in the Zeb2 cKO mice as 
compared to 115/324 (36%) in the wild-type littermate controls (Figure 2.12), a 
statistically significant decrease of glomerulotubular integrity, suggesting that Zeb2 
deletion causes the formation of atubular glomeruli.  
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Figure 2.12: Congenital atubular glomeruli in the Zeb2 nephron-specific knockout 
mice.  
(A) LTL staining shows glomerular proximal tubule connection (arrow) in wild-type 
littermates but reduced in Zeb2
flox/flox
;Six2-cre
+
 mice (n=5 in each group). (B) Percentage 
of LTL-positive glomeruli out of total glomeruli counted in single sagittal kidney sections 
of 5 Zeb2 cKO and 5 wild type littermates (n=604 for Zeb2 cKO glomeruli and n=324 for 
wild type glomeruli). The 25% difference in LTL-positive glomerular staining in Zeb2 
conditional knockout compared to their wild-type littermates reflects loss of 
glomerulotublar integrity in the knockout mice. 
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2.5.4 Zeb2 knockout mice have abnormal tubular development 
 
Atubular glomeruli can be caused by atrophy of the proximal tubules in polycystic 
kidney disease (Galarreta et al., 2014). To determine if reduced glomerulotubular 
integrity is associated with renal proximal tubule atrophy in Zeb2 cKO, we analyzed the 
mRNA levels of markers for the proximal tubule (Hnf1a and Vil1), the podocyte (Nphs1 
and Nphs2), and the collecting duct (Upk3a), all normalized to the collecting duct marker 
Ppp1r3c at postnatal day 8 (P8) (Massa et al., 2013). We found that only the proximal 
tubule mRNA markers were significantly reduced in the Zeb2
flox/flox
;Six2-cre
+
 mice 
compared to the levels in the wild-type littermates (Figure 2.13A). To determine if the 
reduction of proximal tubule mRNA at P8 is caused by an early defect preceding the 
formation of glomerular cysts in Zeb2 cKO mice, we analyzed the levels of mRNA 
markers in E14.5 kidneys. Similar to P8, a significant decrease of the proximal tubular 
markers was detected in the E14.5 Zeb2
flox/flox
;Six2-cre
+
 kidneys as compared to their 
wild-type littermates (Figure 2.13B). Consistent with this finding, the mean kidney size 
of the E16.5 Zeb2 cKO embryos was smaller than that of their wild-type littermate 
controls (Figure 2.14). Taken together, these data suggest that loss of Zeb2 in the kidney 
causes early proximal tubule developmental defects resulting in reduced 
glomerulotubular integrity and congenital atubular glomeruli formation.   
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Figure 2.13: Decreased tubular markers’ expression in the Zeb2 nephron-specific 
knockout mice.  
(A) At Postnatal day 8 (P8), decreased level of tubular mRNA markers (Vil1 and Hnf1a) 
and similar levels of podocyte markers (Nphs1 and Nphs2) when adjusted to a collecting 
duct marker (Pppp1r3c). An additional collecting duct marker, Upk3a was used as a 
control (n=3 in each group, mean relative quantification adjusted to Pppp1r3c +/- 
standard deviation, *p-value < 0.05). (B) In E14.5 embryonic kidneys, decreased level of 
tubular mRNA markers (Vil1 and Hnf1a) and similar levels of the metanephric 
mesenchyme markers (Pax2 and Wt1) and of the collecting duct markers (Pppp1r3c and 
Upk3a) (mean relative quantification adjusted to Gapdh +/- standard deviation, n=3 in 
each group, * p-value<0.05). 
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Figure 2.14: Reduced kidney size in the Zeb2 nephron-specific knockout mice.  
The Zeb2 cKO embryos have reduced kidney length at E16.5 as compared to wild type 
littermates as measured using an Olympus microscope and the cellSens software (mean 
length in mm, n=14 Zeb2 cKO kidneys from 7 embryos and n=11 wild type littermate 
kidneys from 6 embryos, * p-value<10
-3
). 
 
2.5.5 Decreased apoptosis in the early stages of glomerular development of Zeb2 
conditional knockout embryos 
 
Apoptosis is part of normal kidney development during C-shaped body (CSB) and 
S-shaped body (SSB) formation when the connections between the glomeruli and the 
proximal tubules are established (Coles et al., 1993; Ho, 2014; Omori et al., 2000; Ruf et 
al., 2003). We hypothesized that abnormal apoptosis in CSB and SSB contributes to the 
congenital atubular glomeruli formation in the Zeb2 conditional knockout mice. TUNEL 
assays on developing kidneys of E15.5 and E16.5 Zeb2 cKO embryos and littermate 
controls were performed to test this possibility. 11/34 (32%) CSB/SSB had at least one 
apoptotic cell in 5 kidneys of Zeb2 cKO embryos, while 25/39 (64%) CSB/SSB had at 
least one apoptotic cell in 4 kidneys of wild-type littermate controls (Figure 2.15). These 
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data suggest that loss of Zeb2 causes reduced apoptosis in CSB and SSB, which may 
affect tubular development and ultimately result in congenital atubular glomeruli.   
 
 
 
Figure 2.15: Decreased 
apoptosis in the C- and S-
shaped bodies in Zeb2 
knockout mice.  
(A) TUNEL staining shows 
reduced number of apoptotic 
cells (arrows) in Zeb2 
conditional knockout kidneys 
using both Pax2-cre
+
 and Six2-
cre
+
 (n=5 for mutant kidneys 
and n=4 for wild-type kidneys). 
(B) Immunofluorescence with 
TUNEL (rhodamine 
fluorochrome) and an antibody 
against Lama1 (green) to 
delineate the developing 
structures using a basement 
membrane marker. (C) Reduced 
apoptosis in the C-shaped 
bodies and S-shaped bodies of 
the Zeb2 conditional knockouts. 
11/34 (32%) CSB/SSB had ≥ 1 
TUNEL+ cell in 5 kidneys of 
Zeb2 cKO embryos, and 25/39 
(64%) CSB/SSB had ≥ 1 
TUNEL+ cell in 4 kidneys of 
wild-type littermate controls 
(mean percentage +/- standard 
deviation, *p-value<0.01).  
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No significant differences in cell proliferation in the kidneys of Zeb2 conditional 
knockouts compared to wild-type littermates 
 
Renal cystogenesis is often associated with increased cell proliferation (Paul and 
Vanden Heuvel, 2014). To determine if increased cell proliferation also plays a role in the 
formation of glomerular cysts in Zeb2 cKO mice, I quantified the proliferation of the 
parietal epithelial cells lining the glomerular cysts in the kidney of Zeb2 cKO and 
undilated Bowman’s capsules in the wild type littermate controls. By measuring the 
positive signals of the cell mitotic proliferation marker phosphorylated histone H3 
(pHH3), no significant difference of cell proliferation was observed in Zeb2 knockout 
kidneys compared to the wild-type controls (Figure 2.16), suggesting that loss of Zeb2 
does not affect cell proliferation in the Bowman’s capsule. 
  
  
67 
 
Figure 2.16: No significant change in cell proliferation in the Bowman’s capsule of 
Zeb2 knockout mice.  
(A) Staining with an antibody against phosphorylated Histone H3 (pHH3) as a marker of 
proliferation in E17.5 Zeb2
flox/flox
;Pax2-cre
+ 
embryonic kidneys. (B) Staining with an 
antibody against phosphorylated Histone H3 (pHH3) as a marker of proliferation in P12 
Zeb2
flox/flox
;Six2-cre
+
 kidneys. (C) No significant difference in proliferation between the 
wild type and the conditional knockout mice in the Bowman’s capsule layer, the 
percentage of glomeruli with ≥1 cell positive for pHH3 in their Bowman’s capsules out 
of all the glomeruli in single sagittal sections (mutant n=235 glomeruli, wild-type n=220 
glomeruli from 4 kidneys in each group), data are presented as mean percentage +/- 
standard deviation (ns- non significant) 
 
2.5.6 Elevated levels of Pkd1 mRNA and protein in the kidneys of Zeb2
 
conditional 
knockout mice  
 
Glomerular cysts are reported in several mouse models of renal cystic kidney 
disease, including Wwtr1, Glis3, Ofd1 and Pkhd1 knockout mice, the Hnf1β and Dicer 
cKO mice, and Pkd1 over expression transgenic mice (Ferrante et al., 2006; Hossain et 
al., 2007; Kang et al., 2009; Massa et al., 2013; Patel et al., 2012; Pritchard et al., 2000b; 
Williams et al., 2008b). Interestingly, the Hnf1β cKO mice develop glomerular cysts due 
to a drastic reduction in the levels of proximal tubular markers at E14.5 and lack of mid-
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limb of the S-shaped body development, resembling the Zeb2 cKO phenotype (Massa et 
al., 2013). To determine if loss of Zeb2 affects the expression of these six genes and the 
microRNA miR-200, we examined mRNA and microRNA levels in the kidney tissues of 
E14.5 and E18.5 Zeb2 cKO and wild-type littermate controls. Although there was no 
significant difference in the expression levels of any of the six genes and miR-200 at 
E14.5 before glomerular cyst formation (Figure 2.17A), we detected decreased 
expression of Glis3 and increased expression levels of Hnf1β and Pkd1 in the Zeb2 cKO 
compared to the wild-type littermate controls at E18.5 (Figure 2.17B). Interestingly, the 
expression level of Pkd1 mRNA was the most significantly upregulated in the Zeb2 cKO 
kidneys at postnatal day 8 (P8) (Figure 2.18A). Consistent with the mRNA levels, PKD1 
coding protein polycystin-1 (PC1) was also found to be expressed at high level in the 
glomeruli of postnatal day 7 (P7) Zeb2
flox/flox
;Six2-cre
+
 mice but not at E16.5 and E17.5 
when the glomerular cysts are initially observed (Figure 2.18B). Interestingly, the PC1 
expression was upregulated in non-cystic glomeruli but not in the glomeruli with dilated 
Bowman’s space (Figure 2.18C). These data suggest that loss of Zeb2 in the kidney leads 
to upregulation of polycystin-1 expression in non-cystic glomeruli after the initial phase 
of glomerular cyst formation. 
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Figure 2.17: Abnormal expression levels of genes associated with GCKD after the 
appearance of the glomerular cysts.  
(A) No difference at E14.5 in the mRNA levels of 6 genes and the miRNA level of 
miR200 which were all associated with a glomerulocystic phenotype in mice (mean 
relative quantification adjusted to Gapdh +/- standard deviation, n=3). (B) Significantly 
increased level of Pkd1 mRNA at E18.5 and P8 and increased level of Hnf1β mRNA at 
E18.5 and decreased level of Glis3 mRNA at E18.5 (mean relative quantification 
adjusted to Gapdh +/- standard deviation, n=5, *p-value <0.05).  
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Figure 2.18: Increased Pkd1 expression in 
the kidney of Zeb2 conditional knockout 
mice.  
(A) Significant upregulation of Pkd1 mRNA 
at E18.5 and P8 but not E14.5 in Zeb2 cKO 
kidneys compared to wild-type controls 
(mean relative quantification adjusted to 
Gapdh, n≥3, *p <0.05). (B) 
Immunofluorescence staining show 
increased levels of polycystin 1 (PC1) 
protein in the glomeruli of Zeb2
flox/flox
;Six2-
cre
+
 kidney at P7 (middle and lower panels), 
but not at E17.5 (upper panel). PC1 staining 
in the glomeruli was confirmed by co-
expression of WT1, a glomerular podocyte 
marker (lower panel). (C) Double 
immunofluorescence staining with PC1, 
WT1 and DAPI in Zeb2 cKO kidney shows 
increased levels of polycystin 1 (PC1) 
protein was detected only in non-cystic 
glomeruli (glom 1) but not in an adjacent 
glomerulus (glom 2) with significantly 
enlarged Bowman’s space (cy). The 
podocytes (arrows) and parietal epithelial 
cells (arrowheads) are visible.    
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2.5.7 Heterozygous deletion of Pkd1in the kidneys of Zeb2
 
conditional knockout mice 
exacerbates renal cystic phenotype  
 
Since we observed increased levels of Pkd1 in the Zeb2 cKO mice, we decided to 
genetically reduce the expression of Pkd1 in the nephron using a Pkd1 conditional 
knockout floxed allele and the Six2-cre deleter mice. In summary, the data collected 
suggest that decreased Pkd1 level in the nephron exacerbates the Zeb2 cKO phenotype 
(data  not shown). In addition, kidneys of Pkd1
flox/+
;Six2-cre
+
 mice have higher levels of 
Pkd1 mRNA (data  not shown) than both the Zeb2
flox/flox
;Six2-cre
+
 kidneys and 
Zeb2
flox/flox
;Pkd1
flox/+
;Six2-cre
+
 kidneys, suggesting that Pkd1 upregulation could be 
secondary to a decrease level of Pkd1 in the nephrons. Therefore, loss of Zeb2 in the 
nephron may decrease the levels of Pkd1 in the nephron, while upregulating Pkd1 
expression in other cell types where Zeb2 is not deleted. 
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2.6 Discussion 
 
 
2.6.1 Interpretations 
 
Proposed pathogenesis leading to kidney failure in the Zeb2 cKO mice 
 
In this study, we found that ZEB2 is broadly expressed in the developing kidney. 
Conditional deletion of Zeb2 with Pax2-cre and Six2-cre, two Cre strains active in the 
developing nephron, resulted in the same glomerular cyst phenotype, indicating that 
ZEB2 is required for normal nephron development. Decreased levels of proximal tubular 
markers at E14.5, reduced kidney size at E16.5 and reduced apoptosis at the CSB and 
SSB phases in the Zeb2 cKO mice suggest that an early defect of the proximal tubule 
development leads to congenital atubular glomeruli formation, accumulation of 
glomerular filtrate and cystic expansion of the Bowman’s space. In addition, abnormal 
nephrogenesis in Zeb2 cKO mice also result in reduced number of non-cystic functional 
glomeruli, which undergo hyperfiltration and hypertrophy leading to secondary FSGS 
and eventually renal failure. Therefore, the initial defect in nephrogenesis during 
embryonic kidney development in Zeb2 cKO mice correlates with early kidney failure 
after birth. 
 
 
  
73 
Zeb2 is expressed in nephron epithelial cells 
 
We detected ZEB2 expression only in a subset of nephron epithelial cells, and not 
in the cap mesenchyme (Figure 2.1 and 2.2). Since deletion of Zeb2 in the nephron 
epithelial cells (e.g. tubular epithelial cells, podocytes and glomerular parietal cells) with 
the Six2-cre caused severe GCKD and renal failure phenotype (Kobayashi et al., 2008), 
we concluded that Zeb2 plays an important role in the development of the epithelial layer 
of the nephron, as it is in the lens epithelial layer (Manthey et al., 2014a; Manthey et al., 
2014b).   
 
Zeb2 is mainly expressed in the stromal cells 
 
Based on the expression pattern of Zeb2 we identified in this study and the gene 
expression data from the GUDMAP database in the kidney, Zeb2 is broadly expressed in 
the developing kidney stromal cells (Harding et al., 2011; Kobayashi et al., 2008; 
McMahon et al., 2008; Ohyama and Groves, 2004). Therefore, we deleted Zeb2 in the 
developing mouse stromal cells using Foxd1-cre. These mice developed a severe growth 
retardation phenotype that can be observed at 3 weeks of age when they need to be 
euthanized due to poor body condition and renal failure (data  not shown). However, at 
the histological level, no cysts were observed in the Zeb2
flox/flox
;Foxd1-cre
+
 cKO mice, 
supporting a specific role of ZEB2 in the developing nephrons. Further analysis of these 
mice is needed in order to understand the role of Zeb2 in the stromal cells.  
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Early defect in tubular development 
 
The reduced kidney size at E16.5 and the similar number of glomeruli in the Zeb2 
cKO compared to the wild-type littermates suggest abnormal development of a specific 
segment of the nephron. Decreased levels of tubular markers in the Zeb2 cKO mice at 
E14.5, before the appearance of the cysts, imply an early defect in tubular differentiation. 
Consistent with our findings, haploinsufficiency of Zeb2 was reported to be associated 
with delayed nephrogenesis in a transgenic rat model, however the kidney phenotype was 
not investigated in detail (El-Kasti et al., 2012). 
 
Another model with a drastic reduction in the levels of tubular markers at E14.5 
and lack of tubular development is the Hnf1β cKO mice, which also develops glomerular 
cysts (Massa et al., 2013). Unexpectedly, a slight upregulation of Hnf1β mRNA in Zeb2 
cKO E18.5 embryonic kidneys as compared to wild-type controls was observed. This 
upregulation of Hnf1β may reflect a compensatory mechanism in the developing nephron 
lacking Zeb2, since it was observed only after cyst formation. Our findings in this project 
suggest that loss of Zeb2 is associated with primary congenital atubular glomeruli 
probably due to developmental defects of the glomerulotubular junction. 
  
Reduced apoptosis in the Comma-shaped and S-shaped bodies 
 
At the cellular level, reduced apoptosis in C-shaped and S-shaped bodies (CSB 
and SSB) was observed in the Zeb2 cKO embryonic kidneys compared to littermate 
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controls. Apoptosis plays an important role in normal nephrogenesis (Ahn et al., 2013; 
Massa et al., 2013). Here we show for the first time that decreased apoptosis during 
nephrogenesis, is observed in primary non-lethal GCKD. Loss of Zeb2 during 
development has been shown to differently affect apoptosis in various organs (Maruhashi 
et al., 2005; Miquelajauregui et al., 2007; Seuntjens et al., 2009; Yoshimoto et al., 2005). 
Apoptosis dysregulation during nephrogenesis may lead to abnormal tubular 
development and ultimately to congenital atubular glomeruli. 
 
Congenital Atubular glomeruli 
 
Atubular glomeruli were first described in animal models of chronic nephropathy 
and then in human patients with chronic pyelonephritis (Marcussen and Olsen, 1990). In 
1996, the connection between atubular glomeruli and glomerular cysts was first described 
(Gibson et al., 1996), yet I did not find a report investigating atubular glomeruli 
formation in models or patients with glomerular cysts. Proximal tubular injury and loss of 
tubular epithelial cells are known to cause atubular glomeruli, however they usually do 
not lead to glomerular cysts, but rather to small glomeruli (Forbes et al., 2011; Forbes et 
al., 2013; Marcussen, 1995; Xu et al., 2013). Atubular glomeruli and glomerular cysts are 
described in polycystic kidney disease in human, mice and rats, but are thought to be 
secondary to large cysts inducing tubular injury that destroys the glomerulotubular 
junctions (Colgin et al., 2002; Tanner et al., 2002).  
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 In the Zeb2 cKO model, there is no congenital urinary tract obstruction, no 
tubular or collecting duct cysts, but a congenital proximal tubular defect. This study 
produced the first viable mouse model of primary congenital atubular glomeruli, which 
will be valuable for the general scientific community. 
 
The Zeb2
flox/flox
;Six2-cre mice die from kidney failure 
 
GCKD in Zeb2 cKO mice leads to renal failure within 8 weeks after birth with 
enlarged cysts, glomerulosclerotic lesions in the non-cystic glomeruli, elevated BUN, 
albuminuria, but minimum renal fibrotic lesions. Considering that glomerulosclerosis was 
not noticed in the embryonic kidneys, it may be secondary to post-natal hyperfiltration 
caused by the numerous cystic glomeruli and abnormal nephrogenesis as proposed in the 
Illustration 2.2 above (Helal et al., 2012). Since the tubules are responsible for the 
reabsorption of albumin under normal conditions, the proteinuria observed in the Zeb2 
cKO mice might be a result of abnormal tubular function or damage to podocytes in the 
non-cystic glomerular. This early renal failure may be reminiscent of the end-stage renal 
disease (ESRD) found in children with congenital forms of renal cystic diseases 
(Hildebrandt and Otto, 2005; Kurschat et al., 2014).  
 
Increased PC1 expression has been reported in other models of cystic kidney disease. 
 
Increased expression of PC1 was detected in the glomeruli of Zeb2 conditional 
knockout mice.  
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Mutations in PKD1 cause Autosomal dominant polycystic kidney 
disease (ADPKD), one of the commonest monogenic diseases in patients (Torres et al., 
2007). PKD1 is located at chromosome 16p13.3 next to the TSC2 gene and encodes a 
4,302 amino acid membrane protein polycystin-1 (also called PC1) (The International 
Polycystic Kidney Disease Consortium, 1995) (1995). The expression pattern of PC1 in 
the kidney is not completely understood, and different results of PC1 immunostaining 
have been reported. (Geng et al., 1997; Palsson et al., 1996; Peters et al., 1996; Ward et 
al., 1996). However it is accepted that PC1 expression in the kidney is developmentally 
regulated with highest expression in the embryonic kidney and downregulated after birth. 
 
In human patients, higher PKD1 expression was found in both non-cystic kidney 
diseases (e.g. Expression data from kidney biopsies of liver disease patients: GSE50892) 
and ADPKD (Expression data from renal cysts of autosomal dominant polycystic kidney 
disease (ADPKD) patients: GSE7869) (Song et al., 2009). Previous studies have showed 
that the expression of polycystin-1 is significantly increased in the cyst-lining epithelium 
in ADPKD kidneys although it was primarily expressed intracellularly (Palsson et al., 
1996). Other groups have found higher Pkd1 levels in cystic kidney diseases in mice. For 
example, the Inv mutant mice with cystic kidney disease have an increased level of Pkd1 
expression (Expression profiling by array: GSE4462) (Sugiyama and Yokoyama, 2006). 
The Dicer conditional knockout mice also develop tubular and glomerular cyst with an 
increased level of Pkd1 expression (Patel et al., 2012). Therefore, the increased 
expression of Pkd1 in the Zeb2 cKO kidneys might be secondary to kidney disease and 
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not directly related to the function of ZEB2 as a transcription factor in the kidney. On the 
other hand, other mice models of GCKD have decreased or unchanged Pkd1 levels, 
suggesting that not all glomerular cysts would lead to an upregulation of Pkd1 mRNA 
levels (Hossain et al., 2007; Kang et al., 2009).  
 
2.6.2 Future research opportunities 
 
Do MWS patients develop GCKD? 
 
In patients, ZEB2 heterozygous loss-of-function mutations cause the MWS. We 
began our research on the role of Zeb2 in kidney development because MWS patients 
have an increased risk for kidney anomalies. However, a cystic phenotype has never been 
described in MWS patients. This discrepancy between the known phenotypes in MWS 
and the murine phenotype may be due to the difference between heterozygote and 
homozygote deletion in the kidney, or to the differences between human and mice (Elsea 
and Lucas, 2002; Routtenberg, 1995). It might also be related to the difficulty to detect 
GCKD in patients. Since nonenhanced T2-weighted magnetic resonance imaging (MRI) 
is the most sensitive tool to identify GCKD in patients, it might be indicated in patients 
with MWS (Romero et al., 1993). As more patients are diagnosed with MWS, the clinical 
presentation seems to be more variable than previously thought (Glessner et al., 2014; 
Heinritz et al., 2006) and cystic kidney disease may be eventually added to the list of 
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anomalies found in MWS, enabling a better differential diagnosis, both at the pediatric 
and the prenatal setting (Zhou et al., 2014). 
 
The renal phenotype of the Zeb2 heterozygote knockout mice is unknown 
 
The MWS is caused by heterozygote mutations in ZEB2. At the molecular level, 
the phenotype is probably due to haplo-insufficiency, meaning that the amount of the 
ZEB2 protein is not sufficient to maintain a normal development. However, the Zeb2 
heterozygous knockout mice are viable (Van de Putte et al., 2003a). Nevertheless, no 
renal analysis has been performed on these heterozygotes so far, especially in older mice 
after six months of age. Therefore, we are following a subset of heterozygotes to 
determine if they develop any renal tract phenotype.  
 
Do patients with GCKD harbor mutations in ZEB2? 
 
Heterozygous missense mutations in ZEB2 were found in some atypical forms of MWS 
(Heinritz et al., 2006). Heterozygous missense mutations or homozygous variants in 
ZEB2 may cause isolated GCKD in patients. As shown in other genetic disorders, the 
same gene can cause a variety of disorders both syndromic and non-syndromic (Kohl et 
al., 2014; Negrisolo et al., 2011; Scolari et al., 2014). Because a large number of isolated 
congenital kidney anomalies are caused by monogenic mutations, ZEB2 may be a new 
renal cystic disease gene to be added in the growing panel of genes causing kidney 
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anomalies in the future (Vivante et al., 2014). We have recently established a 
collaboration with Dr. Friedhelm Hildebrandt lab at Boston Children’s Hospital to further 
explore this research opportunity to screen the ZEB2 gene in patients with cystic kidney 
disease.  
 
Will ZEB2 lead to the discovery of more GCKD causal genes? 
 
ZEB2 is a transcription factor regulating the expression of many genes. However, 
it is unknown which genes are regulated by ZEB2 during kidney development. From the 
results generated on the ZEB2 research of other organ systems, new genes important in 
renal development and cystogenesis might be discovered unexpected (Manthey et al., 
2014b). In addition, a well designed gene expression profiling experiment with kidney 
tissues isolated from Zeb2 conditional knockout mice and wild-type controls might 
facilitate the discovery of new GCKD causal genes. Towards this direction, we have 
already started to breed Zeb2
flox+
;Six2-cre
+ 
mice with mice carrying the mT/mG construct 
(B6.129(Cg)-Gt(ROSA)26Sor
tm4(ACTB-tdTomato,-EGFP)Luo
/J) to isolate cells that express Six2-
cre in both controls and Zeb2 cKO embryos.  
 
Potential role of the Smad signaling pathway in cystogenesis 
 
Studies have shown that ZEB2 binds activated SMADs at the biochemical level, 
(Conidi et al., 2013; Postigo, 2003). For example, ZEB2 interacts with SMAD8 during 
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ocular lens development (Yoshimoto et al., 2005). In addition, ZEB2 activates Smad7 
expression during CNS myelination (Weng et al., 2012). During kidney development, 
SMAD signaling (including SMAD7 and SMAD8) is activated in the renal vesicle stage 
onward to the proximal nephron tubules (Arnold et al., 2006; Blank et al., 2008; Vrljicak 
et al., 2004).  
In addition, two gene knockout mouse models that develop glomerular cysts, the 
Wwtr1 and Glis3, encode proteins that also interact with SMADs (Hossain et al., 2007; 
Kang et al., 2009; Makita et al., 2008; Varelas et al., 2008; Yang et al., 2012). The Glis3 
mRNA level was reduced in the Zeb2 cKO embryonic kidneys at E18.5 but not at E14.5 
compared to their wild type littermates. This finding raises the possibility that the 
pathogenesis in Zeb2 cKO mice may be partially mediated by lower Glis3 expression 
level.  
Further analysis is warranted in order to define whether dysregulation of the 
SMAD signaling pathway is responsible for the development of atubular glomeruli and 
renal cystic phenotype in the Zeb2 cKO mice. 
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Potential role of the Wnt signaling pathway in the ZEB2-associated glomerular cystic 
phenotype 
 
Zeb2 represses the expression of Sfrp1, an inhibitor of Wnt signaling, in the 
mouse hippocampus (Miquelajauregui et al., 2007). Similarly, deletion of Zeb2 during 
lens development, leads to the upregulation of Dkk1, another repressor of the Wnt 
signaling pathway (Manthey et al., 2014a). Wnt signaling dysregulation has been shown 
to cause renal cystic phenotype. Overexpression of a transgenic β-catenin leads to the 
formation of renal cysts in the collecting duct, the renal tubules and the glomeruli (Saadi-
Kheddouci et al., 2001). Similarly, activation of the Wnt signaling pathway using 
conditional expression of Wnt9b in Six2-cre positive cells leads to renal tubular cyst 
formation (Kiefer et al., 2012). Although these two models upregulated the Wnt signaling 
and caused tubular cysts, it is possible that downregulation of the Wnt signaling pathway 
during nephrogenesis may also affect tubular development leading to renal cysts. 
However, the potential effect of Zeb2 deletion on the Wnt signaling during nephron 
development remains to be determined. 
 
2.7 Conclusions 
 
In conclusion, by studying animal models of a disease gene causing a human 
syndrome associated with an increased risk of kidney disease, we identified Zeb2 as a 
novel gene important in nephrogenesis and glomerulotubular junction formation. Loss of 
Zeb2 in mice results in reduced glomerulotubular integrity, congenital atubular glomeruli 
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and primary glomerular cystic disease. Future studies are needed to elucidate the 
downstream genes regulated by ZEB2 during kidney development and to characterize the 
cell type and mechanism of Pkd1 overexpression in non-cystic glomeruli. On the human 
genetics side, it will be important to determine whether MWS patients also develop 
glomerular cysts and whether a subset of patients with glomerulocystic disease carries 
ZEB2 mutations. As a transcription factor, ZEB2 may also provide a starting point for 
further identification of new genes important in glomerulotubular junction development 
and that, when mutated, may cause GCKD in patients. 
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CHAPTER THREE: Loss of Robo2 alleviates the glomerular phenotype 
of Ilk podocyte-specific knockout mice.  
 
3.1 Summary 
 
Roundabout 2 (ROBO2) is a transmembrane protein that plays an important role 
in kidney development. Recently we have shown that ROBO2 interacts with nephrin via 
an adaptor protein, NCK, and ROBO2 inhibits nephrin-induced actin polymerization. 
Integrin-linked kinase (ILK) is another important podocyte protein that interacts with 
NCK and nephrin, and promotes actin polymerization and cell adhesion. Previous studies 
have shown that podocyte-specific deletion of Ilk in mice results in proteinuria, renal 
failure and premature death. Here, we hypothesize that ROBO2 can form a complex with 
ILK in podocytes via NCK and that loss of Robo2 in podocytes would alleviate the 
abnormal glomerular phenotype in Ilk knockout mice.  
Although no direct interaction between ROBO2 and ILK was detected by yeast 
two-hybrid assay, co-immunoprecipitation analysis showed that ROBO2 and ILK form a 
protein complex through NCK and PINCH. Survival analysis of 86 mice up to one year 
revealed that Robo2-Ilk double homozygous mice survived longer than Ilk single 
homozygous mice. Electron microscopy showed that there was an improvement in 
podocyte and glomerular basement membrane ultrastructure of the Robo2-Ilk double 
homozygous mice in comparison to the Ilk single homozygous mice at 4 weeks of age. 
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Our results suggest that ROBO2 and ILK form a protein complex through NCK 
and PINCH. Loss of Robo2 improves the glomerular ultrastructure and the survival of Ilk 
podocyte-specific knockout mice. 
 
3.2 Background and Introduction 
 
As described in Chapter One, the kidney glomerular filtration barrier is formed by 
a three-layered structure: the visceral epithelial cells (i.e. podocytes), the glomerular 
basement membrane (GBM) and the endothelial cells. The podocytes are terminally 
differentiated epithelial cells that form long primary processes and a complex network of 
interdigitating secondary processes (also called foot processes) wrapping around the 
glomerular capillaries. The podocyte foot processes interdigitate and form the slit 
diaphragm structure of approximately 40-nm width to prevent the leakage of large serum 
protein (e.g. albumin) into the urine (Simons and Huber, 2008). The organization and 
regulation of the actin cytoskeleton in the podocytes are essential for the normal foot 
process structure.  
Nephrin (encoded by NPHS1 gene) is the first slit diaphragm protein identified by 
human genetic studies: mutations in NPHS1 cause congenital nephrotic syndrome of the 
Finnish type (OMIM 256300) (Kestila et al., 1998). Nephrin from the neighboring 
podocytes undergoes homophilic interaction and maintains the slit diaphragm structure 
(Wartiovaara et al., 2004). Patients and mouse models lacking nephrin exhibit severe 
proteinuria (i.e. leaking of large amounts of protein from the blood to the urine through 
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damaged glomerular filtration barrier), and foot process effacement (Kestila et al., 1998) 
that is caused by actin cytoskeleton rearrangements. Previous studies have shown that 
nephrin has an outside-in signal transducing role that affects the actin cytoskeleton of the 
foot process structure through phosphorylation of its intracellular domain (George and 
Holzman, 2012). 
In addition to forming the specialized cell junctions (i.e. the slit diaphragm) 
between the foot processes, the podocytes also adhere to the GBM through integrins. This 
adhesion and attachment of the podocytes to the GBM is essential for a functional 
glomerular filtration barrier and loss of podocytes from the GBM can lead to proteinuria 
and glomerulosclerosis. 
 
3.2.1 The glomerular basement membrane 
 
The GBM is a specialized extracellular matrix structure between the glomerular 
endothelia and the podocytes (Menon et al., 2012). It is especially thick because it derives 
from the fusion of separate extracellular matrix components produced by the podocytes 
and the endothelial cells during glomerulogenesis (Abrahamson, 1985; Miner, 2011). 
Across the GBM, water and small molecules in the blood are filtered while large plasma 
proteins such as albumin are restricted. The GBM contains laminin, type IV collagen, 
nidogen, and heparan sulfate proteoglycan agrin, components found in all basement 
membranes (Miner, 2011). Mutations in genes that encode laminin and type IV collagen 
cause inherited human kidney disease Pierson syndrome (OMIM 609049) and Alport 
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syndrome (OMIM 20378, 301050), which are associated with severe albuminuria and 
haematuria.  
 
The podocytes express GBM components laminins and type IV collagens 
 
Type IV Collagen α3α4α5 and laminin-521 are the major components of the 
GBM. They are secreted by both the glomerular endothelia and the podocytes. Both the 
type IV collagen and the laminin form the basal laminae that are about 100-200 nm thick. 
Although the early type IV collagen α1α2α1 is produced by both endothelial cells and 
podocytes, type IV collagen α3α4α5 is found in the fully mature GBM and is produced 
only by the podocytes (Abrahamson et al., 2009).  
In the Alport syndrome, the GBM is defective due to an absence of or defective 
type IV collagen α3α4α5, however the presence of type IV collagen α1α2α1 and the 
dysregulation of the laminins may also be part of the pathology (Abrahamson et al., 
2007). The defective GBM may also convey inappropriate signals to the endothelial cells 
and podocytes, which, in turn, causes progressive Alport disease (Abrahamson et al., 
2007). Additionally, changes in the GBM structure can also trigger intracellular signaling 
events that influence podocyte adhesion (Lennon et al., 2014).  
Laminin is a high molecular weight protein that forms a heterotrimeric complex 
containing an α-chain, a β-chain and a γ-chain. Laminin α2β5γ1 (also referred to as 
laminin-251 or LM-251) is the major laminin in the mature GBM, which is transitioned 
from laminin α1β1γ1 (i.e. LM-111, which is the first laminin formed in developing 
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GBM) and laminin α5β1γ1 (i.e. LM-511). The mechanisms for silencing expression of 
LM-111 and LM-511, and upregulating LM-521 during glomerular development are not 
well understood (Abrahamson, 2012).  
Integrins are the major podocyte cell adhesion proteins that interact with the 
laminin and type IV collagen in the GBM. The laminin binds integrin α3β1, whereas 
integrins α1β1 and α2β1 are the receptors for type IV collagens (Mathew et al., 2012). 
Interestingly, removal of these integrins in the podocytes also affects the GBM structure. 
Podocyte specific deletion of integrin β1 and germline knockout of integrin α3 lead to a 
splitting GBM phenotype, while integrin α2 knockout mice develop irregular GBM with 
protrusions towards the podocytes (Girgert et al., 2010; Kreidberg et al., 1996; Pozzi et 
al., 2008). In addition, deletion of the integrin-linked kinase (ILK) or constitutive 
upregulation of the Wnt signaling in mice can also lead to abnormal GBM phenotype 
(Dai et al., 2006; El-Aouni et al., 2006; Kato et al., 2011).   
 
3.2.2 The integrin linked kinase (ILK) function in the podocytes 
 
Integrin linked kinase (ILK) is a 59 kDa protein interacting with PINCH (encoded 
by LIMS1 gene) at its N-terminal and α/β/γ-PARVIN at its C-terminal (Yamaji et al., 
2001). ILK binds directly to the integrin β1 cytoplasmic tail and is important for signal 
transduction at cell adhesion sites (Hannigan et al., 1996; Ishii et al., 2001). ILK also 
plays an important role in the podocytes as Ilk podocyte-specific knockout mice develop 
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proteinuria, abnormal splitting of GBM, renal failure and premature death (Dai et al., 
2006; El-Aouni et al., 2006). 
 
ILK plays a role in actin cytoskeleton dynamics 
 
Increasing evidences suggest that ILK is a pseudokinase (Lange et al., 2009; 
Wickstrom et al., 2010), which functions as a scaffold protein and forms complexes 
connecting integrins to the actin cytoskeleton. ILK induces actin polymerization through 
a protein complex involving PARVIN, PINCH and NCK (Sakai et al., 2003; Wu and 
Dedhar, 2001). The interaction between ILK and the actin-binding protein α- PARVIN is 
required for kidney development because mutations in Ilk disrupting α-PARVIN binding 
cause renal agenesis in mice (Lange et al., 2009). Furthermore, a similar kidney 
phenotype is observed when α-PARVIN is genetically deleted in mice (Lange et al., 
2009). In the tracheal smooth muscle tissues, the assembly of the ILK protein complex at 
membrane adhesion sites regulates N-WASp-mediated actin polymerization (Zhang et 
al., 2007), which was shown to be important in the maintenance of podocytes’ foot 
processes (Schell et al., 2013). 
 
ILK and cell adhesion 
 
The assembly of a protein complex involving ILK and PINCH is important in the 
formation of cell-matrix adhesion sites (Zhang et al., 2002). Disruption of the PINCH-
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ILK complex reduces podocyte-matrix adhesion and foot process formation (Yang et al., 
2005). Accordingly, podocyte-specific Ilk deletion causes podocyte depletion as shown 
by the reduction of podocyte number in each glomerulus (Dai et al., 2006; Kanasaki et 
al., 2008). This is probably due to podocyte detachment and loss in the urine as podocyte 
specific proteins WT1 and podocin can be detected in the urine of podocyte specific Ilk 
knockout mice (Dai et al., 2006; Kanasaki et al., 2008).  
 
ILK and GBM formation 
 
ILK expression also regulates extracellular matrix formation. In the lens, deletion 
of Ilk leads to a disorganized basement membrane characterized by discontinuous and 
diffuse expression of type IV collagen and laminin (Cammas et al., 2012). Lens-specific 
deletion of Ilk also leads to an abnormal retention of collagen reactivity within the fiber 
cells (Teo et al., 2014). In the mouse cortex, ILK acts as an intracellular mediator for 
integrin-dependent basal lamina formation (Niewmierzycka et al., 2005).  
GBM phenotype in podocyte-specific Ilk knockout mice includes a splitting of the 
GBM that is similar to the phenotype reported in the integrins β1and α3 knockout mice 
(Dai et al., 2006; El-Aouni et al., 2006; Kanasaki et al., 2008). This phenotype is 
probably related to the role of ILK as a scaffold protein because the Ilk mutant mice 
without kinase activity do not have any abnormal GBM phenotype (Lange et al., 2009). 
In addition, a significant decrease of type IV collagen α3, α4 and α5 chain expression was 
observed in 12 weeks old Ilk knockout mice (El-Aouni et al., 2006). Interestingly, the 
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GBM splitting phenotype observed in the podocyte-specific Ilk knockout mice is 
reminiscent of Alport syndrome (Kalluri et al., 1997). Taken together, these results 
suggest that the GBM phenotype observed in the Ilk cKO may be caused by the 
decreased adhesion of the podocytes to the GBM combined with a dysregulation of the 
GBM composition. 
 
3.2.3 ROBO2 functions in the podocytes 
 
ROBO2 regulates actin cytoskeleton in the podocytes  
 
ROBO2 is the cell surface receptor for the repulsive guidance cue SLIT2 and 
plays crucial roles during early kidney development and ureteric bud outgrowth 
(Grieshammer et al., 2004; Lu et al., 2007b). We have recently found that SLIT2/ROBO2 
signaling also play an important role in regulating actin polymerization in the podocytes. 
ROBO2 activation reduces nephrin-linked actin polymerization through the adaptor 
protein NCK (Fan et al., 2012) (Illustration 3.1). Interestingly, Slit/Robo signaling has 
also been shown to regulate CDC42 and downstream N-WASp-mediated actin 
polymerization in neurons (Wong et al., 2001).  
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Illustration 3.1: Robo2 inhibits Nephrin-induced actin polymerization. 
A proposed model of inhibitory effects of Slit/Robo signaling on nephrin to influence 
podocyte foot process structure: Under physiological conditions (e.g., during foot process 
development), nephrin intracellular phosphorylated tyrosine domains (YDxV-p) recruit 
Nck through its interaction with the SH2 domain. Nck, in turn, recruits cytoskeleton 
regulators through its SH3 domains to promote actin polymerization. Slit2 binds Robo2 
to increase Robo2 intracellular domain interaction with SH3 domains of Nck, which 
would prevent binding of Nck to cytoskeletal regulators and result in an inhibition of 
nephrin-induced actin polymerization. Balanced actin polymerization is maintained 
during podocte development for a normal foot process structure. Abbreviations: Ig: 
Immunoglobulin domain; FN3: Fibronectin type 3 domain; SH2: Src homolog 2 domain; 
SH3: Src homolog 3 domain; CC0, CC1, CC2, CC3: Cytoplasmic Conserved region 0, 1, 
2, 3. (published in Fan et al. Cell Reports, 2012 with permission). 
 
  
93 
ROBO2 stimulation destabilizes cell adhesion 
 
The ROBO protein was named after the discovery of its role in repulsion (Seeger 
et al., 1993). In addition to its role in actin cytoskeleton regulation, SLIT-ROBO 
signaling also inhibits cell adhesion (Rhee et al., 2002). ROBO antagonizes E-cadherin 
mediated adhesion (Santiago-Martinez et al., 2008) and forms a complex with Abelson 
kinase (Abl) and N-cadherin, which induces β-catenin activation (Rhee et al., 2007). 
Activation of β-catenin in the podocytes has been shown to inhibit podocyte attachment 
to different matrices (Kato et al., 2011). Similarly, srGAP3, a Slit-Robo Rho GTPase 
activating protein, also inhibits focal adhesion (Endris et al., 2011). 
 
The Slit/Robo signaling and the ECM 
 
Our lab has found that ROBO2 is expressed on the basal podocyte surface 
adjacent to the glomerular basement membrane (Fan et al., 2012). SLIT2 is a large 
glycoprotein with a Laminin G-like module that is also called ALPS domain because it is 
present in proteins Agrin, Laminin, Perlecan and Slit (Rothberg and Artavanis-Tsakonas, 
1992). 
Interestingly, the LMX1B transcription factor regulates both the expression of 
type IV Collagen and Slit2 (Morello et al., 2001; Yan et al., 2011). SLIT2 has 2 homologs 
in mammals, SLIT1 and SLIT3, which have about 60% homology (Brose et al., 1999). In 
the Zebrafish, SLIT1 binds to the type IV Collagen, Col4α5, a major component of the 
GBM (Xiao et al., 2011). Slit3 has been shown to genetically interact with Frem1, which 
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encodes an extracellular protein, during renal development, suggesting a common 
function (Beck et al., 2013). In Drosophila cardiac morphogenesis, genetic interaction 
studies show that SLIT has a strong phenotypic interaction with integrins, laminin and 
collagen, as well as with ILK (MacMullin and Jacobs, 2006).  
Taken together, the activation of the Slit/Robo signaling in the podocytes is 
probably affected by the GBM composition. 
 
Loss of Robo2 in the podocytes has a renoprotective effect from glomerular injury  
 
Recent results from our lab suggest that loss of Robo2 in the podocytes has a 
renoprotective effect. The podocyte foot processes of the Nephrin-Robo2 double 
knockout mice were relatively preserved when compared to the Nephrin single knockout 
mice (Fan et al., 2012). Similarly, the structure of podocyte foot processes in the Robo2 
knockout mice is protected after induced glomerular injured with both nephrotoxic serum 
(NTS) and protamine sulfate (Anna Pisarek-Horowitz, manuscript in preparation). In the 
wild type mice, Slit2 and Robo2 expression is upregulated after NTS injury, suggesting 
increased Slit/Robo signaling (Anna Pisarek-Horowitz, manuscript in preparation). 
Interestingly, NTS injury is induced by the binding of heterologous antibody that 
recognizes the β1 Integrin molecule (O'Meara et al., 1992). As described previously, 
podocyte-specific deletion of integrin β1 in mice leads to a splitting GBM phenotype 
(Pozzi et al., 2008) although NTS injury does not cause GBM splitting (Anna Pisarek-
Horowitz, manuscript in preparation). 
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Taken together, loss of Robo2 in the podocytes has a renoprotective effect from 
glomerular injury. The steadiness of the foot processes after injury indicate that these foot 
processes undergo less cytoskeleton remodeling when they lack ROBO2. Following 
injury, active Slit/Robo signaling may inhibit actin polymerization and destabilize the 
adhesion of the podocytes to the GBM leading to more foot process effacement and 
detachment.  
 
3.2.4 Both ILK and ROBO2 form complexes with Nephrin through NCK  
 
Podocyte cytoskeleton plasticity is necessary for maintaining a normal functional 
kidney filtration barrier (Greka and Mundel, 2012). We have showed that ROBO2 
interacts with nephrin through NCK (Figure 3.1) (Fan et al., 2012) and NCK has been 
reported to interact with the ILK-PINCH complex (Wu and Dedhar, 2001). NCK is an 
adaptor protein that can bind an array of proteins and promote actin polymerization 
(Chaki and Rivera, 2013). Interestingly, ILK also forms a complex with nephrin (Dai et 
al., 2006) and nephrin phosphorylation regulates podocyte adhesion through the PINCH-
ILK complex (Zha et al., 2013). However, it is unclear if NCK mediates the interactions 
between ILK and nephrin to enable the complex formation. The effect of ILK loss on 
nephrin expression and distribution in the podocytes is not well-defined (Dai et al., 2006). 
NCK contains one SH2 domain in the C-terminus and three SH3 domains near the 
N-terminus. Our lab has showed that ROBO2 interacts with the first two SH3 domains of 
NCK (Fan et al., 2012). PINCH is known to bind the third SH3 domains of NCK (Tu et 
  
96 
al., 1998), while Nephrin interacts with the SH2 domain of NCK at its C-terminus (Jones 
et al., 2006). Therefore it is very likely that ROBO2 can also form a complex with ILK 
through NCK.   
 
3.3 Hypothesis 
 
Podocyte-specific deletion of Ilk leads to the development of a thick and split 
GBM. The mechanism leading to this phenotype is unclear. ILK has been shown to play 
a role podocyte adhesion and actin polymerization. We and others have shown that the 
Slit2/Robo2 signaling can destabilize cell adhesion and reduce actin polymerization. Our 
preliminary data also demonstrated that loss of Robo2 in the podocytes has a 
renoprotective effect from glomerular injury. In addition, both ILK and ROBO2 form 
complexes with podocyte protein nephrin through the adaptor protein NCK, and loss of 
Robo2 can alleviates the abnormal podocyte phenotype in nephrin knockout mice. 
Therefore, we hypothesized that ROBO2 and ILK form a protein complex, which impacts 
podocyte attachment and glomerular basement membrane integrity. 
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3.4 Materials and Methods 
 
3.4.1 Biochemical analysis of protein-protein interaction and complex formation  
 
Cell culture, His-tagged protein coprecipitation, and immunoprecipitaion were 
performed as previously described (Fan et al., 2003). Briefly, HEK cells were transfected 
with either a His-and Myc-tagged full length Robo2 construct or a His-and Myc-tagged 
mutant Robo2 construct without the NCK binding site (ΔNBD). ROBO2 was then pulled 
down with Ni-NTA beads and run in a Western gel. The gel was then immune-labeled 
with antibodies against MYC, NCK, PINCH and ILK. The DupLEX-A yeast two-hybrid 
system (OriGene Tech) was used to characterize ROBO2, ILK, PINCH and NCK1 
interaction according to manufacturer’s instructions (these experiments were performed 
by Dr. Xueping Fan). 
 
3.4.2 Mice strains 
 
The generation and genotyping of Robo2
flox/flox
 and Ilk
flox/flox
 mice conditional 
allele were described previously (Lu et al., 2007b; Terpstra et al., 2003). Ilk
flox/flox
 mice 
were kindly provided by Dr. Kenn Albrecht. Pod-Cre mice harboring the p2.5P-Cre 
transgene under the regulation of a fragment of the human NPHS2 promoter were 
purchased from the Jackson laboratories (Strain name: B6.Cg-Tg(NPHS2-cre)295Lbh/J, 
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Stock number: 008205) (Illustrations 3.2). Animal protocols were approved by the 
Institutional Animal Care and Use Committee (IACUC) at Boston University Medical 
Campus (#14388). 
 
 
 
Illustration 3.2: Alleles used to analyze genetic interaction between ILK and 
ROBO2 in the podocytes. 
(A) Representation of the Robo2 gene with the LoxP sites around exon 5 (red 
triangles). The Cre-recombinase creates an allele that undergoes nonsense 
mediated decay. 
(B) Representation of the Ilk gene with the LoxP sites between exons 4 and 5 and 
after exon 12 (red triangles). The Cre-recombinase creates an allele that 
undergoes nonsense mediated decay. 
(C) Illustration of the Cre-recombinase under the promoter of the podocin gene 
(Nphs2) 
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3.4.3 Mouse DNA extraction and genotyping 
 
Mice were genotyped from tail samples. DNA was extracted using hotshot NaOH 
method as previously described (Truett et al., 2000). All genotyping were performed 
using PCR method on a thermal cycler (MyCycler, BioRad).  
 
3.4.4 Tissue collection and preparation 
 
The mouse kidneys at defined ages were dissected and either fixed overnight in 
4% paraformaldehyde for the histology analysis, or in EM fixatives for electron 
microscopy analysis. For histological analysis, the samples were then washed 2 times in 
1xPBS on ice and preserved in 70% EtOH until they were processed for paraffin 
embedding. Serial 4-7 um tissue sections were cut using a MT-920 microtome (Microm). 
 
3.4.5 Ultrastructural analysis of the glomeruli  
 
For transmission electron microscopy, kidneys were fixed in EM fixatives 
containing 2% glutaraldehyde in 0.15 M sodium cacodylate, dehydrated in graded 
ethanol, embedded in Epon, sectioned, and stained with uranyl acetate and lead citrate. 
Ultrathin kidney sections were examined using a JEM-1011 electron microscope. For 
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scanning electron microscopy, kidneys were prepared following the standard protocol. 
The EM imaging was performed by Anna Pisarek-Horowitz. 
 
3.4.6 Survival analysis 
 
The survival rates were analyzed using the Epi Info
TM
 software (CDC, 
http://wwwn.cdc.gov/epiinfo/) and the SPSS software.  
 
3.4.7 Urine protein analysis 
 
Urine protein excretion was detected by SDS-PAGE followed by Coomassie blue 
staining and quantified using ImageJ. ELISA for nephrin levels in the urine was 
performed (by Dr. Sudhir Kumar) using a commercial ELISA kit from Exocell (Cat 
#1019). 
 
3.4.8 Histological analysis 
 
Paraffin embedded kidney sections were stained by hematoxylin and eosin and visualized 
with a Nikon or Olympus light microscope. 
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3.5 Results 
 
3.5.1 ILK and ROBO2 form a protein complex through PINCH and NCK 
 
We hypothesized that ROBO2 forms a complex with ILK. First, using yeast two-
hybrid assay as previously described (Fan et al., 2012), we were able to confirm the 
interaction between ILK and PINCH, as well as between PINCH and NCK. However, no 
direct interaction was detected between ROBO2 and ILK or PINCH, nor between ILK 
and NCK either (Figure 3.1A).    
 We then performed co-immunoprecipitation assays to test whether ROBO2 and 
ILK form a complex mediated by PINCH and NCK. Since we previously identified the 
NCK binding site in ROBO2 intracellular domain (Fan et al., 2012), we generated a 
ROBO2 construct (His-myc-Robo2-ΔNBD) that does not have the NCK binding domain 
as a negative control. Pull-down of His-myc-Robo2, but not of His-myc-Robo2-ΔNBD, 
from the HEK cell lysates with Ni-NTA beads coprecipitated NCK, PINCH and ILK 
(Figure 3.1B). These data suggest that ROBO2 form a complex with ILK through NCK 
and PINCH (Figure 3.1C). 
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Figure 3.1: Robo2 and Ilk 
form a protein complex 
through Nck and Pinch.  
(A) Yeast two-hybrid assay 
shows direct protein interactions 
between Robo2-ICD and Nck1; 
Nck1 and PINCH; PINCH and 
ILK1. ICD: intracellular domain. 
X-gal: LacZ reporter; -Leu: 
Leucine reporter; +, yeast grew; 
-, yeast did not grow. (B) Co-
precipitation assay shows His-
Myc tagged Robo2 forms protein 
complex with Nck, PINCH and 
ILK1. This protein complex is 
mediated by Nck as His-myc-
Robo2-∆NBD (delete Nck 
binding domain) does not pull 
down Nck, PINCH and ILK1. 
(C) A model of Robo2-Nck-
Pinch-Ilk protein complex in 
podocytes.  
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3.5.2 Generation of Robo2-Ilk double conditional knockout mice 
 
In order to determine if there is a genetic interaction between Robo2 and Ilk in the 
podocytes, we generated Robo2-Ilk double knockout mice. Since the both Ilk and Robo2 
germline knockout mice are not viable after birth (Sakai et al., 2003) (Grieshammer et al., 
2004; Lu et al., 2007b), we generated podocyte-specific conditional knockout mice with 
the podocin-cre transgene allele (Pod-cre) (Moeller et al., 2003) following the breeding 
scheme in Illustration 3.3. The mice were followed up for up to one year. A subset of the 
mice was euthanized at 2, 4 and 6 weeks of age which enable histological and 
ultrastructural analysis (Table 3.1). 
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Illustrations 3.3: Generation of the Robo2
flox/+
;Ilk1
flox/+
;Pod-cre
+ 
mice 
Illustration of the mice breeding scheme introducing three alleles (Ilk
flox
, Robo2
flox
 and 
Pod-cre
+
) in the same mice. 
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Table 3.1: Number of mice analyzed for phenotype and survival studies in Ilk and 
Robo2 cKO mice 
Genotype  2 weeks 
old  
4 weeks 
old  
6 weeks 
old  
survival  
Ilk
flox/flox
;Robo2
+/+
;Pod-cre
+ 
 3  22  18  39  
Ilk
+/+
;Robo2
flox/flox
;Pod-cre
+ 
   10  6   
Ilk
flox/flox
;Robo2
flox/flox
;Pod-cre
+ 
  5  19  10  47  
Ilk
+/+
;Robo2
+/+
;Pod-cre
+ 
  
Or no Pod-cre allele  
11  14  14   
 
 
3.5.3 Loss of Robo2 improves the podocyte ultrastructure of 4 weeks old Ilk cKO mice 
 
We first analyzed the podocyte ultrastructure using scanning electron microscopy 
in the kidneys of 2 weeks old knockout mice. 1/3 (33%) Ilk single cKO mice and 1/3 
(33%) Robo2-Ilk double cKO (dKO) mice displayed visible foot process abnormalities in 
comparison to Robo2 single cKO mice and wild-type controls that did not displayed any 
abnormalities (Figure 3.2). None of the 2 weeks old knockout mice developed 
proteinuria. 
We then analyzed the mice at 4 and 6 weeks of age as all Ilk single cKO mice 
developed severe proteinuria. At 4 weeks old, while 3/3 (100%) Ilk single cKO mice 
exhibited no interdigitating foot processes by scanning electron microscopy, one Robo2-
Ilk DKO mouse displayed visible interdigitating foot processes (Figure 3.3), suggesting 
partial rescue of podocyte foot process defects.  
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However, at 6 weeks of age, both Ilk cKO and Robo2-Ilk DKO exhibited similar 
severe podocyte defects without normal interdigitating foot processes (Figure 3.4). These 
results suggest that loss of Robo2 can only rescue podocyte foot process defects at early 
stage in young Ilk knockout mice.  
 
 
 
Figure 3.2: Podocyte ultrastructure (SEM) in 2 weeks old Ilk and Robo2 cKO mice 
Representative images of 2 weeks old kidneys show interdigitating foot processes in 
wild-type (n=2) (A, B), Ilk cKO (n=3) (C-E), Ilk-Robo2 DKO (n=3) (F-H) 
and Robo2 cKO mice (n=2) (I, J). All the images are obtained from scanning electron 
microscopy at a 15,000x magnification. Each image was taken from a different mouse. 
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Figure 3.3: Loss of Robo2 improves the podocyte ultrastructure of the 4 weeks old 
Ilk
flox/flox
;Pod-cre
+ 
mice. 
(A-D) Representative images of scanning electron microscopy at 7000x magnification in 
4 weeks old mouse kidneys show podocyte foot process structure in (A) wild-type, (B) 
Ilk single cKO (n=3), (C) Robo2-Ilk DKO (n=1), and (D) Robo2 single cKO mice. (E-H) 
High 15000x magnification images of (A -D) show podocyte foot process structure. The 
foot processes in the Ilk cKO are not visible because of the abnormal long cellular 
protrusions or microvilli (B and F). Both Ilk single cKO and Robo2-Ilk DKO mice had 
severe proteinuria at 4 weeks old. 
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Figure 3.4: Podocyte ultrastructure (SEM) in 6 weeks old Ilk and Robo2 cKO mice 
Representative images of 6 weeks old kidneys show interdigitating foot processes in 
wild-type (n=1) (A), Ilk cKO (n=2) (B, C), DKO (n=2) (D, E). All the images are 
obtained from scanning electron microscopy at a 7,000x magnification. Each image was 
taken from a different mouse. 
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3.5.4 Loss of Robo2 alleviates the thickening and splitting phenotype of the glomerular 
basement membrane in young Ilk knockout mice 
 
Previous studies show that podocyte-specific Ilk deletion leads to GBM 
thickening and splitting (Dai et al., 2006; El-Aouni et al., 2006). We performed 
transmission electron microscopy (TEM) analysis of Ilk knockout mice and found the 
same GBM thickening and splitting phenotype in 4 weeks old Ilk single cKO mice 
(Figure 3.5). Interestingly, the GBM width of the Ilk-Robo2 double knockout mice 
decreased without obvious GBM splitting phenotype compared to the littermate Ilk single 
cKO mice (Figure 3.5). These data suggest that loss of Robo2 alleviates the thickening 
and splitting phenotype of the GBM in young Ilk knockout mice.  
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Figure 3.5: Loss of Robo2 decreases GBM thickening and splitting in 4 weeks old 
Ilk
flox/flox
;Pod-cre
+
 single cKO mice. 
Transmission electron micrographs of 4 weeks old mouse glomeruli show abnormal 
irregular GBM thickening and splitting with electron-lucent areas (arrow) in 
Ilk
flox/flox
;Pod-cre
+ 
single cKO (n=2), while the GBM in Ilk
flox/flox
;Robo2
flox/flox
;Pod-cre
+ 
double knockout mice (n=2) show relatively normal thickness without GBM splitting 
phenotype (arrows). Mouse genotype and TEM magnifications are shown.  
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3.5.5 Loss of Robo2 increases the median survival of Ilk cKO mice 
 
To determine if loss of Robo2 would affect the life span of Ilk cKO mice, we 
analyzed the survival of the Ilk cKO mice and the Ilk-Robo2 DKO mice up to one year 
old. An intermediate analysis was performed when the first mice reached one year old. At 
this point, the survival of 21 Ilk 
flox/flox
;Robo2 
flox/flox
;Pod-cre
+ 
 DKO mice and 23 Ilk 
flox/flox
;Pod-cre
+ 
 single cKO mice were analyzed. The Kaplan-Meyer analysis showed that 
the Ilk-Robo2 DKO survived significantly longer than the Ilk single cKO (p<0.05 
Wilcoxon test, p=0.0662 Log-Rank test) (Figure 3.6 and Table 3.2).  
To increase the power of survival analysis, we doubled the number of mice in 
each group and followed them up to one year. After Kaplan-Meyer survival analysis, I 
found that 24 of the 47 (50%) Ilk-Robo2 DKO mice survived more than 161 days while 
20 of the 39 (50%) Ilk single cKO mice died due to renal failure by the age of 106 days 
(Figure 3.7A). This result indicated that loss of Robo2 extended the median survival from 
106 days in Ilk single knockout mice to 161 days in Ilk-Robo2 podocyte-specific double 
knockout mice, a gain of 50% of life span (Figure 3.7B).  
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Figure 3.6: Intermediate  analysis of survival showed that loss of Robo2 improves 
the survival of Ilk cKO Mice. 
Kaplan-Meyer analysis of the first group of mice followed up to one year showed that the 
Ilk 
flox/flox
;Robo2 
flox/flox
;Pod-cre
+ 
 DKO (n=21 mice, green) lived longer than the Ilk 
flox/flox
;Pod-cre
+ 
single cKO (n=23 mice, red). 
 
Table 3.2: Statistical analysis of the survival in the first set of mice (n>20) 
Test  Statistic  D.F.  P-Value  
Log-Rank  3.3743 1 0.0662 
Wilcoxon  4.7571 1 0.0292 
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Figure 3.7: Loss of Robo2 improves the median survival of podocyte-specific single 
Ilk knockout mice. 
(A) Kaplan-Meyer survival analysis of all the mice followed up to one year showed that 
24 out of total 47 (50%) Ilk
flox/flox
;Robo2
flox/flox
;Pod-cre
+ 
DKO (red line) lived to 161 days 
while 20 out of total 39 (50%) Ilk
flox/flox
;Pod-cre
+ 
single cKO (blue line) lived to only 106 
days. (B) The comparison of median survival of 106 days in the Ilk
flox/flox
;Pod-cre
+ 
single 
cKO mice (ILK blue bar) and 161 days in the Ilk
flox/flox
;Robo2
flox/flox
;Pod-cre
+ 
DKO mice, 
a gain of 50% life span. 
 
3.5.6 Loss of Robo2 did not significantly affect proteinuria prevalence and renal 
histology in 4-6 weeks old Ilk podocyte-specific knockout mice 
 
To determine if loss of Robo2 would improve the proteinuria phenotype in the Ilk single 
cKO, I analyzed the proteinuria prevalence in Ilk single cKO and Ilk-Robo2 DKO mice at 
4 weeks and 6 weeks old by visualizing the presence of albumin in the urine. At 4 weeks 
old, while 25/32 (72%) Ilk single cKO mice developed proteinuria, 20/29 (62%) Ilk-
Robo2 DKO mice also had similar amount of albumin in the urine. At 6 weeks, 13/20 
  
114 
(65%) of Ilk single cKO mice and 14/17 (82%) of Ilk-Robo2 DKO mice developed 
proteinuria (Figure 3.8). Consistent with these results, renal histology analysis revealed 
that similar amounts of proteinaceous casts were observed in both Ilk single cKO and Ilk-
Robo2 DKO at 4 weeks and 6 weeks old (data not shown). Taken together, these findings 
suggest that loss of Robo2 did not significantly affect the proteinuria prevalence and renal 
histology in 4-6 weeks old Ilk podocyte-specific knockout mice.  
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Figure 3.8: No significant difference in proteinuria between the Ilk-Robo2 DKO 
mice and the Ilk single cKO mice at 4 weeks. 
(A) Both Ilk-Robo2 DKO and Ilk single cKO mice developed proteinuria at 4 weeks. The 
proteinuria was assessed by detecting urine albumin on SDS page gel and visualized by 
Coomassie blue staining. 1ul urine was loaded in each lane. (B) Each sample was scored 
as positive or negative (with or without proteinuria). No difference of proteinuria 
prevalence was observed at 4 weeks and 6 weeks between the Ilk
flox/flox
;Robo2
flox/flox
;Pod-
cre
+ 
double cKO mice (DKO, red, n=29 at 4 weeks and n=17 at 6 weeks) and the 
Ilk
flox/flox
;Pod-cre
+ 
single cKO mice (Ilk cKO, blue, n=32 at 4 weeks, n=20 at 6 weeks). 
 
3.5.7 Loss of Robo2 does not affect the podocyte loss phenotype in 4 weeks old Ilk 
podocyte-specific knockout mice 
 
Ilk single cKO mice have been reported to have podocyte loss (Dai et al., 2006). 
To determine if loss of Robo2 would affect the podocyte loss phenotype in the Ilk cKO 
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mice, we measured the levels of nephrin in the urine as a biomarker for podocyte loss. 
Preliminary analysis of nephrin levels in the urine from four 4-week old mice with 
proteinuria did not reveal any difference between the Ilk single cKO and the Ilk-Robo2 
DKO mice (data not shown). This finding suggests that loss of Robo2 does not affect the 
podocyte loss phenotype in 4 weeks old Ilk podocyte-specific knockout mice. 
 
3.6 Discussion 
 
In this project, we found that ROBO2 forms a complex with ILK through NCK 
and PINCH, supporting an indirect physical interaction between ROBO2 and ILK in 
vitro. We then investigated the genetic interaction between ILK and ROBO2 in vivo 
using podocyte-specific knockout mice of both genes. Our animal model studies revealed 
that loss of Robo2 improved the survival of the Ilk cKO mice, although the statistical 
significance was obvious only in a sub-group of animals between 10-35 weeks old. At the 
ultrastructural level, loss of Robo2 in the podocytes alleviates the foot processes and 
GBM phenotype in 4 weeks old Ilk cKO mice. However, more samples and 
quantification are needed to confirm this finding. Although no clear difference of 
proteinuria and renal histology were found between the Ilk cKO and Ilk-Robo2 DKO, our 
findings suggest that loss of Robo2 alleviates the phenotype of the Ilk cKO mice. 
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3.6.1 Loss of Robo2 improved the survival of the Ilk single cKO 
 
Despite the large variability in the phenotype of the Ilk cKO mice, the median 
survival of the mice was 50% longer in Ilk-Robo2 double knockout mice as compared to 
Ilk single knockout mice. This result supports a genetic interaction between ILK and 
ROBO2. Consistent with this finding, SLIT, ROBO ligand, has also been reported to 
genetically interact with ILK in Drosophila (MacMullin and Jacobs, 2006). 
Alleviation of a phenotype in animals, in which the double-mutant phenotype is 
less severe than expected, often reflects that the proteins of interest act within the same 
pathway (Mani et al., 2008). We also found that ROBO2 and ILK can form a protein 
complex in vitro, which depends on the NCK-binding-site in the ROBO2 intracellular 
domain, further supporting the possibility that ILK and ROBO2 act within the same 
pathway. We may refer to the phenotype of the Ilk-Robo2 DKO mice as a partial 
suppression of the Ilk single cKO phenotype (St Onge et al., 2007). It indicates that the 
deleterious effect of loss of ILK in the podocytes is partially due to the presence of 
ROBO2. 
 
3.6.2 Loss of ROBO2 improves the GBM phenotype of the Ilk cKO mice. 
 
In addition to the survival benefit, the partial rescue of the Ilk cKO phenotype by 
the deletion of Robo2 was also observed in the glomeruli at the ultrastructural level. At 4 
weeks, loss of Robo2 in the podocytes alleviated the GBM thickening and splitting 
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phenotype of Ilk cKO mice. Because we obtained these data with limited numbers of 
mice, additional studies on more kidney samples together with GBM width quantification 
are needed to confirm this GMB finding. Nonetheless, this alleviation of the GBM 
phenotype suggests that ROBO2 plays a role in the GBM phenotype of the Ilk cKO mice. 
Deletion of ILK in the podocytes may affect the GBM by decreasing podocytes adhesion 
to the GBM and by affecting the secretion of the extracellular matrix proteins. ROBO2 
may also play a role in both processes. 
 
3.6.3 Loss of ROBO2 improve the life span of the Ilk cKO mice 
 
Although the median survival of Ilk-Robo2 DKO is 50% longer than the Ilk single 
cKO, we did not observe any survival advantage in Ilk-Robo2 DKO in the first 10 weeks 
of life, and the survival analysis for the entire one year period using the Wilcoxon and the 
Log-Rank tests did not reach a statistical significance (Figure 3.7). One of the reasons for 
the lack of statistical difference is the wide variability in the phenotype of both the Ilk 
single cKO mice and the Ilk-Robo2 DKO mice. The effect of Ilk deletion in the podocyte 
ranges from severe lethal phenotype (e.g. renal failure at 6 weeks old) to relative milder 
renal phenotype (e.g. no proteinuria at one-year old). This difference probably due to the 
mixed genetic background used in this study. The mice that died before the age of 10 
weeks probably carried genetic variants that increased the severity of the Ilk deletion, 
while the mice that survived more than 35 weeks probably carried genetic variants 
attenuating the deleterious effect of lack of Ilk in the podocytes. Genomic comparison 
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between the mice surviving less than 10 weeks and those surviving more than 35 weeks 
may reveal important modifying genes in podocytopathies. Interestingly, sub-group 
analysis of mice that survived between 10 and 35 weeks showed that the life span of Ilk-
Robo2 DKO mice was significantly improved when compared to Ilk single cKO mice 
(Log Rank p-value<0.05; data not shown), suggesting that, in addition to podocyte foot 
process and GBM structure, loss of Robo2 did alleviate Ilk knockout phenotype even 
when hard outcome such like survival is used as the endpoint. 
 
3.6.4 ILK and ROBO2 may have opposite effects on cytoskeleton remodeling, cell 
adhesion and glomerular basement membrane composition 
 
Actin cytoskeleton remodeling 
 
The partial suppression of the Ilk single cKO phenotype by the deletion of Robo2 
may be related to their opposite roles in actin cytoskeleton remodeling. As described 
earlier, the podocyte cytoskeleton remodeling is a key factor in normal kidney function 
(Schell et al., 2013).  
While ILK signaling has been shown to increase N-WASp-mediated actin 
polymerization (Zhang et al., 2007), Slit/Robo signaling can decrease N-WASp-mediated 
actin polymerization (Wong et al., 2001). Since ILK also forms a complex with nephrin 
(Dai et al., 2006), it may prevent ROBO2 inhibition of nephrin-mediated actin 
polymerization and thereby counterbalance ROBO2 activity.  
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Cell adhesion 
 
Proper adhesion of the podocytes to the GBM is needed for the maintenance of 
the GBM structure as suggested by the phenotype of the mice lacking integrins. Both ILK 
and ROBO2 have been shown to affect cell adhesion. The assembly of a complex 
involving ILK and PINCH is important in the formation of cell-matrix adhesion sites 
(Zhang et al., 2002), while Slit/Robo activation inhibits cell adhesion (Rhee et al., 2002). 
The opposite roles of ILK and ROBO2 on cell adhesion further indicate that they can 
balance each other’s activities. Therefore, deletion of Robo2 in the Ilk deficient podocytes 
may partially restore the adhesion of the podocytes to the GBM because a new balance 
on cell adhesion signaling is reached (Illustration 3.4).  
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Illustration 3.4: ILK and ROBO2 have opposite roles on podocyte structure and 
function. 
(A) ILK and ROBO2 have opposite roles both on cell adhesion and on actin cytoskeleton 
regulation. (A) The podocyte (in green color), expresses both ILK (red) and ROBO2 
(yellow), which reach a balance on cell adhesion and actin cytoskeleton regulation. (B) In 
the Ilk
flox/flox
;Pod-Cre
+ 
podocytes, active Slit2/Robo2 signaling leads to more detachment 
and less active polymerization in the podocytes, resulting in foot process effacement. (C) 
In the absence of both ILK and ROBO2 (i.e. double knockouts), both opposing roles are 
lacking and a new balance is reached in the podocytes, enabling less detachment and 
better actin cytoskeleton structures. 
 
Basement membrane modeling 
 
In other organ systems, ILK was shown to mediate the regulation of basal lamina 
formation and collagen’s secretion (Cammas et al., 2012; Niewmierzycka et al., 2005) 
(Teo et al., 2014). Changes in the GBM composition may activate ROBO2, which may 
have deleterious effects (Fan et al., 2012). The possible role of the Slit/Robo signaling on 
GBM formation or maintenance has to be further investigated. 
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3.7 Limitations 
 
Regarding the genetic interaction analysis, the Ilk single cKO mice have a very 
heterogeneous phenotype in terms of severity of podocyte defects and life span (Dai et 
al., 2006; El-Aouni et al., 2006; Kanasaki et al., 2008). In this study, some of the Ilk 
single cKO mice survived up to a year without kidney failure, suggesting the role of 
modifier genes protecting the podocytes from the loss of ILK. ROBO2 might be one of 
these modifiers and its absence can further affect the phenotype in the Ilk cKO mice. The 
heterogeneity in the phenotype of the Ilk cKO mice may hamper the data analyses in this 
project as normal phenotype in Ilk-Robo2 DKO mice could be associated with a genetic 
background that alleviates the effect of the ILK deletion in the podocytes. Future 
experiments on backcross of Ilk and Robo2 KO mice into a congenic mouse strain with 
the same genetic background may address this limitation.  
 
Albuminuria as a marker of kidney function 
 
The validity of using albuminuria as a surrogate marker for kidney function has 
been controversial (Levey et al., 2009). We did not find a reduced prevalence of 
proteinuria in the Ilk-Robo2 DKO mice when compared to Ilk single cKO mice, despite 
an improvement in podocyte ultrastructure and survival. This discrepancy between the 
two observations may reflect the heterogeneity of the phenotypes as well as the lack of 
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sensitivity of the proteinuria analysis, as detected with Coomassie Blue staining. In order 
to assess its prognostic value, a sensitive proteinuria assay and a large number of urine 
samples are needed. We have collected all the urine samples from mice that were 
followed for survival analysis during the course of this project. A retrospective analysis 
of albuminuria using a sensitive ELISA assay on these collected urine samples may 
uncover its predictive value.   
   
Renal Histology 
 
Because of the high variability of phenotype in the Ilk cKO mice, and the inability 
to determine whether a 4 weeks old mouse would develop a severe course of disease or a 
relatively minor disorder, I analyzed the renal histology only in four weeks old mice with 
proteinuria. These mice probably represent a biased group of mice with the more severe 
renal phenotype as no survival benefit of Ilk-Robo2 DKO was observed in the first 10 
weeks of life compared to the Ilk single cKO. Together with the limited sensitivity of 
H&E histology analysis, we may consider to select mice between 10-35 weeks old in 
order to detect a difference on renal histology. In addition, a counting of the podocyte 
number may represent a more sensitive approach to identify differences between the Ilk 
single cKO and the Ilk-Robo2 DKO mice. 
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3.8 Conclusions 
 
Our results in this project suggest that ROBO2 and ILK form a protein complex 
through NCK and PINCH in podocytes. Loss of Robo2 improves the podocyte and GBM 
ultrastructure and the survival of Ilk podocyte-specific knockout mice. The possible 
improvement of GBM thickening and splitting phenotype in the Ilk-Robo2 DKO mice as 
compared to the Ilk single cKO mice may be explained by increased attachment of the 
podocytes to the GBM, differential cytoskeleton modeling and/or by a change in the 
expression of extracellular proteins. Further experiments are needed to examine these 
mechanisms. Together, our results suggest that ILK and ROBO2 act in a common 
pathway in the podocytes and loss of Robo2 alleviates the glomerular phenotype of Ilk 
podocyte-specific knockout mice.   
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CHAPTER FOUR: SLIT2/ROBO2 signaling regulates extracellular matrix gene 
expression during early ureteric bud outgrowth 
4.1 Summary 
 
ROBO2 is the cell surface receptor for the repulsive guidance cue SLIT2. 
Mutations in ROBO2 and SLIT2 are associated with congenital anomalies of the kidney 
and urinary tract (CAKUT) in humans and mice. Previous studies show that ROBO2 is 
expressed in the metanephric mesenchyme (MM) and SLIT2 is expressed in the ureteric 
bud (UB), and SLIT2-ROBO2 signaling is required for early UB outgrowth in mice and 
restricts the UB to a single site on the Wolffian duct (WD). Mouse mutants without either 
Slit2 or Robo2 develop supernumerary UBs, abnormal ureterovesical junctions, 
multicystic dysplastic kidney, and die after birth from severe hydronephrosis and renal 
failure. However, the molecular mechanism of UB outgrowth defects in Robo2 and Slit2 
knockout mice remains unknown.  
To test the hypothesis that loss of SLIT2-ROBO2 signaling may affect the 
expression of genes that are important in controlling early UB outgrowth, we performed 
microarray gene expression analysis using Affymetrix GeneChip on early MM and UB 
tissues isolated from E10.5 and E11.5 Robo2 and Slit2 knockout mouse embryos.  
Although we did not detect significant change in the mRNA expression of any 
single gene, Gene Set Enrichment Analysis (GSEA) revealed that the expression of 
several gene-sets, all related to the extracellular matrix (ECM) proteins, were down-
regulated in E10.5 and E11.5 Slit2 and Robo2 knockout embryos as compared to their 
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wild type littermate controls. Specifically, Laminins and Collagens were significantly 
downregulated coordinately in the Slit2 and Robo2 knockout embryos. This result was 
further confirmed by the Ingenuity Pathway Analysis (IPA), a different analysis approach 
to identify the top canonical pathways and upstream regulators that are predicted to be 
associated with the dataset.  
Our findings suggest that SLIT2-ROBO2 signaling may induce the expression of 
ECM genes in the MM during early UB outgrowth. This regulation of the ECM around 
the WD may prevent multiple ectopic UB formation. Further experiments are needed to 
confirm this novel finding. 
 
4.2 Background and Introduction 
 
4.2.1 Ureteric bud outgrowth  
 
Development of the kidney and the ureter begins when an epithelial outpouching 
called ureteric bud (UB) sprouts from the caudal region of the Wolffian duct (also called 
mesonephric duct) and invades the adjacent metanephric mesenchyme (MM) (Illustration 
4.1). This process is initiated around 4 weeks of gestation in human and at embryonic 
10.5 days (E10.5) in mouse.  
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Illustration 4.1: Ureteric bud outgrowth 
The ureteric bud in green grows out from the Wolffian duct into the metanephric 
mesenchyme (Rasouly and Lu, 2013). 
 
The UB invasion into the MM is tightly controlled to prevent UB outgrowth 
defects such as ectopic ureteric buds, multiple ureteric buds or absence of budding 
(Dressler, 2009). Mutations in genes controlling early UB formation and positioning 
often cause congenital anomalies of the kidney and urinary tract (CAKUT) phenotypes, 
which include urinary obstruction, VUR, hydronephrosis, short duplex ureter, duplex 
kidney, ectopic and multicystic dysplastic kidney (MCDK) in both human and mouse 
(Table 4.1) (Airik and Kispert, 2007; Basson et al., 2005; Batourina et al., 2005; 
Grieshammer et al., 2004; Hains et al., 2010; Kume et al., 2000; Lu et al., 2007b; Lu et 
al., 2007c; Mackie et al., 1975; Mendelsohn, 2009; Miyazaki et al., 2000; Murawski and 
Gupta, 2006; Uetani and Bouchard, 2009; Wang et al., 2011). 
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Table 4.1: Mutations in genes controlling early ureteric buds outgrowth in human 
and mouse 
Gene  Chr Exp Type of 
protein 
Signaling Human disease 
 (OMIM) 
Urinary tract 
defects in 
animal models 
Ref 
L1CAM Xq28 ue Adhesion 
molecule 
  Ectopic UB, 
duplex ureters, 
megaureter, 
hydronephrosis  
(Debiec et 
al., 2002) 
AGTR2 Xq22-
q23 
um G-protein 
coupled 
angiotensin II 
receptor 
RAS X-linked 
mental 
retardation-88 
(OMIM 
300852) 
Ectopic UB, 
duplex ureters, 
hydroureter, 
hydronephrosis 
(Nishimur
a et al., 
1999) 
NFIA 1p31.3-
p31.2 
ue, 
um 
Nuclear 
Factor 1 
transcription 
factor 
 Chromosome 
1p32-p31 
deletion 
syndrome  
(OMIM 
613735) 
duplex ureters, 
VUR, UPJ 
defects, 
hydroureter, 
hydronephrosis, 
megaureter 
(Lu et al., 
2007a) 
ROBO2 3p12.3 mm Slit receptor, 
Ig 
superfamily 
Robo/ 
Slit 
Vesicoureteral 
reflux 2  
(OMIM 
610878) 
Ectopic UB, 
multiple ureters, 
hydroureter, 
hydronephrosis 
(Griesham
mer et al., 
2004; Lu 
et al., 
2007b) 
SLIT2 4p15.2 ue Secreted 
protein -Robo 
ligand 
Robo/ 
Slit  
 Ectopic UB, 
multiple ureters, 
hydroureter, 
hydronephrosis 
(Griesham
mer et al., 
2004) 
SCARB2 4q21.1  glycoprotein    Kidney and 
ureter 
duplication, 
UPJ 
obstruction, 
hydroureter, 
and 
hydronephrosis 
(Gamp et 
al., 2003) 
SPRY1 4q28.1 wd, 
mm 
Receptor 
Tyrosine 
Kinase 
antagonist 
GDNF/ 
RET  
 Ectopic UB, 
multiple ureters, 
hydroureter, 
hydronephrosis 
(Basson et 
al., 2005) 
GGDNF 5p13.2 mm glial cell line-
derived 
neurotrophic 
factor 
GDNF/ 
RET 
 Renal agenesis (Sanchez 
et al., 
1996) 
FOXC1 6p25 um Forkhead 
transcription 
factor 
Foxc  Axenfeld-
Rieger 
syndrome type 
3 (OMIM 
602482) 
Ectopic UB, 
duplex ureters, 
hydroureter, 
hydronephrosis 
(Kume et 
al., 2000; 
Weisschu
h et al., 
2008) 
Micro-
deletion  
8p11.23-
p11.22 
   Kallmann 
syndrome 2 
 (Levy and 
Knudtzon, 
1993) 
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FGFR1 (OMIM 
147950): VUR 
and ureters 
duplication 
GATA3 10p15  Transcription 
factor 
Wnt  Hypoparathyro
idism-
deafness-renal 
syndrome  
(OMIM 
146255) 
Ectopic UB, 
duplex kidneys, 
enlargement of 
the vas 
deferens, loss of 
uterus 
(Grote et 
al., 2008) 
RET 10q11.21 wd Receptor 
tyrosine 
kinase 
GDNF/ 
RET 
Renal agenesis  
(OMIM 
191830) 
Renal agenesis  (Schuchar
dt et al., 
1994) 
PAX2 10q24 wd, 
ue, 
mm 
Transcription 
factor 
 Papillorenal 
syndrome  
(OMIM 
120330) 
Caudal ureteric 
bud, reflux, 
hydroureter 
(Murawsk
i et al., 
2007) 
BMP4 14q22-
q23 
um Secreted 
molecule- 
TGF-β family 
TGF-β   Ectopic UB, 
duplex ureters, 
ectopic UVJ, 
hydroureter 
(Miyazaki 
et al., 
2000) 
SALL1 16q12.1 mm Spalt-Like 
Transcription 
Factor 1 
Wnt Townes-Brocks 
syndrome 
(OMIM 
107480) 
incomplete uret
eric bud outgro
wth 
(Nishinak
amura et 
al., 2001) 
FOXC2 16q24.1 um Forkhead 
transcription 
factor 
 
Foxc   Ectopic UB, 
duplex ureters, 
hydroureter, 
ureter agenesis 
(Kume et 
al., 2000) 
 
Abbreviations: Chr: chromosomal location; Exp: expression in the urinary tract; 
Signaling: signaling pathway; Ref: References; UB: ureteric bud; TGF-β: transforming 
growth factor-β; VUR: vesicoureteral reflux; RAS: Renin-angiotensin system; UVJ: 
ureterovesical junction; uro: urothelium; UPJ: ureteropelvic junction; wd: Wolffian duct; 
ub: ureteric bud; ue: ureteric epithelium; um: ureteric mesenchyme; smc: smooth muscle 
cells 
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4.2.2 Genes associated with abnormal UB outgrowth  
 
The Glial cell-derived neurotrophic factor (GDNF) encodes a highly conserved 
secreted protein in the MM and induces UB outgrowth during early kidney and ureter 
development (Costantini, 2010; Costantini and Kopan, 2010). It is the most important 
inducer of UB outgrowth and its activity is thought to depend on its receptor RET 
(Costantini, 2010; Costantini and Kopan, 2010) Loss of Gdnf in mice causes absence of 
UB formation and renal agenesis phenotype (Sanchez et al., 1996). Therefore, mutations 
in genes associated with the Gdnf/Ret pathway, like Spry1, Gata3, Bmp4, Slit2/Robo2, 
Foxc1/2, Pax2, Eya1/Six1, and Sall1, all cause abnormal UB outgrowth phenotypes in 
mice (Illustration 4.2) (Basson et al., 2005; Grieshammer et al., 2004; Grote et al., 2008; 
Kiefer et al., 2010; Kume et al., 2000; Lu et al., 2007b; Lu et al., 2007c; Miyazaki et al., 
2000; Nie et al., 2011; Nishinakamura et al., 2001; Xu et al., 1999) . 
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Illustration 4.2 : Genes and signaling pathways involved in UB outgrowth. 
Genes and signaling pathways involved in UB outgrowth. Scheme of signaling pathways 
in and between the ureteric bud (green) and the metanephric mesenchyme (yellow-
orange). The most important inducer of UB outgrowth is GDNF and its receptor RET. 
Ret is expressed by the nephric duct (green) and ureteric bud (green). GDNF is secreted 
by the metanephric mesenchyme (yellow). The coordination of different signaling 
pathways in the anterior mesenchyme and the metanephric mesenchyme play a crucial 
role in the development of a single ureteric bud (Rasouly and Lu, 2013). 
 
GDNF is expressed in the metanephric mesenchyme (Grieshammer et al., 2004). 
In human and rodents, the GDNF mRNA is alternatively spliced: a full-length transcript 
[pre-(α)pro-GDNF] and a shorter transcript [pre-(β)pro-GDNF] that lacks 78 bp in the 
region encoding the pro-domain, and both GDNF mRNA are expressed during kidney 
development (Lonka-Nevalaita et al., 2010). GDNF is synthesized in the form of a 
precursor called pre-pro-GDNF that can be proteolytically cleaved (Lin et al., 1993). 
Interestingly, GDNF can be secreted as either cleaved or uncleaved form. It is cleaved by 
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FURIN inside the cell but not by matrix metalloproteases (Lonka-Nevalaita et al., 2010). 
The cleavage of other neurotrophic proteins has been shown to change their function, 
sometimes into opposite ones (Je et al., 2012). It is unknown which form of GDNF is 
expressed in the MM during early kidney development. 
PAX2 (Paired Box 2) induces Gdnf expression (Brophy et al., 2001). 
Heterozygote mutations in PAX2 cause the papillorenal syndrome (OMIM 120330) that 
is associated with a range of CAKUT phenotypes. PAX2, EYA1 and HOX11 form a 
complex that regulates Gdnf expression (Gong et al., 2007). Pax2 is expressed in the 
pronephros, the UB and the MM, and Pax2 knockout mice have a complete renal 
agenesis phenotype (Dressler et al., 1990).  
SPRY1 (sprouty homolog 1) acts as a negative feedback molecule to inhibit the 
GDNF/RET signaling in the UB. In mice, mutations in Spry1 cause multiple ureteric 
buds and hydroureter (Basson et al., 2005). Accordingly, loss of Spry1 is able to increase 
GDNF/RET signaling activity and rescue mouse UB phenotype in the Gdnf or Ret 
knockout mice (Michos et al., 2010; Rozen et al., 2009). However, no SPRY1 mutations 
have been identified so far in CAKUT patients (van Eerde et al., 2007). 
CAKUT like phenotype such as ureteral stenosis has been described in patients 
with Axenfeld-Rieger syndrome (OMIM 602482) (Weisschuh et al., 2008), which is 
caused by mutations in the FOXC1 (forkhead box C1) gene. Interestingly, Foxc1 has 
been found highly expressed in mouse MM and mutations of mouse Foxc1 and its family 
member Foxc2 result in expansion of Gdnf expression domain in the MM, leading to 
ectopic ureteric bud, duplex ureter, and hydroureter phenotype (Kume et al., 2000). 
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The Townes-Brocks syndrome is caused by heterozygous mutations in the SALL1 
(spalt-like transcription factor 1) gene. Homozygous Sall1 knockout mice develop an 
incomplete UB outgrowth phenotype with increased apoptosis in the MM 
(Nishinakamura et al., 2001). Sall1 mutant mice have a reduced expression of GDNF at 
E11.5, but no difference was observed at E10.5, suggesting SALL1 regulates GDNF 
expression indirectly in the MM after UB outgrowth (Nishinakamura et al., 2001). Over-
expression of Sall1 in mouse metanephric mesenchyme using Six2-cre did not result in a 
kidney anomaly phenotype (Jiang et al., 2010). 
Slit2-Robo2 signaling also plays crucial roles in early ureteric bud outgrowth and 
positioning. Human ROBO2 mutations have been identified in CAKUT patients from 
several unrelated families (Bertoli-Avella et al., 2008; Lu et al., 2007b). Mouse 
knockouts that lack either Slit2 or Robo2 develop supernumerary UB, duplex kidney and 
hydroureter phenotype (Grieshammer et al., 2004; Lu et al., 2007b). Robo2 is a member 
of the immunoglobulin superfamily and encodes a cell adhesion molecule involved in 
axonal guidance and neurogenesis (Dickson and Gilestro, 2006; Fricke et al., 2001). It is 
a receptor for the SLIT2 protein (Brose et al., 1999), and the Slit2-Robo2 signaling acts 
as a chemorepulsive guidance cue to control axon pathfinding and neuron migration 
during nervous system development (Tessier-Lavigne and Goodman, 1996). Robo2 is 
thought to inhibit Gdnf expression (Grieshammer et al., 2004). Like Gdnf, Robo2 is 
expressed in the MM of the nephrogenic zone (Grieshammer et al., 2004; Piper et al., 
2000), while Slit2 is expressed in the nephric duct and UB (Grieshammer et al., 2004). 
However, the function and molecular regulation of the Slit2/Robo2 signaling during 
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ureteric budding remain unknown. When Robo2 was deleted specifically in the MM 
using either Rarb2-cre or Six2-cre, the homozygous conditional knockout mice did not 
develop a multiple ureteric bud phenotype (Weining Lu, unpublished data). 
 
Since PAX2 and ROBO2 have opposite effects on Gdnf expression during UB 
outgrowth (Brophy et al., 2001; Grieshammer et al., 2004), we hypothesized that Robo2 
and Pax2 operate in vivo in a common genetic pathway to regulate Gdnf expression and 
UB outgrowth during mouse kidney development. However, after examination of 
potential genetic interaction in vivo between Robo2 and Pax2 using three different 
approaches, we did not find any evidence that ROBO2 and PAX2 function in a common 
genetic pathway (data not shown).  
 
 
4.3 Hypothesis 
 
The expression of Gdnf is changed in MM during UB outgrowth in both Slit2 and 
Robo2 knockout mice; however the mechanism leading to such change is unknown. We 
hypothesized that the Slit2/Robo2 signaling affects extracellular matrix components gene 
expression in the metanephric mesenchyme (as it affects extracellular matrix of the GBM 
in Ilk cKO mice) to control the UB outgrowth. To test this hypothesis, we performed 
microarray gene expression analysis using Affymetrix GeneChip Mouse Gene 1.0 ST 
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Array on early MM and UB tissues collected from E10.5 and E11.5 Robo2 and Slit2 
knockout mouse embryos. 
 
4.4 Materials and Methods 
 
4.4.1 General experimental design 
 
We designed three independent experiments with biological replicates in each 
group (Group 1: E10.5 Robo2 homozygous knockouts versus wild type controls; Group 
2: E10.5 Slit2 homozygous knockouts versus wild type controls; Group 3: E11.5 Robo2 
knockouts versus wild type controls) and analyzed common genes that are differentially 
expressed in all three groups. 
 
4.4.2 Mice strains 
 
Mouse protocols were approved by the Institutional Animal Care and Use 
Committee (IACUC) at Boston University Medical Center (#14388). The generation of 
the Robo2
-
 and Slit2
- 
alleles was described previously (Lu et al., 2007b; Plump et al., 
2002). Adult and embryos were genotyped as previously described. Timed pregnancies 
were set up by checking females for vaginal plugs in the morning to determine if mating 
has occurred during the night. Robo2
+/-
 mice were bred with Robo2
+/-
 mice and Slit2
+/- 
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mice were bred with Slit2
+/- 
mice to generate homozygotes and wild-type littermates 
collected at E10.5 and E11.5.  
 
4.4.3 Tissue collection and RNA isolation 
 
The pregnant females were euthanized at E10.5 and E11.5 and the embryos were 
collected. The areas of the ureteric buds were microdissected (by Anna Pisarek-
Horowitz). The microdissected tissue was preserved in RNAlater (Cat #76106, Qiagen) 
in -40°C and the remaining tissue was used for genotyping. RNA was extracted directly 
from the RNAlater solution using the RNeasy micro kit (Cat # 74004, Qiagen). 
 
 
4.4.4 Microarray experimental design  
 
Based on the genotype of the embryos, the experiment was divided into three 
groups as described in 4.4.1 above. Since SLIT2 is the ligand for the ROBO2 receptor, 
and the two knockouts abrogate the same pathway and produce the same abnormal UB 
phenotype, the E10.5 Slit2
-/-
 and the Robo2
-/-
 were considered as biological replicates for 
a subset of data analysis. 
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4.4.5 Microarray experiment 
 
The microarray experiment was performed with the 16 GeneChip Mouse Gene 
1.0 ST Arrays (Cat #901171, Affymetrix) by the microarray core facility at Boston 
University School of Medicine. 
 
4.4.6 Microarray quality control 
 
The normalization and quality assessment were performed by Adam Gower as 
part of the microarray core service. All microarray analyses were performed using the R 
environment for statistical computing (version 2.15.1). 
 The arrays were normalized together using the Robust Multiarray Average 
(RMA) algorithm (Irizarry et al., 2003) from Affymetrix (version 1.36.1) (Gautier et al., 
2004). A Chip Definition File (CDF) mapped the probes on the array to unique Entrez 
Gene identifiers. The result was a matrix in which each row corresponds to an Entrez 
Gene ID and each column corresponds to a sample. The expression values were displayed 
as log2-transformed by default.  
The technical quality of the arrays was assessed by two quality metrics: Relative 
Log Expression (RLE) and Normalized Unscaled Standard Error (NUSE). For each 
sample, median RLE values > 0.1 or NUSE values > 1.05 were considered as out of the 
usual limits, although RLE was used as the quality metric most strongly associated with 
technical quality.  
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The expression of several sex-specific genes (e.g. Xist, Ddx3y, Eif2s3y, Kdm5d, 
and Uty) was also assessed to estimate the dynamic range of the array, as the female-
specific marker Xist and constitutively expressed Y-linked genes were served in females 
as positive and negative expression controls, respectively.  
 
Principal Component Analysis (PCA) 
 
Principal Component Analysis (PCA) is a mathematical transform that collapses 
the variance between samples across all ~20,000 genes on the array into a much smaller 
set of variables called Principal Components (PCs). These "meta-variables" are arranged 
such that PC1 explains the most variance in the data, followed by PC2, etc. PCA was 
performed using all genes, and a plot was made of PC2 vs. PC1 
 
Differential expression analysis  
 
Differential gene expression was assessed using Student's two-sample t test on the 
coefficients of a simple linear model (expression as a function of genotype) created using 
the 'lmFit' function in the limma Bioconductor package (version 3.14.4).  
Student's two-sample t test with equal variance was used to identify genes that were 
differentially expressed with respect to knockout of Robo2 or Slit2 at each timepoint. 
Additionally, at day E10.5, the Robo2
-/-
 and Slit2
-/-
 embryos were pooled together (as 
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were the corresponding wildtype embryos) and a combined wildtype versus knockout 
comparison was made.  
Benjamini-Hochberg False Discovery Rate (FDR) correction was then used to 
obtain FDR-corrected p values (a.k.a. q values), which represent the probability that a 
given result is a false positive based on the distribution of all p values on the array. 
Corrected/adjusted p values such as the FDR q are the best measure of significance for a 
given test when many hypotheses (e.g., ~20,000 genes) are tested at once. 
 
4.4.7 Gene Set Enrichment Analysis (GSEA) 
 
The GSEA was run by Adam Gower in the microarray core facility at Boston 
University. GSEA (version 2.0.13) (Subramanian et al., 2005) was used to identify 
biological terms, pathways and processes that were coordinately up- or down-regulated 
within each pairwise comparison. The Entrez Gene identifiers of the human homologs of 
the genes interrogated by the array were ranked according to the moderated t statistic 
computed for each knockout versus wild type comparison, producing four ranked lists. 
Mouse genes without a human homolog were removed, and the t statistics for multiple 
mouse genes with the same human homolog were averaged prior to ranking. Each list 
was then used to perform a pre-ranked GSEA analysis using the Entrez Gene versions of 
the Biocarta, KEGG, Reactome, and Gene Ontology (GO) gene sets obtained from the 
Molecular Signatures Database (MSigDB) -  
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 (http://www.broadinstitute.org/gsea/msigdb/index.jsp ), version 4.0 (Subramanian et al., 
2007).  
For each ranked list, the GSEA algorithm tests each gene set in turn to determine 
whether its members are distributed nonrandomly within the ranked list. It then assigns a 
p value to each gene set based on how skewed the distribution of the gene set is towards 
the up- or down-regulated end of the ranked list (weighted by the ranking metric, so that 
the genes at the extreme end of the ranked list have more importance in computing the p 
value). 
GSEA determines whether, on the whole, a given set of genes tends to be more 
up-regulated or down-regulated in a given comparison. If the set of genes is related to 
some biological pathway or process, then a significant GSEA result for that gene set 
suggests that the pathway/process is relevant to the experimental comparison.  
 
4.4.8 Ingenuity pathway analysis overview 
 
Ingenuity pathway analysis (IPA) is a web-based software application that enables 
the analysis and interpretation of data derived from microarrays experiments. The data 
analysis and interpretation with IPA builds on a manually curated content of the 
Ingenuity Knowledge Base. IPA algorithms can identify regulators and pathways that are 
relevant to gene expression changes observed in an analyzed dataset. The upstream 
regulator analysis identifies molecules, including miRNA and transcription factors, which 
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may cause the observed gene expression changes. The IPA software is available from the 
Genome Science Institute (GSI) at Boston University: 
 http://www.bumc.bu.edu/gsi/initiatives/ingenuity-ipa/  
 
 
4.5 Results 
 
4.5.1 No single gene expression is significantly altered in Slit2 and Robo2 knockout 
kidney at E10.5 and E11.5 
 
Samples collected 
 
From timed-pregnant females of Robo2 and Slit2 heterozygous matings, 18 
homozygous Robo2 and Slit2 knockout embryos were identified (Table 4.2). We then 
performed microdissection and isolated the mRNA from tissues of UB and MM regions 
in 8 knockout embryos and 8 littermate controls. Total 16 microarray experiments are 
performed with the mRNA isolated from following embryos:  
At E11.5, we were able to compare 3 Robo2
-/-
 and 3 Robo2
+/+
 all from the same 
litter, so we had 3 perfect biological replicates and 3 perfect controls. 
At E10.5, we used 2 wild-type and 2 Robo2
-/-
 embryos (all from one dam) and 3 
wild-type and 3 Slit2
-/-
 embryos (n=2 per group from one dam, n=1 per group from 
another dam). 
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Table 4.2: Embryonic kidney tissues from F1 crossing used in microarray 
experiments 
Genotype  E10.5  E10.5  E11.5  E11.5  
 collected Used for 
microarray 
analysis 
collected Used for 
microarray 
analysis 
Robo2 -/-  3  2  9  3  
Robo2 +/+  2  2 10  3  
Other  20  0 0 0 
Slit2 -/-  6  3  0  0  
Slit2 +/+  3  3  0  0  
Other  5  0 0  0  
 
 
Normalization and quality assessment 
 
All the arrays had median RLE and NUSE values within the limits. The 
expression of Xist was either very high (~11 log2 units) or low (~4 log2 units), and 
varied inversely with that of the Y-linked genes, which was either high (~8-9 log2 units) 
or low (~3-4 log2 units). These results indicated that the arrays had very good dynamic 
range. 
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Probe-level expression of Robo2 and Slit2 
 
The Robo2 locus was disrupted by two loxP sites-mediated excision of the exon 5 
(Lu et al., 2007b). To confirm that this exon deletion was present in the Robo2
-/-
 samples, 
the probe-level expression of Robo2 exon 5 was examined. Expression of the probe 
interrogating exon 5 (red) is absent in all Robo2
-/- 
samples (Figure 4.1). 
Similarly, the expression of probes interrogating Slit2 exons 1 and 2 is greatly reduced in 
the Slit2
-/-
 samples (Figure 4.2), which is consistent with the Slit2 knockout locus that 
was disrupted by partial replacement of exons 1 and 2 with a GFP-Neo cassette (Plump et 
al., 2002). These results indicated that the quality of the microarray data is good. 
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Figure 4.1: Probe-level expression of Robo2  
The probe-level expression of Robo2 was examined as an internal control for the 
genotyping of the samples used in the microarray. Expression of the probe interrogating 
Robo2 exon 5 (red – deleted in Robo2 knockouts) is absent in all Robo2-/- samples. 
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Figure 4.2: Probe-level expression of Slit2  
 The probe-level expression of Slit2 was examined as an internal control for the 
genotyping of the samples used in the microarray. Expression of the probes interrogating 
Slit2 exons 1 and 2 (red - deleted in Slit2 knockouts) are absent in all Slit2
-/- 
samples. 
 
 
Principal Component Analysis (PCA) 
 
The PCA plot shows that there is strong separation between samples from the 
E10.5 and E11.5 timepoints, but within each timepoint, there is little to no separation 
between knockout and wildtype samples (Figure 4.3). These results suggest that there is a 
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strong differential gene expression with respect to time but not to genotype in this 
microarray experiment. 
 
 
Figure 4.3: Principal Component Analysis 
Plot of PC1 versus PC2 comparing the variance between the samples. 
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Differential expression analysis 
 
Fewer genes were differentially expressed than expected by chance at each 
threshold, although there were slightly more than expected by chance at E11.5 (Table 
4.3). Accordingly, there were no genes with an FDR q < 0.25 for any comparison other 
than the E11.5 Robo2 knockout versus wild type. However, in this comparison, 5 of the 6 
genes with an FDR q < 0.25 were the sex-specific genes (i. e. Xist, Ddx3y, Eif2s3y, 
Kdm5d, and Uty), as all of the E11.5 Robo2
-/- 
embryos were male and all of the E11.5 
wildtype (Robo2
+/+
) embryos were female. The sixth gene, with FDR q = 0.24, is 
Dnajc27, which had a significant but small increase of 1.15-fold at E11.5 in the Robo2 
knockout. These data suggest that no single gene expression is significantly altered in 
Slit2 and Robo2 knockout kidney at E10.5 and E11.5. 
 
Table 4.3: No significant differential expression of any gene in any group was 
detected in E10.5-E11.5 Robo2 and Slit2 embryonic kidney tissues  
  
E10.5 E11.5  
P threshold  expected  Robo2-/- 
vs 
wildtype  
Slit2-/- 
vs 
wildtype  
E10.5 
Combined  
Robo2-/- 
vs 
wildtype  
0.05  1059  895  421  656  974  
0.01  212  186  66  95  229  
0.005  106  104  29  44  120  
0.001  21  21  4  8  30  
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Analysis of the expression of candidate genes controlling UB outgrowth in the 
microarray dataset 
 
Even though none of the genes was significantly differentially expressed after the 
FDR correction for multiple hypothesis, the analysis of gene-sets belonging to similar 
pathways can reveal coordinated down or upregulation based on the fold changes such as 
Gdnf and other genes known to control Gdnf expression during early UB outgrowth. 
Interestingly, the expression fold changes of Gdnf and Sall1, two genes that control UB 
outgrowth, had a p-value of 0.01 (Table 4.4). Gdnf expression was slightly increased 
when all the samples collected at E10.5 were analyzed (Table 4.4) and Sall1 was slightly 
increased in the E10.5 Robo2
-/-
 when compared to wild-type littermates (Table 4.4). 
However, all the genes had a FDR=1, indicating absence of differential expression after 
correction. 
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Table 4.4: The expression of candidate genes controlling UB outgrowth in the 
microarray dataset  
(Gdnf and Sall1, two genes had a p-value of 0.01, are highlighted in yellow) 
  
E10.5 
Robo2
-/-
 vs 
Robo2
+/+
 
E10.5 
combined 
KO vs WT 
Gene Description 
fold 
change 
p 
fold 
change 
p 
Bmp4 bone morphogenetic protein 4 1.06 0.53 -1.02 0.74 
Eya1 eyes absent 1 homolog (Drosophila) 1.31 0.26 1.05 0.48 
Foxc1 forkhead box C1 -1.04 0.14 -1.21 0.20 
Foxc2 forkhead box C2 -1.00 0.97 -1.13 0.31 
Gata3 GATA binding protein 3 -1.21 0.43 -1.06 0.61 
Gdnf glial cell line derived neurotrophic factor 1.18 0.31 1.22 0.01 
Hoxa11 homeobox A11 1.06 0.19 1.03 0.77 
Pax2 paired box gene 2 -1.09 0.78 -1.02 0.95 
Ret ret proto-oncogene -1.20 0.28 -1.06 0.58 
Sall1 sal-like 1 (Drosophila) 1.19 0.01 1.12 0.11 
Six1 sine oculis-related homeobox 1 1.82 0.36 1.71 0.12 
Spry1 sprouty homolog 1 (Drosophila) 1.19 0.40 1.07 0.21 
WT- wildtype, combined KO: Slit2
-/-
 and Robo2
-/-
 knockout 
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4.5.2 Genes coding for extracellular matrix proteins are coordinately downregulated in 
the Robo2 and the Slit2 knockouts compared to wild-type littermates 
 
GSEA analysis of Gene Sets enriched in the E10.5 and E11.5 UB and MM tissues from 
Robo2 and the Slit2 knockouts  
 
GESA analysis of all gene expression data and comparisons at both E10.5 and 
E11.5 revealed that genes related to the extracellular matrix (ECM), collagen formation, 
ECM-receptor interaction, focal adhesions, actin cytoskeleton, axon guidance, and 
NCAM1 interactions were significantly coordinately downregulated in the E10.5 and 
E11.5 Robo2 and Slit2 knockout kidneys (Table 4.5). No gene-sets were coordinately 
upregulated at both E10.5 and E11.5 time points. At E10.5, many of the gene-sets most 
significantly upregulated were related to translation (e.g. ribosome) and metabolism (e.g. 
mitochondria) (Table 4.6). These results suggest that loss of Robo2 or Slit2 during UB 
outgrowth may affect the gene expression of ECM compositions in the MM and around 
the UB. 
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Table 4.5: Sets of genes significantly coordinately down-regulated in Slit2 and Robo2 
knockouts compared to the wild-type controls 
Gene sets related to the extracellular matrix are highlighted in yellow. 
Group Gene Set Name  
E10.5 
Robo2
-/-
 vs WT 
E10.5 
Slit2
-/-
 vs WT 
E10.5 combined 
KO vs WT 
E11.5 
Robo2
-/-
 vs WT 
               
  
Size 
NES p FDR 
q 
NES p FDR 
q 
NES p FDR 
q 
NES p FDR 
q 
KEGG  ECM receptor 
interaction 
82 -2.05 0.00 0.12 -2.51 0.00 0.00 -2.77 0.00 0.00 -2.39 0.00 0.00 
GO  extracellular 
matrix part 
55 -2.11 0.00 0.07 -1.71 0.01 0.06 -2.38 0.00 0.00 -2.35 0.00 0.00 
GO  collagen 23 -2.05 0.00 0.09 -1.84 0.00 0.03 -2.44 0.00 0.00 -2.28 0.00 0.00 
GO  proteinaceous 
extracellular 
matrix 
93 -1.93 0.00 0.17 -1.74 0.00 0.05 -2.49 0.00 0.00 -2.24 0.00 0.00 
GO  extracellular 
matrix 
94 -1.87 0.00 0.19 -1.72 0.00 0.05 -2.48 0.00 0.00 -2.21 0.00 0.00 
Reactome  collagen 
formation 
57 -1.83 0.00 0.24 -2.04 0.00 0.01 -2.58 0.00 0.00 -2.17 0.00 0.00 
KEGG  other glycan 
degradation 
16 -1.72 0.02 0.24 -1.80 0.00 0.03 -1.96 0.00 0.01 -2.15 0.00 0.00 
KEGG  focal adhesion 193 -1.74 0.00 0.24 -2.20 0.00 0.00 -2.44 0.00 0.00 -2.11 0.00 0.00 
Reactome  extracellular 
matrix 
organization 
83 -1.81 0.00 0.22 -1.63 0.00 0.08 -2.25 0.00 0.00 -1.99 0.00 0.01 
Reactome  axon guidance 237 -1.87 0.00 0.19 -2.16 0.00 0.00 -2.69 0.00 0.00 -1.90 0.00 0.02 
GO  actin binding 72 -1.72 0.01 0.25 -2.03 0.00 0.01 -2.30 0.00 0.00 -1.77 0.00 0.06 
Reactome  a tetrasaccharide 
linker sequence 
is required for 
gag synthesis 
25 -1.77 0.01 0.22 -1.90 0.00 0.02 -2.26 0.00 0.00 -1.75 0.00 0.07 
GO  actin 
cytoskeleton 
121 -1.88 0.00 0.20 -1.59 0.00 0.10 -2.28 0.00 0.00 -1.73 0.00 0.08 
Reactome  NCAM1 
interactions 
39 -2.20 0.00 0.02 -1.87 0.00 0.02 -2.45 0.00 0.00 -1.67 0.00 0.11 
GO  myosin complex 15 -1.81 0.01 0.21 -1.50 0.06 0.14 -1.67 0.01 0.04 -1.57 0.04 0.17 
KEGG  axon guidance 128 -1.96 0.00 0.14 -1.62 0.00 0.09 -2.23 0.00 0.00 -1.54 0.00 0.18 
GO  regulation of 
anatomical 
structure  
morphogenesis 
25 -1.81 0.02 0.20 -1.55 0.04 0.12 -1.89 0.00 0.01 -1.51 0.04 0.20 
Reactome  signaling by 
ROBO receptor 
27 -1.76 0.01 0.23 -1.53 0.03 0.13 -1.90 0.00 0.01 -1.51 0.03 0.20 
KEGG: Kyoto Encyclopedia of Genes and Genomes, GO: Gene Ontology, NES: 
Normalized Enrichment Score, p:  nominal p-value, FDR q: FDR-corrected p value; FDR 
q < 0.25 is significant, WT- wildtype, combined KO: Slit2
-/-
 and Robo2
-/-
 knockout 
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Table 4.6: Sets of genes significantly coordinately up-regulated in E10.5 knockout 
compared to the wild-type 
Group Gene Set Name Size NES p 
FD
R q 
GO  structural constituent of ribosome 45 2.28 0.00 0.00 
KEGG  Ribosome 40 2.20 0.00 0.00 
Reactome  peptide chain elongation 38 2.07 0.00 0.01 
Reactome  
conversion from APCc CDC20 to APCc CDH1 in late 
anaphase 16 2.00 0.00 0.02 
GO  mitochondrial ribosome 20 1.99 0.00 0.02 
Reactome  synthesis of glycosylphosphatidylinositol GPI 17 1.97 0.00 0.02 
Reactome  mitochondrial protein import 44 1.95 0.00 0.02 
GO  organellar ribosome 20 2.00 0.00 0.02 
Reactome  influenza viral rna transcription and replication 54 1.95 0.00 0.02 
GO  ribosomal subunit 18 2.01 0.00 0.02 
Reactome  
formation of the ternary complex and subsequently the 
43s complex 29 1.89 0.00 0.04 
GO  Ribosome 29 1.88 0.00 0.04 
Reactome  3 UTR mediated translational regulation 57 1.87 0.00 0.04 
Reactome  APC C CDC20 mediated degradation of cyclin B  16 1.85 0.00 0.05 
Reactome  
SRP dependent cotranslational protein targeting to 
membrane 59 1.85 0.00 0.05 
GO  Translation 146 1.85 0.00 0.05 
Reactome  nucleotide like purinergic receptors 15 1.82 0.01 0.06 
GO  cellular protein catabolic process 55 1.76 0.00 0.12 
Reactome  phosphorylation of the APC C  16 1.74 0.01 0.13 
Reactome  APC CDC20 mediated degradation of NEK2A  19 1.73 0.01 0.14 
GO  mitochondrial inner membrane 58 1.72 0.00 0.15 
GO  mitochondrial envelope 86 1.69 0.00 0.15 
BioCarta  TH1TH2 pathway 19 1.70 0.01 0.15 
Reactome  Translation 93 1.70 0.00 0.16 
Reactome  
inhibition of the proteolytic activity of APC c required 
for the onset of anaphase by mitotic spindle checkpoint 
components 18 1.70 0.01 0.16 
GO  mitochondrial part 128 1.70 0.00 0.16 
Reactome  respiratory electron transport 57 1.68 0.00 0.17 
Reactome  
respiratory electron transport atp synthesis by 
chemiosmotic coupling and heat production by 
uncoupling proteins 69 1.67 0.00 0.17 
KEGG  oxidative phosphorylation 101 1.66 0.00 0.17 
BioCarta  cytokine pathway 18 1.67 0.01 0.18 
KEGG  glycosylphosphatidylinositol GPI anchor biosynthesis 25 1.66 0.02 0.18 
GO  DNA dependent DNA replication 51 1.65 0.01 0.18 
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GO  protein catabolic process 65 1.64 0.01 0.18 
GO  regulation of DNA metabolic process 44 1.64 0.00 0.18 
GO  mitochondrial membrane 77 1.62 0.00 0.20 
GO  mitochondrial membrane part 44 1.62 0.01 0.20 
GO  anion transport 29 1.63 0.01 0.20 
GO  inorganic anion transmembrane transporter activity 19 1.62 0.02 0.20 
GO  integral to organelle membrane 49 1.60 0.00 0.23 
GO  cytokine metabolic process 40 1.58 0.02 0.24 
KEGG  parkinsons disease 97 1.58 0.00 0.24 
GO  organelle inner membrane 66 1.59 0.01 0.24 
GO  hydrogen ion transmembrane transporter activity 25 1.58 0.02 0.24 
KEGG: Kyoto Encyclopedia of Genes and Genomes, GO: Gene Ontology, NES: 
Normalized Enrichment Score, p:  nominal p-value, FDR q: FDR-corrected p value; FDR 
q < 0.25 is significant, WT- wildtype, combined KO: Slit2
-/-
 and Robo2
-/-
 knockout 
  
 
Laminin and collagen coding genes are coordinately downregulated in E10.5 and 
E11.5 Slit2 and Robo2 knockouts versus wild type controls 
 
 
I was specifically interested in the genes driving the association between the gene-
sets and the differential expression in Slit2
-/-
 or Robo2
-/- 
knockout samples versus 
wildtype controls. Besides the “axon guidance” and the “actin cytoskeleton” gene-sets, 
all gene-sets differential expressed are related to the extracellular matrix (ECM). Analysis 
of the leading edges of these gene-sets revealed that genes encoded laminins and 
collagens are the genes driving the significant association between these gene-sets and 
differential expression in the dataset. Therefore I looked at the differential gene 
expression of genes encoded Laminins and collagens in the dataset (mean log2>8) in all 
the comparisons (Tables 4.7 and 4.8). Although the corrected significance has not been 
reached for any of these genes (FDR=1), many of the individual p-values based on the 
student t-test were lower than 0.05. To better visualize these results, heatmaps were 
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drawn using the mouse homologs of genes in the leading edges of the “GO cellular 
component- extracellular matrix” and the “reactome collagen formation” gene-sets at 
E10.5 (Figure 4.4). The intensities of the heatmaps revealed that most laminin and 
collagen coding genes were coordinately downregulated in E10.5 Robo2
-/-
 and the Slit2
-/-
 
knockouts when compared to the wild-type controls (Figure 4.4).  
 
Table 4.7: Most differential expressed Laminin coding genes at E10.5-E11.5 in the 
UBand MM (Mean log2 >8).  
Individual p-values based on the student t-test were lower than 0.05 are highlighted in 
yellow. 
 
E10.5 
Robo2
-/-
  
vs 
 Robo2
+/+ 
 
E10.5 
Slit2
-/-
  
vs  
Slit2
+/+ 
 
E10.5 
Combined KO  
vs  
WT 
 
E11.5 
Robo2
-/-
  
vs  
Robo2
+/+ 
 
Gene 
fold 
change 
P-value 
fold 
change 
P-value 
fold 
change 
P-value 
fold 
change 
P-value 
Lama1 -1.55 0.11 -1.28 0.05 -1.38 0.00 -1.12 0.05 
Lama4 -1.40 0.56 -1.03 0.83 -1.15 0.48 1.03 0.80 
Lama5 -1.44 0.16 -1.05 0.57 -1.20 0.09 -1.14 0.01 
Lamb1 -1.40 0.12 -1.17 0.07 -1.25 0.01 -1.11 0.00 
Lamb2 -1.21 0.02 -1.05 0.46 -1.11 0.18 -1.05 0.35 
Lamc1 -1.47 0.17 -1.31 0.10 -1.37 0.01 -1.12 0.00 
WT- wildtype, combined KO: Slit2
-/-
 and Robo2
-/-
 knockout 
 
  
  
155 
Table 4.8: Table 4.6: Most differential expressed Collagen coding genes at E10.5-
E11.5 in the UB and MM (Mean log2 >8).  
Individual p-values based on the student t-test were lower than 0.05 are highlighted in 
yellow. 
 
E10.5  
Robo2
-/-
 vs 
Robo2
+/+
  
E10.5  
Slit2
-/-
 vs  
Slit2
+/+
  
E10.5  
combined KO vs 
WT  
E11.5  
Robo2
-/-
 vs 
Robo2
+/+
  
Gene  
fold 
change  P-value  
fold 
change  P-value  
fold 
change  P-value  
fold 
change  P-value  
Col12a1  -1.87  0.01  -1.11  0.42  -1.36  0.03  -1.38  0.26  
Col18a1  -1.28  0.22  -1.20  0.12  -1.23  0.02  -1.11  0.00  
Col1a1  -1.57  0.03  -1.34  0.18  -1.42  0.01  -1.15  0.03  
Col1a2  -1.42  0.15  -1.16  0.23  -1.24  0.08  -1.04  0.63  
Col23a1  -1.16  0.32  -1.11  0.31  -1.13  0.17  1.01  0.84  
Col2a1  -1.06  0.86  -1.09  0.49  -1.08  0.56  1.03  0.68  
Col3a1  -1.32  0.07  -1.12  0.40  -1.19  0.07  -1.14  0.07  
Col4a1  -1.37  0.18  -1.20  0.09  -1.26  0.01  -1.12  0.04  
Col4a2  -1.36  0.18  -1.28  0.12  -1.31  0.01  -1.10  0.01  
Col4a3bp  -1.05  0.85  1.05  0.72  1.02  0.86  1.08  0.17  
Col5a1  -1.24  0.03  -1.10  0.33  -1.15  0.04  -1.12  0.03  
Col9a1  -1.15  0.03  -1.20  0.07  -1.18  0.05  -1.06  0.59  
WT- wildtype, combined KO: Slit2
-/-
 and Robo2
-/-
 knockout 
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Figure 4.4: Heatmaps from leading edges for gene-sets downregulated in E10.5 
Robo2 and Slit2 knockout kidneys 
(A) The leading edge genes from “extracellular matrix” visualized in a heat map. The 
heatmap is color-coded when compared to average, Blue is below average 
(downregulate), white is at average (no change) and red is above average 
(upregulated). The darker the color is the bigger the difference is from average. 
Each row represents a gene (labeled on the right). Each column represents a 
sample. Gray columns: wild-type, Orange columns: Robo2
-/-
, Purple columns: 
Slit2
-/-
.  
(B) The leading edge genes from “reactome collagen formation” visualized in a heat 
map. The heatmap is color-coded when compared to average, Blue is below 
average (downregulate), white is at average (no change) and red is above average 
(upregulated). The darker the color is the bigger the difference is from average. 
Each row represents a gene (labeled on the right). Each column represents a 
sample. Gray columns: wild-type, Orange columns: Robo2
-/-
, Purple columns: 
Slit2
-/-
.  
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4.5.3 Pathways related to the extracellular matrix proteins are downregulated in the 
Robo2 and the Slit2 knockout compared to wild-type littermates 
 
Ingenuity pathway analysis - associated pathways  
 
The ingenuity pathway analysis (IPA) enables to identify pathways relevant to the 
gene expression changes observed in the microarray dataset (IPA®, QIAGEN Redwood 
City, www.qiagen.com/ingenuity). Canonical pathway analysis using the IPA related the 
gene expression changes in the combined E10.5 experiments to the following pathways: 
Inhibition of matrix metalloproteases; Role of JAK1, JAK2 and TYK2 in interferon 
signaling; iNOS signaling; ILK signaling; Glycolysis and Ubiquitol-10 biosynthesis, and 
Hepatic fibrosis / hepatic stellate cell activation (Figure 4.5). These IPA data is consistent 
with the results obtained by GESA analysis described above. 
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Figure 4.5: Pathway analysis with IPA on E10.5 combined dataset 
Pathways identified by the IPA as relevant to the gene expression changes observed in 
the microarray dataset in the combined E10.5 experiments. As presented here, the 
different pathways have connection between one another. The darker the red color, the 
stronger the downregulation of this biological process is.  
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Ingenuity pathway analysis - upstream regulators 
 
IPA can also identify upstream regulators that may cause the observed gene 
expression changes. By analyzing datasets from E10.5 and E11.5 kidneys, we identified 
following potential upstream regulators of SLIT2-ROBO2 pathway during early UB 
outgrowth: COL4A3, TP53, PRL, ramipril, TGFB1, LMNB1, IGF1R (Table 4.9). Both, 
COL4A3 and LMNB1 are ECM molecules that can affect outside-in signaling (Legate et 
al., 2009).  
In order to understand why the IPA analysis identified IGF1R and TGFβ1 as two 
upstream regulators of the gene expression changes in the dataset, I looked at the 
downstream targets of IGF1R and TGFβ1. The schemes of the Further IPA analysis 
revealed that the association of IGF1R is also related to a downregulation of collagens 
Three of the IGF1R target genes that were downregulated are Col1a1, Co14a1 and 
Col4a2 (Figure 4.6). Interestingly, Tgfb1 expression can also be regulated by IGFR1 and 
was found to be reduced in the knockout mice compared to wild type littermates at E10.5 
(Figure 4.6). Similarly, the association of TGFb1 with the gene expression changes is 
also related to the ECM: 8 of the targets of TGFB1 are collagen and laminin (Col13a1, 
Lamb1, Col4a2, Col4a1, Col1a1, Col5a1, Col18a1, Lamc1) and their gene expression 
was downregulated in this dataset (Figure 4.7). 
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Table 4.9: Upstream regulators analysis by IPA 
 
E10.5  
Combined KO versus WT 
E11.5 
 
 
Z score p-value  Z score p-value  
COL4A3 NA  2.13E-07 NA 2.63E-05 
TP53 -1.098  3.89E-07 -1.662 2.87E-06 
PRL -1.947  1.83E-06 -1.999  1.13E-03 
TGFB1 -2.582  6.63E-06 -2.572  2.13E-02 
LMNB1 NA  5.47E-03 NA  1.88E-05 
IGF1R  -2.076  1.97 E-04  -1.535  3.41 E-05  
WT- wildtype, combined KO: Slit2
-/-
 and Robo2
-/-
 knockout 
 
Figure 4.6: Targets of IGF1R and their differential expressions in E10.5 ureteric 
buds (Slit2
-/-
 and Robo2
-/-
 combined). 
Illustration showing the genes that lead the IPA analysis to identify IGF1R inhibition as a 
possible upstream regulator controlling some of the differential gene expression pattern 
observed in the microarray dataset when all the E10.5 samples were combined. Six of the 
IGF1R target genes were downregulated (Col1a1, Clo4a1, Col4a2, Fasn, Tgfb1, Acads) 
and three of the genes inhibited by IGF1R were upregulated in this dataset (Cd68, Ifngr2, 
Mcpt8). As illustrated here, three targets were inconsistent with the option that IGF1R is 
inhibited (Col18a1, Cycs, Atp5j).  
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Figure 4.7: Targets of TGFB1 and their differential expressions in E10.5 ureteric 
buds (Slit2
-/-
 and Robo2
-/-
 combined). 
Illustration showing the genes that lead the IPA analysis to identify TGFB1 inhibition as 
a possible upstream regulator explaining some of the differential gene expression pattern 
observed in the microarray dataset when all the E10.5 samples were combined. Twelve of 
the targets of TGFB1 were downregulated in this dataset (Col13a1, Adam12, Lamb1, 
Col4a2, Col4a1, Col1a1, Slit2, Mmp14, Col5a1, Col18a1, Lamc1, Slit3). As illustrated 
here, many of these targets are not direct targets of TGFB1, but through mediator 
including CTGF, ERBB2, PRL, β-estradiol, estrogen receptors, β-catenin (CTNNB1), 
MYC, TP53 and JUN.  
 
 
4.6 Discussion 
4.6.1 Interpretations 
 
The Slit2/Robo2 signaling may prevent multiple ureteric buds by changing the ECM 
composition around the Wolffian duct 
 
A coordinate downregulation of ECM associated genes (e.g. collagen and laminin 
coding genes) in E10.5 and E11.5 Robo2
-/-
 and the Slit2
-/-
 UB and MM tissues was 
revealed by both the GSEA and the IPA analyses. These results suggest that the multiple 
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UB phenotype in Slit2 and Robo2 knockout mice might be caused by decreased 
expression of genes encoding extra-cellular matrix proteins. Under physiological 
condition (e.g. in the wild type mice), SLIT2-ROBO2 signaling may maintain a high 
level of ECM protein coding gene expression to strengthen the MM tissue structure and 
prevent ectopic UB formation (Illustration 4.3, top panel). When SLIT2-ROBO2 
signaling is absent (e.g. in patients with SLIT2/ROBO2 mutations or in Slit2/Robo2 
knockout mice), the ECM protein coding gene expression are downregulated, possibly 
resulting in an abnormal ECM enabling ectopic UB outgrowth (Illustration 4.3, bottom 
panel).  
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Illustration 4.3: Generation of a hypothesis 
Top panel: illustration of the wild type (wt): absence of SLIT2-ROBO2 signaling in the 
area of normal ureteric budding and ECM regulation by the SLIT2-ROBO2 signaling 
around the Wolffian duct to prevent ectopic UB formation. MM- metanephric 
mesenchyme (green); WD- wolffian duct (pink).  
Bottom panel: illustration of the Robo2 or Slit2 knockout, in the absence of SLIT2-
ROBO2 signaling (e.g. due to a genetic deletion of either Slit2 or Robo2): the expression 
of ECM proteins is downregulated, leading to ectopic UB formation. 
 
Interestingly, Slit3, a close family member of Slit2, has been shown to genetically 
interact with Fras1-related extracellular matrix gene 1 (Frem1), which encodes an 
extracellular protein (Beck et al., 2013). A statistically significant increase in the 
prevalence of renal agenesis phenotype has been found in Frem1
-/-
;Slit3
+/−
 double 
knockout mice (13.6%) as compared to Frem1
-/-
 single knockout mice (2.7%, p<0.02). 
This increase in prevalence was more than an additive effect of homozygosity for 
the Frem1
-/-
 (2.7%) and heterozygosity for Slit3
+/−
 (0%) alone (Beck et al., 2013). This 
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aggravating genetic interaction may reflect a common role for the ECM proteins FREM1 
and SLIT3 in UB outgrowth. Since SLIT3 and SLIT2 share a common ALPS domain 
structure and high overall sequence homology with one another (Brose et al., 1999), it is 
possible that SLIT2, like SLIT3, shares functions with other ECM proteins like FREM1 
during UB outgrowth.  
Although the role of the ECM surrounding the Wolffian duct at the time of UB 
outgrowth has not been investigated thoroughly, the ECM has been shown to play an 
important role during branching morphogenesis (Santos and Nigam, 1993). Regulation of 
the ECM composition is partially controlled by matrix metalloproteases (MMP) that 
degrade extracellular proteins (Pohl et al., 2000; Riggins et al., 2010). During kidney 
development, MMPs regulate ureteric bud morphogenesis in vitro (Pohl et al., 2000). 
Some ECM proteins, such as Type IV collagen, heparan sulfate proteoglycans, and 
vitronectin, can also inhibit kidney branching morphogenesis in vitro (Santos and Nigam, 
1993). In vivo, increased levels of ECM proteins such as collagen IV, laminins, perlecan, 
and nidogen (e.g. due to a decrease in the matrix metalloproteinase MMP14) are 
associated with a decrease in UB branching morphogenesis (Riggins et al., 2010). ECM 
proteins can also signal to the surrounding cells through their interactions with integrins 
(Zent et al., 2001) or act as co-receptors (Linton et al., 2007). This knowledge about 
branching morphogenesis suggests that changes in the ECM composition may play an 
important role in inhibiting ectopic UB outgrowth. 
 
  
166 
The Slit2/Robo2 signaling may interact with the TGF-β1 signaling pathway in the 
ureteric bud 
 
The results from IPA analysis suggest TGF-β1 as a possible upstream regulator 
inhibiting gene expression changes observed in the UB and MM of Robo2
-/-
 and the  
Slit2
-/-
 knockout mice. TGF-β has been shown in vitro to reduce branching 
morphogenesis and ureteric bud outgrowth in vitro (Bush et al., 2004), suggesting that 
TGF-β1inhibition would lead to more ureteric budding. ROBO2 mutations have been 
identified in CAKUT patients with VUR (Lu et al., 2007b). Interestingly, SNPs in TGF-
β1 have also been associated with familial VUR (Kuroda et al., 2007), suggesting that 
TGF-β1 may play a role in UB and UVJ formation. TGF-β1 induces Robo1 expression in 
mammary epithelial cells and SLIT2-ROBO1 activation inhibits mammary branching 
morphogenesis (Macias et al., 2011). ROBO2 and TGF- β also function as modifiers for 
Drosophila Dystroglycan-Dystrophin Complex (Kucherenko et al., 2008), suggesting that 
they might interact in additional cellular environment. Therefore, it is possible that TGF-
β1 may also induce Robo2 expression in the MM during UB outgrowth. 
 
The Slit2/Robo2 signaling may interact with the Insulin-like receptor during UB 
outgrowth 
 
Another upstream regulator identified by IPA analysis is IGF1R, the insulin-like 
growth factor 1 receptor. IGF1R inhibition and downregulation in vitro reduce the size of 
kidney explants (Wada et al., 1993), and also decrease the biosynthesis of matrix proteins 
such as type IV collagen, laminin, and proteoglycans (Wada et al., 1993). Like ROBO2, 
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IGF1R is expressed in the metanephric mesenchyme (Duong Van Huyen et al., 2003). 
Interestingly, IGF1R ligand IRS-1 has also been shown to interact with NCK (Lee et al., 
1993), suggesting that ROBO2 may form a complex with IGF1R through NCK and IRS-
1. So ROBO2 and IGF1R may coordinately induce expression of ECM genes in the MM 
during UB outgrowth. 
 
The SLIT2-ROBO2 signaling may be regulated by metalloproteases during UB 
outgrowth 
 
Although active SLIT2-ROBO2 signaling may enhance ECM structure in MM to 
prevent ectopic UB formation, a single normal UB needs to be formed at the correct 
location in the caudal region of the Wolffian duct during UB outgrowth. This condition 
requires the SLIT2-ROBO2 signaling not being active in the area of the normal UB 
budding, but only around the normal budding area to prevent abnormal ectopic UB 
formation. Regulations of several molecules at transcriptional and translational levels 
might be needed to accomplish this activity.  
 
First, at the transcriptional level, different isoforms of ROBO2 might be 
differentially expressed in the area of the normal ureteric bud, which may have different 
interaction capacity with downstream molecules. For example, we have recently found 
that alternative splicing of Robo2 can generate isoforms with or without NCK binding 
site in the ROBO2 protein and that both isoforms are highly expressed during early 
kidney development (Anna Pisarek Horowitz and Xueping Fan, unpublished data). 
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Second, at the protein level, ROBO2 might be inactivated in the area of normal 
budding by metallopeptidases (MMPs). In our microarray dataset, ADAM10, MMP2 and 
MMP14 are found to be the top MMPs expressed at E10.5 and E11.5 (Table 4.10). 
Adam10 was found to be expressed in kidneys explants in vitro (Stuart et al., 2003) and 
MMP2 and MMP14 have been shown to be expressed in the metanephric mesenchyme at 
E12.5 (Legallicier et al., 2001).  
 
 
Table 4.10: Top genes encoded metallopeptidase that are expressed in E10.5 and 
E11.5 UB and MM tissues from Slit2 and Robo2 knockout mice. 
  
Mean log2 
  
E10.5 
Robo2+/+  
E10.5 
Robo2-/-  
E10.5 
Slit2+/+  
E10.5 
Slit2-/-  
E11.5 
Robo2+/+  
E11.5 
Robo2-/-  
Mmp2  matrix metallopeptidase 2  10.89  10.60  10.88  10.62  11.14  11.05  
Mmp14  
matrix metallopeptidase 14  
MT1-MMP  
10.04  9.84  10.14  9.87  10.23  10.10  
Adam10  
disintegrin and 
metallopeptidase domain 10  
9.66  9.70  9.80  9.61  9.88  9.81  
 
 
One of our proposed models of post-translational regulation of Robo2 is through 
the matrix metalloprotease kuzbanian (ADAM10 in mice). In Drosophila, kuzbanian 
/ADAM10 cleaves Robo extracellular domain and activates the SLIT-ROBO signaling 
(Coleman et al., 2010). ADAM10 may be expressed around the WD but not in the area of 
the normal UB outgrowth (Illustration 4.3).  
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Alternatively, metalloproteases may inhibit SLIT2-ROBO2 signaling in the area of 
normal UB outgrowth. A previous study shows that deletion of the matrix 
metalloproteinase MT1-MMP (MMP14) lead to increased expression levels of the ECM 
proteins, including collagen IV, laminins, perlecan, and nidogen (Riggins et al., 2010). 
Our microarray data showed that MMP14 is also expressed in the UB and MM in E10.5 
and E11.5 mice. Therefore, it is possible that MMP14 may inhibit the SLIT2-ROBO2 
signaling in the area of normal UB outgrowth, which can reduce the expression of ECM 
proteins such as collagen and laminins to allow a single UB outgrowth. 
 
4.6.2 Limitations 
 
The fact that no single gene was significantly differentially expressed in our 
microarray dataset might be explained by an insufficient enrichment of cells normally 
affected by the SLIT2-ROBO2 signaling in the tissue collected. If most of the cells in the 
dissected tissues are not affected by SLIT2-ROBO2 signaling, no significant gene 
expression change could be detected because of the dilution of the changes. Although 
there is a need to first validate the gene expression changes using real-time RT-PCR, the 
changes detected might be very limited and only reflect the subtle difference similar to 
the microarray data because of the heterogeneity of the tissues collected. Another method 
to validate the findings could be a staining (either IHC/IF or ISH) showing the 
composition of the extracellular matrix. However, the microarray data suggest a 
coordinate decrease of the collagens and laminins expression and not a reduction of one 
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specific ECM protein. In addition, staining with either IHC or ISH might not be sensitive 
enough to detect such subtle decrease of expression.  
         The hypothesis/model developed here presumes that the SLIT2-ROBO2 signaling is 
not active in the region of normal UB budding. In order to test this hypothesis, further 
experiments are needed. Since we found that alternative splicing of Robo2 can affect the 
NCK binding site of ROBO2 (Anna Pisarek Horowitz / Xueping Fan, unpublished data), 
in situ hybridization or immunostaining detecting two ROBO2 isoforms may provide 
new information about the regulation of SLIT2-ROBO2 signaling during UB outgrowth.  
           Alternatively, protein level modifications by MMPs may also regulate ROBO2 or 
SLIT2 activities, which might be differentially cleaved in different areas of the 
metanephric mesenchyme. Immunostaining may also enable to detect cleaved and 
uncleaved isoforms of ROBO2 or SLIT2. For example, an expression comparison 
between the Robo2 N-terminal fragment (ROBO2-N) and C-terminal fragment (ROBO2-
C) at E10.5-E11.5 may reveal differential expression patterns in the MM around the UB 
during UB outgrowth. 
 
4.7 Conclusions 
 
GSEA and IPA analyses in this project enabled us to develop a new 
hypothesis/model on the role of the SLIT2-ROBO2 signaling during early UB outgrowth. 
Deletion of Slit2 and Robo2 in mice leads to a coordinated downregulation of the 
expression of ECM protein coding genes. Since ROBO2 is expressed in the metanephric 
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mesenchyme, this microarray data suggest that the Slit2/Robo2 signaling regulates the 
ECM composition around the nephric duct during UB outgrowth. Since the Slit/Robo 
signaling should not be active in the normal UB budding area, the ECM composition 
might be different in the normal UB outgrowth area when compared to the anterior or 
posterior regions of the MM surrounding the nephric duct. Previous reports have shown 
the importance of ECM in UB outgrowth and kidney branching morphogenesis, and 
GDNF, the main factor regulating UB outgrowth is also secreted into the ECM and may 
be affected by its composition. Altogether, this project enables the development of a new 
hypothesis regarding the molecular mechanism through which the SLIT2-ROBO2 
signaling may regulate UB outgrowth. Further investigations are warranted to test this 
hypothesis. 
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5. SUMMARY AND CONCLUSIONS 
 
 
Congenital kidney birth defects are a relatively common health problem, which 
account for 20-30% of all anomalies identified in the prenatal period with limited 
diagnostic and treatment options. Prenatal genetic diagnosis can help in prognosis of the 
defects observed and genetic counseling for the patient’s family. However, most of the 
patients do not benefit from a genetic diagnosis because the molecular bases of most 
kidney birth defects remain unclear. To understand the molecular basis of these disorders, 
it is necessary to study human disease genes in animal models during kidney 
development. In my thesis research, I studied three disease genes (i.e. Zeb2, Ilk, Robo2) 
in mice models at three stages of kidney development: nephrogenesis, glomerular 
podocyte, and early ureteric bud outgrowth. 
     
In the first project of this thesis, we studied a mouse model of a gene causing a 
human syndrome associated with increased risk for kidney anomalies and identified Zeb2 
as a novel gene important in early nephrogenesis. Zeb2 conditional knockout mice (Zeb2 
cKO) develop primary glomerulocystic kidney disease starting at E16.5 days and renal 
failure by 8 weeks of age. In the Zeb2 cKO mice, we observed the presence of atubular 
glomeruli which explain the formation of primary glomerular cysts in the absence of 
tubular dilatation. Decreased expression of renal proximal tubular markers was observed 
at E14.5 preceded cyst formation, suggesting that abnormal tubular development is the 
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cause for congenital atubular glomeruli formation. This is the first description of a 
primary glomerulocystic kidney disease caused by congenital atubular glomeruli. 
At the molecular level, none of the genes associated with glomerular cysts were 
differentially expressed in the Zeb2 cKO mice at E14.5. It suggests that loss of the 
transcription factor ZEB2 may affect the expression of genes that have not been 
identified to be associated with glomerular cysts so far.  
After cyst formation, Pkd1 expression was upregulated in non-cystic glomeruli. 
Such upregulation has been reported on other cystic kidneys, and might be a non-specific 
event. In order to examine the effect of this upregulation, we genetically reduced the 
levels of Pkd1. Surprisingly; we found an exacerbated renal cystic phenotype in the 
Zeb2-Pkd1 double KO mice.  
Together, our results suggest that ZEB2 and PKD1 may genetically interact 
during nephron development in mice and ZEB2 might be a novel PKD1 modifier gene. 
This study also implies that ZEB2 is a novel candidate gene for glomerular cystic disease 
in patients. 
 
The second and third projects of this thesis explore the function of another two 
kidney disease genes, ILK and ROBO2, in the podocytes and during early ureteric bud 
outgrowth. Our results from the second project showed that integrin-linked kinase (ILK) 
and ROBO2 form a complex in the podocytes, and that loss of Robo2 alleviates the 
survival and the ultrastructural defects of the podocyte and GBM in the Ilk podocyte 
specific knockout mice. Our findings suggest that, in addition to podocyte cytoskeleton, 
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ROBO2 may affect podocyte adhesion to the GBM and the expression of the GBM 
components. 
In the third project, we also explored the molecular function of ROBO2 on gene 
expression in early ureteric bud formation. We found that ROBO2 may affect the 
expression of genes encoding extracellular matrix proteins by the metanephric 
mesenchyme. These two projects led us to form a new hypothesis that ROBO2 may 
regulate the expression of extracellular matrix proteins in the glomerular basement 
membrane and around the Wolffian duct during kidney development. 
 
In conclusion, this thesis exemplifies the strength of combining human and mouse 
genetics to advance our understanding of functions of human kidney disease genes, and 
to discover new genes important in kidney development. In the past five years, I found 
Zeb2 as a new gene important in kidney development and renal cystic disease, and 
identified a novel role of Robo2 in regulating extracellular matrix in the podocytes and 
during early ureteric bud outgrowth. My thesis research also raises a range of scientific 
questions regarding the mechanistic roles of Zeb2, Ilk, and Robo2 in kidney development, 
which opens many new research opportunities for future scientific inquiry.  
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